
<html lang="en"     class="pb-page"  data-request-id="dc531bd7-97a1-4d8a-b57c-800d1caaf672"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2008.51.issue-6;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm7010996;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure-Guided Design of Aminopyrimidine Amides as Potent, Selective Inhibitors of Lymphocyte Specific Kinase: Synthesis, Structure–Activity Relationships, and Inhibition of in Vivo T Cell Activation" /></meta><meta name="dc.Creator" content="Erin F.  DiMauro" /></meta><meta name="dc.Creator" content="John  Newcomb" /></meta><meta name="dc.Creator" content="Joseph J.  Nunes" /></meta><meta name="dc.Creator" content="Jean E.  Bemis" /></meta><meta name="dc.Creator" content="Christina  Boucher" /></meta><meta name="dc.Creator" content="Lilly  Chai" /></meta><meta name="dc.Creator" content="Stuart C.  Chaffee" /></meta><meta name="dc.Creator" content="Holly L.  Deak" /></meta><meta name="dc.Creator" content="Linda F.  Epstein" /></meta><meta name="dc.Creator" content="Ted  Faust" /></meta><meta name="dc.Creator" content="Paul  Gallant" /></meta><meta name="dc.Creator" content="Anu  Gore" /></meta><meta name="dc.Creator" content="Yan  Gu" /></meta><meta name="dc.Creator" content="Brad  Henkle" /></meta><meta name="dc.Creator" content="Faye  Hsieh" /></meta><meta name="dc.Creator" content="Xin  Huang" /></meta><meta name="dc.Creator" content="Joseph L.  Kim" /></meta><meta name="dc.Creator" content="Josie H.  Lee" /></meta><meta name="dc.Creator" content="Matthew W.  Martin" /></meta><meta name="dc.Creator" content="David C.  McGowan" /></meta><meta name="dc.Creator" content="Daniela  Metz" /></meta><meta name="dc.Creator" content="Deanna  Mohn" /></meta><meta name="dc.Creator" content="Kurt A.  Morgenstern" /></meta><meta name="dc.Creator" content="Antonio  Oliveira-dos-Santos" /></meta><meta name="dc.Creator" content="Vinod F.  Patel" /></meta><meta name="dc.Creator" content="David  Powers" /></meta><meta name="dc.Creator" content="Paul E.  Rose" /></meta><meta name="dc.Creator" content="Stephen  Schneider" /></meta><meta name="dc.Creator" content="Susan A.  Tomlinson" /></meta><meta name="dc.Creator" content="Yan-Yan  Tudor" /></meta><meta name="dc.Creator" content="Susan M.  Turci" /></meta><meta name="dc.Creator" content="Andrew A.  Welcher" /></meta><meta name="dc.Creator" content="Huilin  Zhao" /></meta><meta name="dc.Creator" content="Li  Zhu" /></meta><meta name="dc.Creator" content="Xiaotian  Zhu" /></meta><meta name="dc.Description" content="The lymphocyte-specific kinase (Lck), a member of the Src family of cytoplasmic tyrosine kinases, is expressed in T cells and natural killer (NK) cells. Genetic evidence, including knockout mice an..." /></meta><meta name="Description" content="The lymphocyte-specific kinase (Lck), a member of the Src family of cytoplasmic tyrosine kinases, is expressed in T cells and natural killer (NK) cells. Genetic evidence, including knockout mice an..." /></meta><meta name="dc.Publisher" content=" American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 6, 2008" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm7010996" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2008 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm7010996" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm7010996" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm7010996" /></link>
        
    
    

<title>Structure-Guided Design of Aminopyrimidine Amides as Potent, Selective Inhibitors of Lymphocyte Specific Kinase: Synthesis, Structure–Activity Relationships, and Inhibition of in Vivo T Cell Activation | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm7010996" /></meta><meta property="og:title" content="Structure-Guided Design of Aminopyrimidine Amides as Potent, Selective Inhibitors of Lymphocyte Specific Kinase: Synthesis, Structure–Activity Relationships, and Inhibition of in Vivo T Cell Activation" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0013.jpeg" /></meta><meta property="og:description" content=" The lymphocyte-specific kinase (Lck), a member of the Src family of cytoplasmic tyrosine kinases, is expressed in T cells and natural killer (NK) cells. Genetic evidence, including knockout mice and human mutations, demonstrates that Lck kinase activity is critical for normal T cell development, activation, and signaling. Selective inhibition of Lck is expected to offer a new therapy for the treatment of T-cell-mediated autoimmune and inflammatory disease. With the aid of X-ray structure-based analysis, aminopyrimidine amides 2 and 3 were designed from aminoquinazolines 1, which had previously been demonstrated to exhibit potent inhibition of Lck and T cell proliferation. In this report, we describe the synthesis and structure–activity relationships of a series of novel aminopyrimidine amides 3 possessing improved cellular potency and selectivity profiles relative to their aminoquinazoline predecessors 1. Orally bioavailable compound 13b inhibited the anti-CD3-induced production of interleukin-2 (IL-2) in mice in a dose-dependent manner (ED50 = 9.4 mg/kg)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm7010996"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm7010996">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm7010996&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm7010996&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm7010996&amp;href=/doi/10.1021/jm7010996" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2008</span><span class="cit-fg-volume">, 51</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 1681-1694</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/51/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm701098w" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm701129j" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Guided Design of Aminopyrimidine Amides as Potent, Selective Inhibitors of Lymphocyte Specific Kinase: Synthesis, Structure–Activity Relationships, and Inhibition of in Vivo T Cell Activation</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Erin+F.++DiMauro">Erin F. DiMauro</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Newcomb">John Newcomb</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+J.++Nunes">Joseph J. Nunes</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean+E.++Bemis">Jean E. Bemis</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christina++Boucher">Christina Boucher</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lilly++Chai">Lilly Chai</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stuart+C.++Chaffee">Stuart C. Chaffee</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Holly+L.++Deak">Holly L. Deak</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Linda+F.++Epstein">Linda F. Epstein</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ted++Faust">Ted Faust</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Gallant">Paul Gallant</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anu++Gore">Anu Gore</a></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Gu">Yan Gu</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brad++Henkle">Brad Henkle</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Faye++Hsieh">Faye Hsieh</a></span><span class="author-xref-symbol "><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Huang">Xin Huang</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+L.++Kim">Joseph L. Kim</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Josie+H.++Lee">Josie H. Lee</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+W.++Martin">Matthew W. Martin</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+C.++McGowan">David C. McGowan</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniela++Metz">Daniela Metz</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Deanna++Mohn">Deanna Mohn</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kurt+A.++Morgenstern">Kurt A. Morgenstern</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Antonio++Oliveira-dos-Santos">Antonio Oliveira-dos-Santos</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vinod+F.++Patel">Vinod F. Patel</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Powers">David Powers</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+E.++Rose">Paul E. Rose</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Schneider">Stephen Schneider</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+A.++Tomlinson">Susan A. Tomlinson</a></span><span class="author-xref-symbol "><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan-Yan++Tudor">Yan-Yan Tudor</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+M.++Turci">Susan M. Turci</a></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+A.++Welcher">Andrew A. Welcher</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huilin++Zhao">Huilin Zhao</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Zhu">Li Zhu</a></span><span class="author-xref-symbol "><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaotian++Zhu">Xiaotian Zhu</a></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div><div class="corresp-info"><strong>*</strong> To whom correspondence should be addressed. Phone: 617-444-5189 . Fax: 617-621-3907. E-mail: <a href="/cdn-cgi/l/email-protection#1b7e7f72767a6e69745b7a767c7e7535787476"><span class="__cf_email__" data-cfemail="0461606d696571766b44656963616a2a676b69">[email protected]</span></a></div><div class="corresp-fn" id="fn1">†Department of Medicinal Chemistry.</div><div class="corresp-fn" id="fn2">#Department of HTS and Molecular Pharmacology (Amgen at MA and CA).</div><div class="corresp-fn" id="fn3">∥Department of Molecular Structure.</div><div class="corresp-fn" id="fn4">⊥Department of Pharmaceutics.</div><div class="corresp-fn" id="fn5">‡Department of Inflammation.</div><div class="corresp-fn" id="fn6">§Department of Pharmacokinetic and Drug Metabolism.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm7010996&amp;href=/doi/10.1021%2Fjm7010996" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2008</span></span><span class="cit-volume">, 51</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 1681–1694</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 6, 2008</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 September 2007</li><li><span class="item_label"><b>Published</b> online</span>6 March 2008</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 March 2008</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm7010996" title="DOI URL">https://doi.org/10.1021/jm7010996</a></div><div class="article_header-article-copyright"><strong>Copyright © 2008 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1681%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DErin%2BF.%2BDiMauro%252C%2BJohn%2BNewcomb%252C%2BJoseph%2BJ.%2BNunes%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D51%26issueNum%3D6%26contentID%3Djm7010996%26title%3DStructure-Guided%2BDesign%2Bof%2BAminopyrimidine%2BAmides%2Bas%2BPotent%252C%2BSelective%2BInhibitors%2Bof%2BLymphocyte%2BSpecific%2BKinase%253A%2BSynthesis%252C%2BStructure%25E2%2580%2593Activity%2BRelationships%252C%2Band%2BInhibition%2Bof%2Bin%2BVivo%2BT%2BCell%2BActivation%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1694%26publicationDate%3DMarch%2B2008">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm7010996"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1954</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">15</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm7010996" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Guided Design of Aminopyrimidine Amides as Potent, Selective Inhibitors of Lymphocyte Specific Kinase: Synthesis, Structure–Activity Relationships, and Inhibition of in Vivo T Cell Activation&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Erin&quot;,&quot;last_name&quot;:&quot;F. DiMauro&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Newcomb&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;J. Nunes&quot;},{&quot;first_name&quot;:&quot;Jean&quot;,&quot;last_name&quot;:&quot;E. Bemis&quot;},{&quot;first_name&quot;:&quot;Christina&quot;,&quot;last_name&quot;:&quot;Boucher&quot;},{&quot;first_name&quot;:&quot;Lilly&quot;,&quot;last_name&quot;:&quot;Chai&quot;},{&quot;first_name&quot;:&quot;Stuart&quot;,&quot;last_name&quot;:&quot;C. Chaffee&quot;},{&quot;first_name&quot;:&quot;Holly&quot;,&quot;last_name&quot;:&quot;L. Deak&quot;},{&quot;first_name&quot;:&quot;Linda&quot;,&quot;last_name&quot;:&quot;F. Epstein&quot;},{&quot;first_name&quot;:&quot;Ted&quot;,&quot;last_name&quot;:&quot;Faust&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Gallant&quot;},{&quot;first_name&quot;:&quot;Anu&quot;,&quot;last_name&quot;:&quot;Gore&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Gu&quot;},{&quot;first_name&quot;:&quot;Brad&quot;,&quot;last_name&quot;:&quot;Henkle&quot;},{&quot;first_name&quot;:&quot;Faye&quot;,&quot;last_name&quot;:&quot;Hsieh&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;L. Kim&quot;},{&quot;first_name&quot;:&quot;Josie&quot;,&quot;last_name&quot;:&quot;H. Lee&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;W. Martin&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;C. McGowan&quot;},{&quot;first_name&quot;:&quot;Daniela&quot;,&quot;last_name&quot;:&quot;Metz&quot;},{&quot;first_name&quot;:&quot;Deanna&quot;,&quot;last_name&quot;:&quot;Mohn&quot;},{&quot;first_name&quot;:&quot;Kurt&quot;,&quot;last_name&quot;:&quot;A. Morgenstern&quot;},{&quot;first_name&quot;:&quot;Antonio&quot;,&quot;last_name&quot;:&quot;Oliveira-dos-Santos&quot;},{&quot;first_name&quot;:&quot;Vinod&quot;,&quot;last_name&quot;:&quot;F. Patel&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Powers&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;E. Rose&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Schneider&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;A. Tomlinson&quot;},{&quot;first_name&quot;:&quot;Yan-Yan&quot;,&quot;last_name&quot;:&quot;Tudor&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;M. Turci&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;A. Welcher&quot;},{&quot;first_name&quot;:&quot;Huilin&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Xiaotian&quot;,&quot;last_name&quot;:&quot;Zhu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2008&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;06&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;51&quot;,&quot;pages&quot;:&quot;1681-1694&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm7010996&quot;},&quot;abstract&quot;:&quot;The lymphocyte-specific kinase (Lck), a member of the Src family of cytoplasmic tyrosine kinases, is expressed in T cells and natural killer (NK) cells. Genetic evidence, including knockout mice and human mutations, demonstrates that Lck kinase activity is critical for normal T cell development, activation, and signaling. Selective inhibition of Lck is expected to offer a new therapy for the treatment of T-cell-mediated autoimmune and inflammatory disease. With the aid of X-ray structure-based analysis, aminopyrimidine amides 2 and 3 were designed from aminoquinazolines 1, which had previously been demonstrated to exhibit potent inhibition of Lck and T cell proliferation. In this report, we describe the synthesis and structure–activity relationships of a series of novel aminopyrimidine amides 3 possessing improved cellular potency and selectivity profiles relative to their aminoquinazoline predecessors 1. Orally bioavailable compound 13b inhibited the anti-CD3-induced production of interleukin-2 (IL-2) in mic&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7010996&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7010996" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7010996&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7010996" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm7010996&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7010996" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm7010996&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm7010996&amp;href=/doi/10.1021/jm7010996" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm7010996" /></input><a href="/doi/pdf/10.1021/jm7010996" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (785 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm7010996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm7010996%26sid%3Dliteratum%253Aachs%26pmid%3D18321037%26genre%3Darticle%26aulast%3DDiMauro%26date%3D2008%26atitle%3DStructure-Guided%2BDesign%2Bof%2BAminopyrimidine%2BAmides%2Bas%2BPotent%252C%2BSelective%2BInhibitors%2Bof%2BLymphocyte%2BSpecific%2BKinase%253A%2BSynthesis%252C%2BStructure%25E2%2580%2593Activity%2BRelationships%252C%2Band%2BInhibition%2Bof%2Bin%2BVivo%2BT%2BCell%2BActivation%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D51%26issue%3D6%26spage%3D1681%26epage%3D1694%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/51/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7010996&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The lymphocyte-specific kinase (Lck), a member of the Src family of cytoplasmic tyrosine kinases, is expressed in T cells and natural killer (NK) cells. Genetic evidence, including knockout mice and human mutations, demonstrates that Lck kinase activity is critical for normal T cell development, activation, and signaling. Selective inhibition of Lck is expected to offer a new therapy for the treatment of T-cell-mediated autoimmune and inflammatory disease. With the aid of X-ray structure-based analysis, aminopyrimidine amides <b>2</b> and <b>3</b> were designed from aminoquinazolines <b>1</b>, which had previously been demonstrated to exhibit potent inhibition of Lck and T cell proliferation. In this report, we describe the synthesis and structure–activity relationships of a series of novel aminopyrimidine amides <b>3</b> possessing improved cellular potency and selectivity profiles relative to their aminoquinazoline predecessors <b>1</b>. Orally bioavailable compound <b>13b</b> inhibited the anti-CD3-induced production of interleukin-2 (IL-2) in mice in a dose-dependent manner (ED<sub>50</sub> = 9.4 mg/kg).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Signal transduction pathways mediated by the T cell receptor (TCR<a class="ref internalNav" href="#fn7" aria-label="a">a</a>) <div class="NLM_fn" id="fn7">a<p class="last">Abbreviations: Lck, lymphocyte-specific kinase; TCR, T cell receptor; IL-2, interleukin 2; PTK, protein tyrosine kinase; MLR, human mixed lymphocyte reaction; DFG, aspartic acid−phenylalanine−glycine; MAPK, mitogen activated protein kinase; VEGF, vascular endothelial growth factor.</p></div> have been extensively researched.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Novel immunosuppressive agents that target components of these pathways may be useful as therapies for T-cell-mediated inflammatory or autoimmune diseases such as rheumatoid arthritis, polyarthritis scleroderma, inflammatory bowel disease, type I diabetes, multiple sclerosis, ulcerative colitis, Crohn’s disease, Sjogren’s disease, polymyositis, dermatomyositis, vasculitis, myasthenia gravis, psoriasis, and lupus. Such therapies could also prove advantageous in transplant organ or graft rejection.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">The Src family of cytoplasmic protein tyrosine kinases includes Src, Lck, Fyn, Lyn, Hck, Fgr, Blk, and Yes.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Lck and Fyn have been shown to have important roles in TCR-mediated signal transduction.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> TCR signals propagated by the stimulation of Lck ultimately lead to gene regulation events triggering cytokine release, proliferation, and survival of antigen specific T cells, thereby amplifying immune responses. Defects in T cell maturation and signaling, which affect expression and/or catalytic activity, have been observed in Lck knockout mice and humans with Lck mutations.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> These findings suggest that a small-molecule inhibitor of Lck activity could prove useful as an immunosuppressive agent.</div><div class="NLM_p">In recent years, we and others have disclosed several classes of small-molecule Lck inhibitors.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Some of these agents have demonstrated oral bioavailability and inhibitory activities in rodent models of T-cell-dependent immune responses.<a onclick="showRef(event, 'ref1 cit6d cit6e cit6f cit6i cit6j cit6k cit6l cit6m cit6n cit6o cit6p'); return false;" href="javascript:void(0);" class="ref ref1 cit6d cit6e cit6f cit6i cit6j cit6k cit6l cit6m cit6n cit6o cit6p">(1, 6d-6f, 6i-6p)</a> 2-Aminoquinazolines <b>1</b> (−L− = −CONH−, −NHCO−, or −NHCONH−) were identified via high-throughput screening of our kinase-preferred compound collection as potent, ATP-competitive inhibitors of Lck.<a onclick="showRef(event, 'cit6p'); return false;" href="javascript:void(0);" class="ref cit6p">(6p)</a> Compounds with general structure <b>1</b> also exhibited potent inhibitory activity against T-cell proliferation and activation as measured by the human mixed lymphocyte reaction (MLR) and the T cell receptor/anti-CD3-induced production of interleukin-2 (IL-2). Extensive medicinal chemistry efforts were invested toward understanding the SAR of the 2-aminoquinazolines. These efforts led to the identification of orally bioavailable compounds with inhibitory activity in the anti-CD3-induced model of IL-2 production in mice and moderate to good selectivity profiles. Analysis of several X-ray cocrystal structures of aminoquinazolines <b>1</b> and Lck revealed key H-bonding interactions in the ATP-binding site, which are depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. We sought to improve the selectivity of our aminoquinazoline series by taking advantage of the sequence differences among structurally related kinases in and around the ATP-binding pocket (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Specifically, we targeted structural modifications that would allow for an additional H-bonding interaction with the threonine gatekeeper residue (T316) in Lck. We hypothesized that such a new interaction would increase selectivity over kinases with non-threonine gatekeeper residues (namely, Tie-2, Jak3, and KDR).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Support for this hypothesis is provided by imatinib, which selectively inhibits a subset of kinases (BCR-Abl, cKit, PDGFR) through preferential binding to the inactive (DFG-out) conformation of the protein and hydrogen bonding to the threonine gatekeeper residue.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Furthermore, a single point mutation at the Abl gatekeeper residue (T315I) results in resistance to imatinib. Toward this end, we designed aminopyrimidine amides with general structures <b>2</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> and <b>3</b>. Herein, we describe synthesis, X-ray structure, structure–activity relationships, and pharmacological characterization of aminopyrimidine amides <b>3</b> and the identification of an orally bioavailable Lck inhibitor (<b>13b</b>) with dose-dependent efficacy in a mouse model of T-cell receptor stimulated IL-2 production.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of aminopyrimidine amides <b>2</b> and <b>3</b> from aminoquinazolines <b>1</b>: −L− = −CONH−, −NHCO−, or −NHCONH−.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7010996&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Sequence Comparison at Gatekeeper Residue and Extended Hydrophobic Pocket</div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead valign="middle"><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="middle">Lck</th><th class="rowsep1" align="center" valign="middle">Thr316<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></th><th class="rowsep1" align="center" valign="middle">Met292</th><th class="rowsep1" align="center" valign="middle">Leu295</th><th class="rowsep1" align="center" valign="middle">Leu300</th><th class="rowsep1" align="center" valign="middle">Ile355</th><th class="rowsep1" align="center" valign="middle">Tyr360</th></tr></thead><tbody><tr valign="top"><td align="left">Tie2</td><td align="left">Ile</td><td align="left">Leu</td><td align="left">Leu</td><td align="left">Ile</td><td align="left">Leu</td><td align="left">Phe</td></tr><tr valign="top"><td align="left">Jak3</td><td align="left">Met</td><td align="left">Leu</td><td align="left">Leu</td><td align="left">Ile</td><td align="left">Leu</td><td align="left">Cys</td></tr><tr valign="top"><td align="left">P38α</td><td align="left">Thr</td><td align="left">Leu</td><td align="left">Met</td><td align="left">Val</td><td align="left">Ile</td><td align="left">Ile</td></tr><tr valign="top"><td align="left">KDR</td><td align="left">Val</td><td align="left">Leu</td><td align="left">Ile</td><td align="left">Val</td><td align="left">Leu</td><td align="left">Cys</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup>a</sup><p class="last">Gatekeeper residue.</p></div></div></div></div><div id="sec1_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78568" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78568" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Aminopyrimidine amides (<b>3</b>, −L− = −CONH−, i.e., <b>10a</b>,<b>b</b>) were prepared as depicted in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. 2,5-Diaminopyrimidines <b>6</b> were prepared from 2-amino-5-nitropyrimidines <b>5</b>, which were either commercially available (<b>5a</b>, R<sup>1</sup> = H) or derived from the S<sub>N</sub>Ar reaction of 2-chloro-5-nitropyrimidine (<b>4</b>) and anilines (i.e., <b>6b</b>, R<sup>1</sup> = 4-(4-methylpiperizino)aniline) or amines (i.e., <b>6c</b>,<b>d</b>). Commercially available 3-iodo-4-methylbenzoyl chloride (<b>7</b>) was condensed with 3-(trifluoromethyl)aniline in the presence of triethylamine to provide iodoamide <b>8</b>, which was then subjected to palladium-catalyzed carbonylative esterification and subsequent saponification to afford acid <b>9</b>. Condensation of <b>9</b> with 2,5-diaminopyrimidines <b>6a</b>,<b>b</b> provided the final compounds <b>10a</b>,<b>b</b>. The synthesis of aminopyrimidine reverse amides (<b>3</b>, −L− = −NHCO−, i.e., <b>13a</b>−<b>d</b>, <b>14</b>–<b>22</b>) was also accomplished in a convergent manner (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Nitrobenzamides <b>12</b>, prepared by the reaction of 2,5-diaminopyrimidines <b>6</b> and acid chlorides, were reduced to the corresponding anilines and selectively coupled to acids or acid chlorides to generate reverse amides. Similarly, aminopyrimidine amide ureas (<b>3</b>, −L− = −NHCONH−, i.e., <b>23a</b>,<b>b</b>) were prepared from <b>12</b> via reduction of the nitro group and reaction of the derived aniline with isocyanates. These synthetic routes proved to be quite general such that a variety of reverse amides and ureas could be prepared in moderate to good overall yields.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0011.jpeg" id="gs1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Aminopyrimidine Amides, Reverse Amides, and Ureas<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7010996&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 4-(4-methylpiperazino)aniline, TFA, IPA, 80 °C (<b>5b</b>, 88%); (b) 3-morpholinopropan-1-amine, DIPEA, IPA, 70 °C (<b>5c</b>, 100%); (c) 1-methylpiperidin-4-amine, NaH, THF (<b>5d</b>, 100%); (d) 10% Pd/C, H<sub>2</sub>, CH<sub>3</sub>OH/EtOAc; (e) 3-(trifluoromethyl)aniline, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub> (84%); (f) CO(g), CH<sub>3</sub>OH, Pd(OAc)<sub>2</sub>, dppp, NEt<sub>3</sub>, 70−100 °C (85%); (g) LiOH, THF/H<sub>2</sub>O (92%); (h) EDC−HCl, HATU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub> (<b>10a</b>, 65%; <b>10b</b>, 91%); (i) (i) acid, SOCl<sub>2</sub>, 80 °C, (ii) aniline, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (j) 1-isocyanato-3-(trifluoromethyl)benzene, benzene, 75 °C (<b>23a</b>, 20%; <b>23b</b>, 46%).</p></p></figure><div class="NLM_p">In some instances, unsubstituted 2-aminopyrimidine nitrobenzamide <b>12a</b> was converted to iodide <b>24</b> via a Sandmeyer reaction (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> S<sub>N</sub>Ar reactions of iodide <b>24</b> were accomplished under thermal, basic conditions with alkylamines (i.e., <b>13e</b>) or under thermal, acidic conditions with anilines. The nitrobenzamide products were then reduced to the corresponding anilines and coupled to acids or acid chlorides to generate the final compounds. Variations on the central aryl ring were typically introduced early in the synthetic route beginning with appropriately functionalized, commercially available benzoic acids (i.e., <b>25</b>, <b>26</b>, <b>30</b>). Final compounds were thus prepared following standard procedures, as depicted in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0012.jpeg" id="gs2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Aminopyrimidine Reverse Amides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7010996&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) isoamyl nitrite, CuI, CH<sub>2</sub>I<sub>2</sub>, THF, 70 °C (21%); (b) 2-morpholinoethanamine, DIPEA, IPA, 70 °C (100%); (c) 10% Pd/C, H<sub>2</sub>, CH<sub>3</sub>OH/EtOAc; (d) 3-(trifluoromethyl)benzoyl chloride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub> (63%); (e) (i) acid, SOCl<sub>2</sub>, 80 °C, (ii) aniline, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (f) EDC−HCl, HATU, DIPEA, DMF (42%); (g) BEt<sub>3</sub>, Pd(OAc)<sub>2</sub>, S-Phos, K<sub>3</sub>PO<sub>4</sub>, THF, 60 °C (20%).</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03724" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03724" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Structure–Activity Relationships (SAR)</h3><div class="NLM_p">To test our hypothesis that the introduction of an H-bond donor moiety would confer enhanced selectivity over kinases that possess a gatekeeper residue other than threonine, we investigated a series of direct 2-aminopyrimidine amide analogues of our nonselective 2-aminoquinazoline leads (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Replacement of the 2-aminoquinazoline with a 2-aminopyrimidine amide leads to a 10- to 75-fold loss of potency on Lck, as evidenced by comparison of the in vitro profiles for representative amides (<b>34</b> vs <b>10a</b>), reverse amides (<b>35</b> vs <b>13a</b>), and ureas (<b>36</b> vs <b>23a</b>). The potency loss is counteracted by the introduction of a 4-(4-methylpiperazino)anilino substituent at the 2-position in the pyrimidine series (<b>10b</b>, <b>13b</b>, <b>23b</b>). We speculate that this gain in enzyme potency results from additional stabilizing van der Waals interactions between the aryl ring of the aniline substituent and the two lipophilic residues (Leu251 of the glycine-rich loop and Gly332) between which it is situated.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Interestingly, reverse amide <b>13b</b> demonstrated greater selectivity than amide <b>10b</b> and greater cellular potency than urea <b>23b</b>. Unfortunately, the arylpiperazine <b>13b</b> does not afford a substantial improvement in selectivity over KDR relative to aminoquinazoline <b>35</b> (40-fold vs 15-fold). In KDR, the valine gatekeeper residue is relatively small and can presumably tolerate a proximal hydrophilic amide moiety.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Aminoquinazolines vs Aminopyrimidine Amides<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0001.gif" alt="" id="gr5" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the mean of two or more separate determinations, in duplicate.</p></div></div></div><div class="NLM_p">X-ray crystallography was used to confirm our hypothesis that a 2-aminopyrimidine amide binds to Lck in a manner similar to that observed for the 2-aminoquinazoline but also engages the threonine gatekeeper in an H-bonding interaction (between the amide NH and the oxygen of T316). The cocrystal structures of Lck and aminopyrimidine amide <b>10b</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a) and Lck and aminopyrimidine reverse amide <b>19</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b) were solved at 2.2 and 2.3 Å resolution, respectively. In both structures, the inhibitor occupies the ATP-binding site and induces the protein to assume a DFG-out conformation.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The aminopyrimidine ring makes two hydrogen bond contacts to the hinge region of the enzyme at M319 (<b>10b</b>, 3.04 and 2.78 Å; <b>19</b>, 2.99 and 2.89 Å). As hypothesized, the pyrimidine amide moiety engages the gatekeeper residue (T316) in an H-bond interaction (<b>10b</b>, 3.07 Å; <b>19</b>, 3.11 Å), acting as an H-bond donor to the threonine oxygen. The arylamide moiety makes hydrogen bond contacts with the backbone NH of D382 (<b>10b</b>, 2.89 Å; <b>19</b>, 2.97 Å) from the DFG sequence and E288 (<b>10b</b>, 2.80 Å; <b>19</b>, 2.99 Å) from the C-helix. The aryl ring of the second amide thus occupies the extended hydrophobic pocket, making van der Waals contacts to several lipophilic residues. This type of DFG-out binding mode was previously observed for the parent 2-aminoquinazolines and is not observed for most other reported Src-family kinase inhibitors such as PP1 and PP2.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In view of the marked similarity in binding mode between amides and reverse amides with Lck, we are currently unable to offer a rational explanation for the superior selectivity of <b>13b</b> relative to <b>10b</b>. Similarities in the binding modes of aminopyrimidine amides and quinazolines are demonstrated by the overlay of two cocrystal structures with Lck (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c). As observed in the cocrystal structures, substituents on the 2-amino group of the pyrimidine can extend to the solvent front and may be engaged in additional binding interactions with residues lining the hinge region and the glycine-rich loop.<a onclick="showRef(event, 'ref13 cit6s ref9'); return false;" href="javascript:void(0);" class="ref ref13 cit6s ref9">(13, 6s, 9)</a></div><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0009.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cocrystal structures: (a) Lck and aminopyrimidine amide <b>10b</b>; (b) Lck and aminopyrimidine reverse amide <b>19</b>; (c) overlay of aminopyrimidine amide <b>10b</b> (green) with quinazoline <b>34</b> (blue) in Lck.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7010996&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In light of the gain in potency observed for <b>13b</b> relative to <b>13a</b> and the potential for additional H-bonding<a onclick="showRef(event, 'cit6s'); return false;" href="javascript:void(0);" class="ref cit6s">(6s)</a> or van der Waals<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> interactions with residues lining the hinge region, we examined the effect on potency and selectivity of smaller tertiary amine containing chains to the 2-position of the pyrimidine (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, <b>13c</b>−<b>e</b>). Although these analogues proved quite selective over KDR, Tie-2, and Jak3, their Lck kinase and cellular potency was significantly less than <b>13b</b>. As anticipated, the H-bond donor to the hinge is important for potency; a substantial loss in potency was also observed with the unsubstituted pyrimidine <b>37</b>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR: Variations on the Pyrimidine Substituent<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0002.gif" alt="" id="_i11" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0003.gif" alt="" id="gr7" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the mean of two or more separate determinations, in duplicate.</p></div></div></div><div class="NLM_p">Selected SAR from variations on the arylamide is summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Moderate potency and good selectivity (vs KDR, Tie-2, and Jak3) was observed with isoxazole <b>15</b>, benzamide <b>16</b>, and 2-methoxybenzamide <b>17</b>. These three analogues possessed kinase selectivity profiles comparable to that of lead <b>13b</b> but were less potent. Compounds lacking the southern aryl ring, such as acetamide <b>14</b>, were also significantly (>50-fold) less potent than <b>13b</b> on Lck. Exceptional enzyme and cellular potency, comparable to that of lead <b>13b</b>, was consistently observed for meta<i>-</i> or para<i>-</i>substituted derivatives, such as <b>18</b>–<b>22</b>. Of these, <b>20</b> proved most selective over KDR (>200-fold).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR: Variations on the Arylamide<a class="ref internalNav" href="#tbl4-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0004.gif" alt="" id="_i13" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0005.gif" alt="" id="gr8" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl4-fn1"><div class="footnote" id="tbl4-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the mean of two or more separate determinations, in duplicate.</p></div></div></div><div class="NLM_p">An examination of the central aryl ring situated in the classical hydrophobic pocket led to compounds with significantly improved selectivity profiles (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). On the basis of SAR from the parent aminoquinazoline series, we surmised that a small lipophilic substituent such as methyl or chloro at R<sup>1</sup> was important for cellular potency. We also discovered that the larger ethyl substituent was tolerated with only a moderate (2- to 5-fold) loss of Lck potency and afforded excellent selectivity over p38α (i.e., <b>33</b>). Small substituents at R<sup>2</sup>, such as methyl or chloro, were also better tolerated by Lck than by p38α (<b>29</b> and <b>27</b>). Unfortunately, none of these more selective analogues demonstrated acceptable cellular potency. The narrow SAR is consistent with expectations, given the lack of space in this region of the binding site (see X-ray structures, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'cit6p ref14'); return false;" href="javascript:void(0);" class="ref cit6p ref14">(6p, 14)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. SAR: Variations on the Central Aryl Ring<a class="ref internalNav" href="#tbl5-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0006.gif" alt="" id="_i15" /></img><div class="scrollable-table-wrap"><table class="table single-image frame_topbot"><colgroup><col align="left" /></col></colgroup><tbody><tr valign="top"><td align="left"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0007.gif" alt="" id="gr9" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl5-fn1"><div class="footnote" id="tbl5-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the mean of two or more separate determinations, in duplicate.</p></div></div></div><div class="NLM_p">On account of their in vitro potencies and selectivity profiles, selected aminopyrimidine amides were advanced into our secondary cellular screening assay, which measures the compound’s inhibitory effect on the anti-CD3 induced production of IL-2 in 50% human whole-blood (WB IL-2) (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Compounds <b>13b</b>, <b>18</b>−<b>20</b>, and <b>22</b> were very potent inhibitors of IL-2 production in human whole blood. On the basis of the general inhibitory activity in the p38α kinase assay (<10 nM) for this series, three representative compounds, <b>13b</b>, <b>18</b>, and <b>19</b>, were further counterscreened for inhibitory activity in the lipopolysaccharide-induced production of TNFα in 50% human whole blood (WB TNFα). The whole blood cellular selectivity factor (WB IL-2 IC<sub>50</sub>/WB TNFα IC<sub>50</sub>) was substantial for all three compounds (102-, 63-, and 685-fold, respectively). For several compounds, the protein binding profiles were examined in plasma from three species (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Cellular Assay (WB IL-2) and Counterscreen (WB TNFα) in 50% Human Whole Blood and Protein Binding<a class="ref internalNav" href="#tbl6-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="2" align="center" valign="middle" char=".">IC<sub>50</sub> (µM)</th><th colspan="3" align="center" valign="middle" char=".">protein binding (%)</th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="middle">compd</th><th class="rowsep1" align="center" valign="middle" char=".">WB IL-2</th><th class="rowsep1" align="center" valign="middle" char=".">WB TNFα</th><th class="rowsep1" align="center" valign="middle" char=".">human</th><th class="rowsep1" align="center" valign="middle" char=".">mouse</th><th class="rowsep1" align="center" valign="middle" char=".">rat</th></tr></thead><tbody><tr valign="top"><td align="left"><b>13a</b></td><td align="char" char=".">1.27</td><td align="char" char=".">>10</td><td align="char" char="."> </td><td align="char" char="."> </td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>13b</b></td><td align="char" char=".">0.007</td><td align="char" char=".">0.718</td><td align="char" char=".">96.7</td><td align="char" char=".">97.8</td><td align="char" char=".">99.4</td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="char" char=".">0.016</td><td align="char" char=".">1.01</td><td align="char" char=".">96.4</td><td align="char" char=".">98.2</td><td align="char" char=".">97.7</td></tr><tr valign="top"><td align="left"><b>19</b></td><td align="char" char=".">0.002</td><td align="char" char=".">1.37</td><td align="char" char=".">98.1</td><td align="char" char=".">98.4</td><td align="char" char=".">98.6</td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="char" char=".">0.013</td><td align="char" char="."> </td><td align="char" char=".">95.8</td><td align="char" char=".">98.1</td><td align="char" char=".">98.9</td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="char" char=".">0.043</td><td align="char" char="."> </td><td align="char" char=".">96.8</td><td align="char" char=".">98.8</td><td align="char" char=".">98.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl6-fn1"><div class="footnote" id="tbl6-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the mean of two or more separate determinations, in duplicate.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Pharmacokinetic Profile</h3><div class="NLM_p">Selected PK data for discrete intravenous (iv) and oral (po) dosing in male Sprague–Dawley rats are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. Clearance ranged from low (<b>22</b>, 0.29 L/h/kg) to greater than hepatic blood flow (<b>21</b>, 6.64 L/h/kg), and oral bioavailability was generally low (4–22%). Compound <b>13b</b> exhibited a moderate rate of clearance, volume of distribution, oral exposure, and bioavailability. In light of the rat pharmacokinetic profile and the exceptional in vitro potency, <b>13b</b> appeared suitable for assessment via oral dosing in our rodent model of T cell activation.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Mean PK Parameters Following Intravenous Dose (iv) or Oral Dose (po) in male Sprague–Dawley Rats<a class="ref internalNav" href="#tbl7-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col width="12.468827930174564%" align="left" /></col><col width="12.468827930174564%" align="char" char="." /></col><col width="12.468827930174564%" align="char" char="." /></col><col width="12.468827930174564%" align="char" char="." /></col><col width="12.344139650872817%" align="char" char="." /></col><col width="12.593516209476311%" align="char" char="." /></col><col width="12.593516209476311%" align="char" char="." /></col><col width="12.593516209476311%" align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top"><th align="center" valign="middle"> </th><th colspan="3" align="center" valign="middle" char=".">iv<a class="ref internalNav" href="#tbl7-fn2" aria-label="b">b</a></th><th colspan="4" align="center" valign="middle" char=".">po<a class="ref internalNav" href="#tbl7-fn3" aria-label="c">c</a></th></tr><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="middle">compd</th><th class="rowsep1" align="center" valign="middle" char=".">CL ((L/h)/kg)</th><th class="rowsep1" align="center" valign="middle" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="rowsep1" align="center" valign="middle" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="rowsep1" align="center" valign="middle" char=".">AUC<sub>0-∞</sub> (ng· h/mL)</th><th class="rowsep1" align="center" valign="middle" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="rowsep1" align="center" valign="middle" char="."><i>T</i><sub>max</sub> (h)</th><th class="rowsep1" align="center" valign="middle" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top"><td align="left"><b>13b</b></td><td align="char" char=".">1.04</td><td align="char" char=".">3.29</td><td align="char" char=".">3.2</td><td align="char" char=".">419</td><td align="char" char=".">49</td><td align="char" char=".">4.67</td><td align="char" char=".">22</td></tr><tr valign="top"><td align="left"><b>18</b></td><td align="char" char=".">0.49</td><td align="char" char=".">1.61</td><td align="char" char=".">3.8</td><td align="char" char=".">332</td><td align="char" char=".">39</td><td align="char" char=".">0.6</td><td align="char" char=".">8</td></tr><tr valign="top"><td align="left"><b>19</b></td><td align="char" char=".">2.92</td><td align="char" char=".">5.45</td><td align="char" char=".">1.8</td><td align="char" char=".">92</td><td align="char" char=".">28</td><td align="char" char=".">2.75</td><td align="char" char=".">7</td></tr><tr valign="top"><td align="left"><b>20</b></td><td align="char" char=".">1.37</td><td align="char" char=".">3.76</td><td align="char" char=".">2.5</td><td align="char" char=".">58</td><td align="char" char=".">16</td><td align="char" char=".">0.42</td><td align="char" char=".">4</td></tr><tr valign="top"><td align="left"><b>21</b></td><td align="char" char=".">6.64</td><td align="char" char=".">15.8</td><td align="char" char=".">2.9</td><td align="char" char="."> </td><td align="char" char="."> </td><td align="char" char="."> </td><td align="char" char="."> </td></tr><tr valign="top"><td align="left"><b>22</b></td><td align="char" char=".">0.29</td><td align="char" char=".">0.79</td><td align="char" char=".">2.5</td><td align="char" char=".">528</td><td align="char" char=".">191</td><td align="char" char=".">0.33</td><td align="char" char=".">8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl7-fn1"><div class="footnote" id="tbl7-fn1"><sup>a</sup><p class="last"><i>n</i> = 3 animals per study.</p></div><div class="footnote" id="tbl7-fn2"><sup>b</sup><p class="last">Dosed iv at 0.5 mg/kg as a solution in DMSO.</p></div><div class="footnote" id="tbl7-fn3"><sup>c</sup><p class="last">Dosed po at 2 mg/kg as a suspension in 1% Tween-80, 2% HPMC, 97% water.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Selectivity Profile</h3><div class="NLM_p">Prior to in vivo testing, compound <b>13b</b> was screened for inhibitory activity against an extensive panel of kinases (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>).<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Excellent selectivity (>1000-fold) was observed over a number of structurally diverse kinases. As expected, <b>13b</b> was not selective over other members of the Src family (Src, Fyn, Lyn), p38α, Abl, or cFMS, all of which possess a threonine gatekeeper residue. The Src-family kinases are broadly expressed in a variety of tissues with high levels in hematopoietic cells. The lack of intra-Src family selectivity remains a concern because of potential adverse effects from multikinase inhibition. In particular, Lyn knockout mice show defective BCR signaling and decreased peripheral B-cells.<a onclick="showRef(event, 'ref3 ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref3 ref16 ref17">(3, 16, 17)</a> The intra-Src family specificity required for safe clinical application and/or therapeutic treatment of autoimmune or inflammatory disease remains an unknown at this time. Despite numerous reports of assorted chemotypes with varying selectivity profiles,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> a small-molecule inhibitor of Lck has yet to demonstrate successful clinical application in autoimmune, inflammatory disease, or transplant rejection. We believe that the overall kinase selectivity profile offered by this new aminopyrimidine amide class could pave the way to the identification of tool compounds to answer such questions. Compound <b>13b</b> was also tested for its ability to inhibit IL-2 production in Jurkat cells stimulated with phorbol 12-myritstyl 13-acetate (PMA) in the presence of ionophore. In this assay, the IC<sub>50</sub> was >20 µM, which provides further evidence that the inhibition of kinases downstream of Lck is minimal.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Kinase Selectivity Profile of <b>13b</b><a class="ref internalNav" href="#tbl8-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table frame_topbot"><colgroup><col align="left" /></col><col align="char" char="." /></col></colgroup><thead valign="middle"><tr valign="top" class="rowsep1"><th class="rowsep1" align="center" valign="middle">kinase</th><th class="rowsep1" align="center" valign="middle" char=".">IC<sub>50</sub> (µM)</th></tr></thead><tbody><tr valign="top"><td align="left">Lck</td><td align="char" char=".">0.0006</td></tr><tr valign="top"><td align="left">Src</td><td align="char" char=".">0.003</td></tr><tr valign="top"><td align="left">Fyn</td><td align="char" char=".">0.003</td></tr><tr valign="top"><td align="left">Lyn</td><td align="char" char=".">0.0009</td></tr><tr valign="top"><td align="left">p38α</td><td align="char" char=".">0.005</td></tr><tr valign="top"><td align="left">Abl</td><td align="char" char=".">0.002</td></tr><tr valign="top"><td align="left">cFMS</td><td align="char" char=".">0.040</td></tr><tr valign="top"><td align="left">KDR</td><td align="char" char=".">0.024</td></tr><tr valign="top"><td align="left">Tie-2</td><td align="char" char=".">9.95</td></tr><tr valign="top"><td align="left">JNK2</td><td align="char" char=".">4.29</td></tr><tr valign="top"><td align="left">Syk</td><td align="char" char=".">>5</td></tr><tr valign="top"><td align="left">TrkA</td><td align="char" char=".">>5</td></tr><tr valign="top"><td align="left">IRK</td><td align="char" char=".">>5</td></tr><tr valign="top"><td align="left">Itk</td><td align="char" char=".">>25</td></tr><tr valign="top"><td align="left">CDK5</td><td align="char" char=".">>25</td></tr><tr valign="top"><td align="left">PAK2</td><td align="char" char=".">>25</td></tr><tr valign="top"><td align="left">RON</td><td align="char" char=".">>25</td></tr><tr valign="top"><td align="left">Jak3</td><td align="char" char=".">>25</td></tr><tr valign="top"><td align="left">Jak2</td><td align="char" char=".">1.03</td></tr><tr valign="top"><td align="left">PIM1</td><td align="char" char=".">>30</td></tr><tr valign="top"><td align="left">Aurora1</td><td align="char" char=".">>8.3</td></tr><tr valign="top"><td align="left">Aurora2</td><td align="char" char=".">>25</td></tr><tr valign="top"><td align="left">PKAα</td><td align="char" char=".">>85</td></tr><tr valign="top"><td align="left">PKBα</td><td align="char" char=".">>100</td></tr><tr valign="top"><td align="left">MSK1</td><td align="char" char=".">>100</td></tr><tr valign="top"><td align="left">P70S6K</td><td align="char" char=".">>100</td></tr><tr valign="top"><td align="left">ERK1</td><td align="char" char=".">>100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl8-fn1"><div class="footnote" id="tbl8-fn1"><sup>a</sup><p class="last">IC<sub>50</sub> values are the mean of two or more separate determinations, in duplicate.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Pharmacodynamic Profile</h3><div class="NLM_p">Compound <b>13b</b> was further evaluated as an inhibitor in the anti-CD3-induced IL-2 production model in female BALB/c mice (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Upon oral administration at 10, 30, and 100 mg/kg, <b>13b</b> exhibited statistically significant dose-dependent inhibition of IL-2 production. In this study, terminal plasma levels (at 2.5 h) of <b>13b</b> were determined in order to estimate the levels of exposure at each dose. At the estimated ED<sub>50</sub> (9.4 mg/kg) the mean terminal plasma concentration (EC<sub>50</sub>) was ∼175 nM. This concentration provides 25-fold coverage over the in vitro potency in the 50% human whole-blood IL-2 assay (IC<sub>50</sub> = 7 nM) at 2.5 h. When adjusted for free fraction based on mouse protein binding (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>), the EC<sub>50</sub> (fu) for <b>13b</b> is 4 nM,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> which is consistent with the in vitro inhibitory activity in the absence of whole blood (IL-2 IC<sub>50</sub> = 0.6 nM). <b>13b</b> demonstrates comparable in vivo efficacy to cyclosporine A (ED<sub>50</sub> = 10 mg/kg) in this model.<a onclick="showRef(event, 'cit6i'); return false;" href="javascript:void(0);" class="ref cit6i">(6i)</a></div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of <b>13b</b> on Anti-CD3 induced IL-2 production in BALB/c mice. The 12 week old female BALB/c mice were pretreated (po) with <b>13b</b> at 10, 30, or 100 mg/kg. After 1.0 h the mice were challenged (iv) with anti-mouse CD3 monoclonal antibody (3 mg/mouse). After 90 min of anti-CD3 challenge, blood was collected via cardiac puncture. IL-2 was measured in serum using the BioSource ELISA kit. Data points represent the mean ± SE; <i>n</i> = 5 animals per group: (∗) <i>p</i> ≤ 0.05 vs vehicle control by Mann–Whitney <i>U</i>-test. Mean plasma concentrations for each dose are expressed in parentheses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7010996&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10108" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10108" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Aminopyrimidine amides <b>3</b>, designed from aminoquinazolines <b>1</b>, were demonstrated to afford improved potency and selectivity for the inhibition of Lck, T cell proliferation, and T cell activation. Our hypothesis that the introduction of an amide H-bond donor moiety would provide an additional site of interaction between the ligand and the gatekeeper residue (T316) of Lck was verified by X-ray crystallographic studies. This interaction presumably contributes to the enhanced selectivity afforded by these compounds relative to the parent aminoquinazolines. Extensive SAR investigations resulted in a diverse collection of novel aminopyrimidine amides, from which compound <b>13b</b> was identified as an orally active agent that exhibited dose-dependent inhibitory activity (ED<sub>50</sub> = 9.4 mg/kg) in the anti-CD3 induced production of IL-2 in mice.</div></div><div id="sec3_1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. Quinazolines <b>34</b>–<b>36</b> were prepared according to previously published procedures.<a onclick="showRef(event, 'cit6p'); return false;" href="javascript:void(0);" class="ref cit6p">(6p)</a> Dry organic solvents (CH<sub>2</sub>Cl<sub>2</sub>, CH<sub>3</sub>CN, DMF, etc.) were purchased from Aldrich packaged under nitrogen in Sure/Seal bottles. Reactions were monitored using Agilent 1100 series LCMS with UV detection at 254 nm and a low resonance electrospray mode (ESI). Medium pressure liquid chromatography (MPLC) was performed on a CombiFlash Companion (Teledyne Isco) with RediSep normal-phase silica gel (35 – 60 μm) columns and UV detection at 254 nm. Preparative reversed-phase HPLC was performed on a Gilson (215 liquid handler) YMC-Pack Pro C18, 150 mm × 30 mm i.d. column, eluting with a binary solvent system A and B using a gradient elution (A, H<sub>2</sub>O with 0.1% TFA; B, CH<sub>3</sub>CN with 0.1% TFA) with UV detection at 254 nm. Purity was measured using Agilent 1100 series high-performance liquid chromatography (HPLC) systems with UV detection at 254 nm (system A, Agilent Zorbax Eclipse XDB-C8 4.6 mm × 150 mm, 5 μm, 5−100% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% TFA for 15 min at 1.5 mL/min; system B, Waters Xterra 4.6 mm × 150 mm, 3.5 μm, 5−95% CH<sub>3</sub>CN in H<sub>2</sub>O with 0.1% TFA for 15 min at 1.0 mL/min). <sup>1</sup>H NMR spectra were recorded on a Bruker AV-400 (400 MHz) spectrometer at ambient temperature or on a Varian 400 MHz or on a Varian 300 MHz spectrometer. Chemical shifts are reported in ppm from the solvent resonance (DMSO-<i>d</i><sub>6</sub> 2.49 ppm). Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constants, and number of protons. Mass spectra were obtained on a high resonance electrospray time-of-flight mass spectrometer in positive ES ionization mode. Combustion analysis was performed by Galbraith Laboratories, Inc., Knoxville, TN. For final compounds that do not have elemental analysis data, the results of HPLC in two diverse chromatographic conditions can be found in the <a class="ref internalNav" href="#si1" aria-label="Supporting Information">Supporting Information</a>.</div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>2-(4-(4-Methylpiperazin-1-yl)phenyl)pyrimidine-2,5-diamine (<b>6b</b>)</h3><div class="NLM_p last">To a mixture of 4-(4-methylpiperazino)aniline (57.7 g, 302 mmol) and <b>4</b> (48.1 g, 302 mmol) in IPA (500 mL) was added trifluoroacetic acid (46 mL, 603 mmol). The mixture was heated to 80 °C for 4 h, then cooled to room temperature. The solid was collected by suction filtration through a Buchner filtration apparatus equipped with a micromembrane filter and washed with IPA (80 mL) and CH<sub>3</sub>OH (100 mL), then dried under vacuum to afford the trifluroacetic acid salt of <b>5b</b> as a pale-yellow amorphous solid (114 g, 266 mmol, 88%). MS (ESI, negative ion) <i>m</i>/<i>z</i>: 315 (MH<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d<sub>6</sub></i>): δ 10.87 (br s, 1H), 10.73 (s, 1H), 9.18 (s, 2H), 7.63–7.61 (m, 2H), 7.02–7.04 (m, 2H), 3.75–3.81 (m, 2H), 3.47–3.50 (m, 2H), 3.05–3.16 (m, 4H), 2.81 (s, 3H). The TFA salt of <b>5b</b> (96 g, 224 mmol) was suspended in water (400 mL), and 2 N NaOH was added until the aqueous layer was pH 14. The solid was collected by suction filtration through a Buchner filtration apparatus equipped with a micromembrane filter, washed with water, and dried under vacuum overnight to afford <b>5b</b> (70 g, 100% yield) [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 315 (MH<sup>+</sup>)] as a red amorphous solid, which was used without further purification. <b>5b</b> (70 g, 224 mmol) was taken up in EtOH (500 mL), and Pd/C (10 g, 10% by weight wet) was added. The mixture was placed in a stirred pressure vessel under 50 psi of H<sub>2</sub> for 48 h. The catalyst was removed by suction filtration and washed with EtOH. The organics were concentrated under reduced pressure and dried under vacuum to afford the title compound (61.4 g, 96% yield) as a tan amorphous solid, which was used without purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d<sub>6</sub></i>): δ 8.68 (s, 1H), 7.91 (s, 2H), 7.49–7.51 (m, 2H), 6.81–6.84 (m, 2H), 4.68 (br s, 2H), 3.0–3.02 (m, 4H), 2.43–2.51 (m, 4H), 2.21 (s, 3H). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 285 (MH<sup>+</sup>).</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>3-(2-Aminopyrimidin-5-yl)-4-methyl-<i>N</i>1-(3-(trifluoromethyl)phenyl)isophthalamide (<b>10a</b>)</h3><div class="NLM_p last">The title compound was prepared from <b>6a</b> (0.071 g, 0.371 mmol) and <b>9</b> (0.100 g, 0.309 mmol) using the procedure described for the synthesis of <b>10b</b>. Purification via column chromatography on silica gel (gradient elution with 2−10% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound (0.083 g, 65%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.71 (s, 1H), 10.39 (s, 1H), 8.67 (s, 2H), 8.38 (s, 1H), 8.28 (d, <i>J</i> = 1.9 Hz, 1H), 8.23 (d, <i>J</i> = 8.5 Hz, 1H), 8.15 (dd, <i>J</i> = 7.9, 1.9 Hz, 1H), 7.75 (t, <i>J</i> = 7.9 Hz, 1H), 7.64 (d, <i>J</i> = 8.0 Hz, 1H), 7.60 (d, <i>J</i> = 8.0 Hz, 1H), 6.70 (s, 2H), 2.61 (s, 3H). HRMS (C<sub>20</sub>H<sub>17</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 416.132 89; found, 416.134 16. Anal. (C<sub>20</sub>H<sub>16</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>·0.5CH<sub>3</sub>OH) C, H, N.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 4-Methyl-<i>N</i>3-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)-<i>N</i>1-(3-(trifluoromethyl)phenyl)isophthalamide (<b>10b</b>)</h3><div class="NLM_p last">A solution of 3-(trifluoromethyl)aniline (0.63 g, 3.9 mmol) and triethylamine (0.55 mL, 3.9 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was cooled in an ice–water bath, and a solution of <b>7</b> (1.0 g, 3.6 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was added slowly. The mixture was warmed to room temperature and stirred for 20 h. The reaction mixture was concentrated and purified via column chromatography on silica gel (gradient elution with 0−100% EtOAc/hexane) to afford <b>8</b> (1.219 g, 84% yield) [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 404 (MH<sup>+</sup>)]. A 45 mL stainless steel cylinder with glass liner was charged with <b>8</b> (1.22 g, 3.01 mmol) and CH<sub>3</sub>OH (15 mL). Argon was bubbled through the mixture, and then bis(diphenylphosphino)propane (0.0683 g, 0.165 mmol), triethylamine (1.00 mL, 7.17 mmol), and palladium(II) acetate (0.0338 g, 0.150 mmol) were added. The cylinder was capped with a pressure gauge, charged with CO gas (200 psi), and heated to 70 °C for 20 h and then at 100 °C for 4 h. The reaction mixture was cooled to room temperature and concentrated. The residue was purified via column chromatography on silica gel (gradient elution with 0−100% EtOAc/hexane) to afford methyl 2-methyl-5-((3-(trifluoromethyl)phenyl)carbamoyl)benzoate (0.858 g, 85% yield) [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 338 (MH<sup>+</sup>)] as an orange oil. Lithium hydroxide (0.154 g, 6 mmol) was added to a solution of methyl 2-methyl-5-((3-(trifluoromethyl)phenyl)carbamoyl)benzoate (0.858 g, 2.54 mmol) in THF (10 mL) and water (2 mL). The mixture was stirred at room temperature for 20 h. The layers were separated, and the aqueous phase was acidified to pH 6 with 6 M HCl (aq) and extracted with EtOAc. The combined organic phases were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford <b>9</b> (0.760 g, 92% yield) [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 324 (MH<sup>+</sup>)] as a light-purple solid. A solution of <b>9</b> (0.200 g, 0.619 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.125 g, 0.650 mmol), 1-hydroxy-7-azabenzotriazole (0.0842 g, 0.619 mmol), diisopropylethylamine (0.323 mL, 1.86 mmol), and <b>6b</b> (0.176 g, 0.619 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was stirred at room temperature for 20 h. The reaction mixture was concentrated and the residue was purified via column chromatography on silica gel (gradient elution with 0−100% 90:10:1, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH/NH<sub>4</sub>OH−CH<sub>2</sub>Cl<sub>2</sub>) to afford the title compound (0.332 g, 91% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.61 (s, 1H), 10.46 (s, 1H), 9.38 (s, 1H), 8.74 (s, 2H), 8.26 (s, 1H), 8.19 (d, <i>J</i> = 1.4 Hz, 1H), 8.10 (d, <i>J</i> = 8.1 Hz, 1H), 8.04 (dd, <i>J</i> = 8.0, 1.5 Hz, 1H), 7.62 (t, <i>J</i> = 8.2 Hz, 1H), 7.56 (d, <i>J</i> = 9.0 Hz, 2H), 7.52 (d, <i>J</i> = 8.1 Hz, 1H), 7.47 (d, <i>J</i> = 7.6 Hz, 1H), 6.89 (d, <i>J</i> = 9.0 Hz, 2H), 3.17 (d, <i>J</i> = 3.7 Hz, 3H), 3.09 - 3.01 (m, 4H), 2.48−2.42 (m, 4H), 2.22 (s, 3H). HRMS (C<sub>31</sub>H<sub>31</sub>F<sub>3</sub>N<sub>7</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 590.248 58; found, 590.249 96. Anal. (C<sub>31</sub>H<sub>30</sub>F<sub>3</sub>N<sub>7</sub>O<sub>2</sub>·CH<sub>3</sub>OH·H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-(2-Aminopyrimidin-5-yl)-2-methyl-5-nitrobenzamide (<b>12a</b>)</h3><div class="NLM_p last"><b>11</b> (0.66 g, 3.64 mmol) was heated to reflux in SOCl<sub>2</sub> (6 mL) for 1 h. After the mixture was cooled to room temperature and concentrated to dryness, the crude acid chloride was taken up in CH<sub>2</sub>Cl<sub>2</sub> (25 mL). <b>6a</b> (0.40 g, 3.64 mmol) was added to the solution, and the mixture was allowed to stir at room temperature overnight. The mixture became a thick white suspension. Triethylamine (0.700 mL, 4.73 mmol) was added. After 2 h, a thick white suspension remained. The mixture was filtered through a Buchner apparatus equipped with a micromembrane filter, washed with CH<sub>2</sub>Cl<sub>2</sub>, and dried on high vacuum to afford the title compound (962 mg, 97%) [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 273 (M<sup>+</sup>)] as an off-white solid, which was used without further purification.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-Methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)-5-nitrobenzamide (<b>12b</b>)</h3><div class="NLM_p last">To a mixture of <b>11</b> (46.0 g, 181 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 L) was added EDC (61.0 g, 318 mmol). The mixture was allowed to stir for 30 min at room temperature. <b>6b</b> (60 g, 211 mmol) was added, and the mixture was allowed to stir for 70 h. Water (2 L) was added. Then 2N NaOH was added until the pH was 14. The organics were extracted into EtOAc (4 L). The aqueous layer was extracted with additional EtOAc, and the combined organics were dried over anhydrous MgSO<sub>4</sub> and concentrated under reduced pressure. The residue was taken up in CH<sub>2</sub>Cl<sub>2</sub>. The solid formed was collected by suction filtration and washed twice with CH<sub>2</sub>Cl<sub>2</sub> (250 mL). The solid was dried under vacuum to obtain the title compound (47.6 g, 51%) as an orange amorphous solid, which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d<sub>6</sub></i>): δ 10.53 (s, 1H), 9.40 (s, 1H), 8.71 (s, 2H), 8.39 (s, 1H), 8.26–8.29 (m, 1H), 7.55–7.65 (m, 3H), 6.88–6.90 (m, 2H), 3.05–3.07 (m, 4H), 2.54 (s, 3H), 2.44–2.47 (m, 4H), 2.22 (s, 3H). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 448 (MH<sup>+</sup>).</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-(2-Amino-5-pyrimidinyl)-2-methyl-5-(((3-(trifluoromethyl)phenyl)carbonyl)amino)benzamide (<b>13a</b>)</h3><div class="NLM_p last">Reduction of <b>12a</b> according to the procedure described in the preparation of <b>23a</b> afforded 5-amino-<i>N</i>-(2-aminopyrimidin-5-yl)-2-methylbenzamide. The title compound was prepared from 5-amino-<i>N</i>-(2-aminopyrimidin-5-yl)-2-methylbenzamide (0.086 g, 0.353 mmol) and 3-(trifluoromethyl)benzoyl chloride (0.052 mL, 0.353 mmol) using the procedure described for the synthesis of <b>27</b>. Purification via column chromatography on silica gel (gradient elution with 0−100% 90:10:1, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH/NH<sub>4</sub>OH−CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound (0.060 g, 41% yield) as an off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.56 (s, 1H), 10.16 (s, 1H), 8.52 (s, 2H), 8.33 (s, 1H), 8.28 (d, <i>J</i> = 7.5 Hz, 1H), 7.99 (d, <i>J</i> = 6.6 Hz, 1H), 7.99 (d, <i>J</i> = 2.2 Hz, 1H), 7.85 - 7.77 (m, 2H), 7.32 (d, <i>J</i> = 8.5 Hz, 1H), 6.55 (s, 2H), 2.37 (s, 3H). HRMS (C<sub>20</sub>H<sub>17</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 416.132 89; found, 416.133 27.</div></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 2-Methyl-<i>N</i>-(2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)-5-(((3-(trifluoromethyl)phenyl)carbonyl)amino)benzamide (<b>13b</b>)</h3><div class="NLM_p last">Reduction of <b>12a</b> in a manner analogous to the method described for the reduction of <b>12a</b> in the preparation of <b>23a</b> afforded amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide. The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (0.113 g, 0.271 mmol) and 3-(trifluoromethyl)benzoyl chloride (0.044 mL, 0.298 mmol) using the procedure described for the synthesis of <b>27</b>. Trituration with CH<sub>2</sub>Cl<sub>2</sub>, filtration, washing with CH<sub>2</sub>Cl<sub>2</sub>, and drying on high vacuum overnight afforded the title compound (0.093 g, 58%) as a light-yellow amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.58 (s, 1H), 10.35 (s, 1H), 9.37 (s, 1H), 8.73 (s, 2H), 8.33 (s, 1H), 8.29 (d, <i>J</i> = 7.9 Hz, 1H), 7.99 (d, <i>J</i> = 6.9 Hz, 1H), 7.93 (d, <i>J</i> = 2.1 Hz, 1H), 7.85 (dd, <i>J</i> = 2.4, 8.2 Hz, 1H), 7.81 (t, <i>J</i> = 7.8 Hz, 1H), 7.56 (d, <i>J</i> = 9.2 Hz, 2H), 7.33 (d, <i>J</i> = 8.7 Hz, 1H), 6.89 (d, <i>J</i> = 9.2 Hz, 2H), 3.06 (m, 4H), 2.47 (m, 4H), 2.39 (s, 3H), 2.23 (s, 3H). HRMS (C<sub>31</sub>H<sub>31</sub>F<sub>3</sub>N<sub>7</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 590.248 58; found, 590.248 12.</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 2-Methyl-<i>N</i>-(2-((3-(4-morpholinyl)propyl)amino)-5-pyrimidinyl)-5-(((3-(trifluoromethyl)phenyl)carbonyl)amino)benzamide (<b>13c</b>)</h3><div class="NLM_p last"><b>4</b> (0.500 g, 3.13 mmol), 3-morpholinopropan-1-amine (1.35 g, 9.39 mmol), and <i>N,N</i>-diisopropylethylamine (3.4 mL, 4.7 mmol) were taken up in IPA (20 mL) in a resealable Pyrex tube and heated at 70 °C for 20 h. After the mixture was cooled to room temperature, the product precipitated out of solution and was collected by filtration through a Buchner equipped with a micromembrane filter, washed with CH<sub>3</sub>OH, and dried to afford <b>5c</b> [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 268 (MH<sup>+</sup>)] as a pale-yellow solid, which was used without further purification. Reduction of <b>5c</b> in a manner analogous to the method described for the reduction of <b>12a</b> in the preparation of <b>23a</b> afforded <b>6c</b> [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 270 (M<sup>+</sup>)] as a thick rust-colored oil, which was used without purification. The title compound was prepared from <b>6c</b> (0.074 g, 0.20 mmol) and 3-(trifluoromethyl)benzoyl chloride (0.030 mL, 0.20 mmol) using the procedure described for the synthesis of <b>27</b>. Trituration with CH<sub>2</sub>Cl<sub>2</sub>, filtration, washing with CH<sub>2</sub>Cl<sub>2</sub>, and drying under high vacuum overnight afforded the title compound (0.062 g, 58%) as a light-yellow amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.56 (s, 1H), 10.15 (s, 1H), 8.54 (s, 2H), 8.32 (s, 1H), 8.28 (d, <i>J</i> = 7.2 Hz, 1H), 7.99 (d, <i>J</i> = 8.2 Hz, 1H), 7.89 (s, 1H), 7.85−7.79 (m, 2H), 7.31 (d, <i>J</i> = 8.6 Hz, 1H), 7.13 (m, 1H), 3.57 (m, 4H), 3.31−3.26 (m, 2H), 2.36 (s, 3H), 2.35−2.30 (m, 6H), 1.68 (m, 2H). HRMS (C<sub>27</sub>H<sub>30</sub>F<sub>3</sub>N<sub>6</sub>O<sub>3</sub>)<sup>+</sup>: calcd, 543.232 60; found, 543.235 18.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 2-Methyl-<i>N</i>-(2-((1-methyl-4-piperidinyl)amino)-5-pyrimidinyl)-5-(((3-(trifluoromethyl)phenyl)carbonyl)amino)benzamide (<b>13d</b>)</h3><div class="NLM_p last">1-Methylpiperidin-4-amine (0.358 g, 3.13 mmol) and NaH (60% dispersion in mineral oil) (0.126 g, 3.13 mmol) were taken up in THF (16 mL) under an atmosphere of dry N<sub>2</sub>. After the mixture was stirred at room temperature for 10 min, <b>4</b> (0.500 g, 3.13 mmol) was added. The mixture was allowed to stir at room temperature for 1 h, then quenched with 1 N HCl, extracted with CH<sub>2</sub>Cl<sub>2</sub>, and concentrated to afford <b>5d</b> [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 239 (M<sup>+</sup>)] as a tan amorphous solid, which was used without further purification. Reduction of <b>5d</b> in a manner analogous to the method described for the reduction of <b>12a</b> in the preparation of <b>23a</b> afforded <b>6d</b> [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 285 (MH<sup>+</sup>)] as a tan solid, which was without further purification. The title compound was prepared from <b>6d</b> (0.063 g, 0.185 mmol) and 3-(trifluoromethyl)benzoyl chloride (0.027 mL, 0.185 mmol) using the procedure described for the synthesis of <b>27</b>. Trituration with CH<sub>2</sub>Cl<sub>2</sub>, filtration, washing with CH<sub>2</sub>Cl<sub>2</sub>, and drying under high vacuum overnight afforded the title compound as an off-white amorphous solid (0.065 g, 68%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.58 (s, 1H), 10.22 (s, 1H), 8.59 (s, 2H), 8.32 (s, 1H), 8.29 (d, <i>J</i> = 8.8 Hz, 1H), 7.99 (d, <i>J</i> = 8.2 Hz, 1H), 7.93 (d, <i>J</i> = 2.3 Hz, 1H), 7.83−7.79 (m, 2H), 7.33−7.30 (m, 2H), 3.88 (br s, 1H), 3.40 (br s, 2H), 3.03 (br s, 2H), 2.73 (br s, 3H), 2.36 (s, 3H), 2.06 (br s, 2H), 1.69 (br s, 2H). HRMS (C<sub>26</sub>H<sub>28</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 513.222 04; found, 513.223 82.</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 2-Methyl-<i>N</i>-(2-((2-(4-morpholinyl)ethyl)amino)-5-pyrimidinyl)-5-(((3-(trifluoromethyl)phenyl)carbonyl)amino)benzamide (<b>13e</b>)</h3><div class="NLM_p last"><b>12a</b> (0.200 g, 0.732 mmol), CuI (0.140 g, 0.732 mmol), and CH<sub>2</sub>I<sub>2</sub> (0.30 mL, 3.73 mmol) were taken up in THF (3.7 mL) in a 16 mm × 100 mm resealable Pyrex tube. The tube was sealed, and the mixture was heated at 70 °C for 2 h. After cooling to room temperature, the crude reaction mixture was taken up in 1:1 EtOAc/1 N HCl, and the layers were separated. The organics were washed with saturated aqueous NH<sub>4</sub>Cl and then dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified via column chromatography on silica gel (elution with 100% EtOAc) to afford <b>24</b> (0.060 g, 21% yield) [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 385 (MH<sup>+</sup>)] as a light-yellow solid. <b>24</b> (0.060 g, 0.156 mmol), 2-morpholinoethanamine (0.200 g, 1.5 mmol), and <i>N,N</i>-diisopropylethylamine (0.041 mL, 0.234 mmol) were taken up in IPA (2.5 mL) in a 16 mm × 100 mm resealable Pyrex tube and heated at 70 °C for 4 h. The mixture was concentrated and purified by preparative thin layer chromatography on silica gel (elution with 2.5% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) to afford 2-methyl-<i>N</i>-(2-(2-morpholinoethylamino)pyrimidin-5-yl)-5-nitrobenzamide (0.060 g, 100%) [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 387 (M<sup>+</sup>)] as yellow amorphous solid. Reduction of 2-methyl-<i>N</i>-(2-(2-morpholinoethylamino)pyrimidin-5-yl)-5-nitrobenzamide in a manner analogous to the method described for the reduction of <b>12a</b> in the preparation of <b>23a</b> afforded 5-amino-2-methyl-<i>N</i>-(2-(2-morpholinoethylamino)pyrimidin-5-yl)benzamide [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 357 (M<sup>+</sup>)] as a light-yellow foam, which was used without further purification. The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(2-(2-morpholinoethylamino)pyrimidin-5-yl)benzamide (0.060 g, 0.168 mmol) and 3-(trifluoromethyl)benzoyl chloride (0.025 mL, 0.168 mmol) using the procedure described for the synthesis of <b>27</b>. Preparative thin layer chromatography on silica gel (elution with 5% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound (0.056 g, 63%) as a light-yellow amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.58 (s, 1H), 10.17 (s, 1H), 8.55 (s, 2H), 8.33 (s, 1H), 8.29 (d, <i>J</i> = 8.1 Hz, 1H), 7.99 (d, <i>J</i> = 7.8 Hz, 1H), 7.90 (d, <i>J</i> = 2.0 Hz, 1H), 7.85−7.79 (m, 2H), 7.32 (d, <i>J</i> = 8.3 Hz, 1H), 6.93 (t, <i>J</i> = 5.8 Hz, 1H), 3.58 (m, 4H), 3.42−3.37 (m, 2H), 2.49−2.45 (m, 2H), 2.41 (m, 4H), 2.37 (s, 3H). HRMS (C<sub>26</sub>H<sub>28</sub>F<sub>3</sub>N<sub>6</sub>O<sub>3</sub>)<sup>+</sup>: calcd, 529.216 95; found, 529.220 00. Anal. (C<sub>26</sub>H<sub>27</sub>F<sub>3</sub>N<sub>6</sub>O<sub>3</sub>·2CH<sub>3</sub>OH) H, C. N: calcd, 13.37; found, 14.28.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 5-(Acetylamino)-2-methyl-<i>N</i>-(2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)benzamide (<b>14</b>)</h3><div class="NLM_p last">The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (0.100 g, 0.24 mmol) and acetyl chloride (0.019 mL, 0.26 mmol) using the procedure described for the synthesis of <b>27</b>. Trituration with CH<sub>2</sub>Cl<sub>2</sub>, filtration, washing with CH<sub>2</sub>Cl<sub>2</sub>, and drying under high vacuum overnight afforded the title compound (0.108 g, 96%) as an off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.32 (s, 1H), 10.07 (s, 1H), 9.45 (s, 1H), 8.73 (s, 2H), 7.75 (d, <i>J</i> = 1.6 Hz, 1H), 7.62 (d, <i>J</i> = 8.9 Hz, 2H), 7.56 (dd, <i>J</i> = 1.8, 8.1 Hz, 1H), 7.23 (d, <i>J</i> = 8.2 Hz, 1H), 6.96 (d, <i>J</i> = 8.8 Hz, 2H), 3.85−3.39 (br m, 4H), 3.25−2.91 (br m, 4H), 2.81 (br s, 3H), 2.33 (s, 3H), 2.05 (s, 3H). HRMS (C<sub>25</sub>H<sub>30</sub>N<sub>7</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 460.245 55; found, 460.244 07. Anal. (C<sub>25</sub>H<sub>29</sub>N<sub>7</sub>O<sub>2</sub>·3H<sub>2</sub>O) C, H, N.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5-Methyl-<i>N</i>-(4-methyl-3-((2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)carbamoyl)phenyl)isoxazole-4-carboxamide (<b>15</b>)</h3><div class="NLM_p last">The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (0.100 g, 0.24 mmol) and 5-methylisoxazole-4-carbonyl chloride (0.038 g, 0.26 mmol) using the procedure described for the synthesis of <b>27</b>. Trituration with CH<sub>2</sub>Cl<sub>2</sub>, filtration, washing with CH<sub>2</sub>Cl<sub>2</sub>, and drying under high vacuum overnight afforded the title compound (0.112 g, 86% yield) as an off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.35 (s, 1H), 10.16 (s, 1H), 9.45 (s, 1H), 9.10 (s, 1H), 8.74 (s, 2H), 7.88 (d, <i>J</i> = 2.4 Hz, 1H), 7.71 (dd, <i>J</i> = 2.0, 8.5 Hz, 1H), 7.62 (d, <i>J</i> = 9.2 Hz, 2H), 7.31 (d, <i>J</i> = 8.2 Hz, 1H), 7.96 (d, <i>J</i> = 8.5 Hz, 2H), 2.70 (s, 3H), 2.37 (s, 3H). HRMS (C<sub>28</sub>H<sub>31</sub>N<sub>8</sub>O<sub>3</sub>)<sup>+</sup>: calcd, 527.251 36; found, 527.251 78.</div></div><div id="sec3_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-Methyl-<i>N</i>-(2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)-5-((phenylcarbonyl)amino)benzamide (<b>16</b>)</h3><div class="NLM_p last">The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (0.080 g, 0.19 mmol) and benzoyl chloride (0.022 mL, 0.19 mmol) using the procedure described for the synthesis of <b>27</b>. Trituration with CH<sub>2</sub>Cl<sub>2</sub>, filtration, washing with CH<sub>2</sub>Cl<sub>2</sub>, and drying under high vacuum overnight afforded the title compound (0.053 g, 53% yield) as a light-yellow amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.37 (s, 1H), 10.34 (s, 1H), 9.37 (s, 1H), 8.73 (s, 2H), 7.98 (m, 3H), 7.63−7.53 (m, 6H), 7.31 (d, <i>J</i> = 8.3 Hz, 1H), 6.89 (d, <i>J</i> = 9.2 Hz, 2H), 3.05 (m, 4H), 2.45 (m, 4H), 2.37 (s, 3H), 2.22 (s, 3H). HRMS (C<sub>30</sub>H<sub>32</sub>N<sub>7</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 522.261 20; found, 522.260 61. Anal. (C<sub>30</sub>H<sub>31</sub>N<sub>7</sub>O<sub>2</sub>·1.5CH<sub>3</sub>OH·0.5 CH<sub>3</sub>CN) C, H, N.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-Methyl-5-(((2-(methyloxy)phenyl)carbonyl)amino)-<i>N</i>-(2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)benzamide (<b>17</b>)</h3><div class="NLM_p last">The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (0.100 g, 0.24 mmol) and 2-methoxybenzoyl chloride (0.037 mL, 0.24 mmol) using the procedure described for the synthesis of <b>27</b>. Purification via column chromatography on silica gel (gradient elution with 0−20% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound (0.092 g, 70% yield) as a yellow amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.34 (s, 1H), 10.22 (s, 1H), 9.36 (s, 1H), 8.73 (s, 2H), 7.92 (s, 1H), 7.75 (d, <i>J</i> = 8.3 Hz, 1H), 7.64 (d, <i>J</i> = 7.6 Hz, 1H), 7.57−7.50 (m, 3H), 7.28 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (d, <i>J</i> = 8.3 Hz, 1H), 7.08 (t, <i>J</i> = 7.5 Hz, 1H), 6.89 (d, <i>J</i> = 8.8 Hz, 2H), 3.91 (s, 3H), 3.05 (m, 4H), 2.46 (m, 4H), 2.36 (s, 3H), 2.22 (s, 3H). HRMS (C<sub>31</sub>H<sub>34</sub>N<sub>7</sub>O<sub>3</sub>)<sup>+</sup>: calcd, 552.271 76; found, 552.271 44. Anal. (C<sub>31</sub>H<sub>34</sub>N<sub>7</sub>O<sub>3</sub>) H, N. C: calcd, 67.5; found, 66.7.</div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-(((3-Fluoro-5-(trifluoromethyl)phenyl)carbonyl)amino)-2-methyl-<i>N</i>-(2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)benzamide (<b>18</b>)</h3><div class="NLM_p last">The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (0.100 g, 0.24 mmol) and 3-fluoro-5-(trifluoromethyl)benzoyl chloride (0.040 mL, 0.26 mmol) using the procedure described for the synthesis of <b>27</b>. Trituration with CH<sub>2</sub>Cl<sub>2</sub>, filtration, washing with CH<sub>2</sub>Cl<sub>2</sub>, and drying under high vacuum overnight afforded the title compound (0.065 g, 44% yield) as a light-yellow amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.72 (s, 1H), 10.35 (s, 1H), 9.37 (s, 1H), 8.72 (s, 2H), 8.07 (m, 1H), 8.01 (m, 1H), 7.85 (s, 1H), 7.74 (dd, <i>J</i> = 1.8, 8.6 Hz, 1H), 7.64 (t, <i>J</i> = 8.9 Hz, 1H), 7.56 (d, <i>J</i> = 8.9 Hz, 2H), 7.33 (d, <i>J</i> = 8.5 Hz, 1H), 6.89 (d, <i>J</i> = 9.1 Hz, 2H), 3.05 (m, 4H), 2.46 (m, 4H), 2.38 (s, 3H), 2.22 (s, 3H). HRMS (C<sub>31</sub>H<sub>30</sub>F<sub>4</sub>N<sub>7</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 608.239 16; found, 608.238 31. Anal. (C<sub>31</sub>H<sub>29</sub>F<sub>4</sub>N<sub>7</sub>O<sub>2</sub>) C, N. H: calcd, 4.81; found, 5.23.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-Methyl-<i>N</i>-(4-methyl-3-(((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)amino)carbonyl)phenyl)-3-(trifluoromethyl)benzamide (<b>19</b>)</h3><div class="NLM_p last">The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (0.080 g, 0.191 mmol) and 2-methyl-3-(trifluoromethyl)benzoyl chloride (0.047 g, 0.210 mmol) using the procedure described for the synthesis of <b>27</b>. Trituration with CH<sub>2</sub>Cl<sub>2</sub>, filtration, washing with CH<sub>2</sub>Cl<sub>2</sub>, and drying under high vacuum overnight afforded the title compound (0.068 g, 59%) as an off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.62 (s, 1H), 10.34 (s, 1H), 9.36 (s, 1H), 8.71 (s, 2H), 7.90 (d, <i>J</i> = 1.9 Hz, 1H), 7.83 (d, <i>J</i> = 7.7 Hz, 1H), 7.71 (t, <i>J</i> = 7.3 Hz, 2H), 7.56−7.52 (m, 3H), 7.31 (d, <i>J</i> = 8.5 Hz, 1H), 6.88 (d, <i>J</i> = 8.8 Hz, 2H), 3.05 (m, 4H), 2.46 (m, 7H), 2.36 (s, 3H), 2.22 (s, 3H). HRMS (C<sub>32</sub>H<sub>33</sub>F<sub>3</sub>N<sub>7</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 604.264 68; found, 604.264 68.</div></div><div id="sec3_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2,2-Difluoro-<i>N</i>-(4-methyl-3-(((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)amino)carbonyl)phenyl)-1,3-benzodioxole-5-carboxamide (<b>20</b>)</h3><div class="NLM_p last">The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (0.080 g, 0.191 mmol) and 2,2-difluorobenzo[<i>d</i>][1,3]dioxole-5-carbonyl chloride (0.046 g, 0.210 mmol) using the procedure described for the synthesis of <b>27</b>. Purification via column chromatography on silica gel (gradient elution with 0−100% 90:10:1, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH/NH<sub>4</sub>OH−CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound (0.069 g, 60% yield) as a light-yellow amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.40 (s, 1H), 10.34 (s, 1H), 9.37 (s, 1H), 8.72 (s, 2H), 7.99 (s, 1H), 7.92 - 7.89 (m, 2H), 7.79 (dd, <i>J</i> = 1.6, 8.3 Hz, 1H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.56 (d, <i>J</i> = 8.8 Hz, 2H), 731 (d, <i>J</i> = 8.3 Hz, 1H), 6.89 (d, <i>J</i> = 8.8 Hz, 2H), 3.08 (m, 4H), 2.55 (m, 4H), 2.37 (s, 3H), 2.29 (s, 3H). HRMS (C<sub>31</sub>H<sub>30</sub>F<sub>2</sub>N<sub>7</sub>O<sub>4</sub>)<sup>+</sup>: calcd, 602.232 19; found, 602.232 34.</div></div><div id="sec3_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-(((4-(1,1-Dimethylethyl)phenyl)carbonyl)amino)-2-methyl-<i>N</i>-(2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)benzamide (<b>21</b>)</h3><div class="NLM_p last">The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (0.080 g, 0.191 mmol) and 4-<i>tert</i>-butylbenzoyl chloride (0.042 mL, 0.210 mmol) using the procedure described for the synthesis of <b>27</b>. Trituration with CH<sub>2</sub>Cl<sub>2</sub>, filtration, washing with CH<sub>2</sub>Cl<sub>2</sub>, and drying under high vacuum overnight afforded the title compound (0.058 g, 53%) as a white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.33 (s, 1H), 10.28 (s, 1H), 9.36 (s, 1H), 8.72 (s, 2H), 7.95 (d, <i>J</i> = 1.8 Hz, 1H), 7.91 (d, <i>J</i> = 8.5 Hz, 2H), 7.81 (dd, <i>J</i> = 2.0, 8.6 Hz, 1H), 7.56 (d, <i>J</i> = 8.5 Hz, 4H), 7.29 (d, <i>J</i> = 8.5 Hz, 1H), 6.89 (d, <i>J</i> = 9.0 Hz, 2H), 3.05 (m, 4H), 2.47 (m, 4H), 2.36 (s, 3H), 2.23 (s, 3H), 1.32 (s, 9H). HRMS (C<sub>34</sub>H<sub>40</sub>N<sub>7</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 578.323 80; found, 578.324 08.</div></div><div id="sec3_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-(((3,5-Bis(methyloxy)phenyl)carbonyl)amino)-2-methyl-<i>N</i>-(2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)benzamide (<b>22</b>)</h3><div class="NLM_p last">The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (0.080 g, 0.191 mmol) and 3,5-dimethoxybenzoyl chloride (0.042 g, 0.210 mmol) using the procedure described for the synthesis of <b>27</b>. Trituration with CH<sub>2</sub>Cl<sub>2</sub>, filtration, washing with CH<sub>2</sub>Cl<sub>2</sub>, and drying under high vacuum overnight afforded the title compound (0.030 g, 27%) as an off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.32 (s, 1H), 10.28 (s, 1H), 9.36 (s, 1H), 8.72 (s, 2H), 7.92 (d, <i>J</i> = 1.9 Hz, 1H), 7.82 (dd, <i>J</i> = 2.0, 8.5 Hz, 1H), 7.55 (d, <i>J</i> = 8.8 Hz, 2H), 7.30 (d, <i>J</i> = 8.1 Hz, 1H), 7.12 (d, <i>J</i> = 2.2 Hz, 2H), 6.88 (d, <i>J</i> = 9.2, 2H), 6.72 (t, <i>J</i> = 2.0 Hz, 1H), 3.82 (s, 6H), 3.05 (m, 4H), 2.46 (m, 4H), 2.37 (s, 3H), 2.22 (s, 3H). HRMS (C<sub>32</sub>H<sub>36</sub>N<sub>7</sub>O<sub>4</sub>)<sup>+</sup>: calcd, 582.282 33; found, 582.282 62.</div></div><div id="sec3_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(2-Amino-5-pyrimidinyl)-2-methyl-5-((((3-(trifluoromethyl)phenyl)amino)carbonyl)amino)benzamide (<b>23a</b>)</h3><div class="NLM_p last"><b>12a</b> (0.300 g, 1.1 mmol) and 10% Pd/C (∼0.150 g) were combined in EtOAc (24 mL) and CH<sub>3</sub>OH (6 mL). The mixture was purged with H<sub>2</sub>, then allowed to stir under 1 atm of H<sub>2</sub> for 24 h. The mixture was filtered through a pad of Celite, and washing with CH<sub>3</sub>OH and CH<sub>2</sub>Cl<sub>2</sub> and drying afforded 5-amino-<i>N</i>-(2-aminopyrimidin-5-yl)-2-methylbenzamide [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 244 (MH<sup>+</sup>)] as a pale-yellow amorphous solid, which was used without purification. 5-Amino-<i>N</i>-(2-aminopyrimidin-5-yl)-2-methylbenzamide (0.108 g, 0.444 mmol) was taken up in benzene (8 mL), and 1-isocyanato-3-(trifluoromethyl)benzene (0.062 mL, 0.444 mmol) was added. The mixture was allowed to stir at room temperature overnight. The reaction mixture was concentrated and the residue was purified via column chromatography on silica gel (gradient elution with 0−5% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) to afford the title compound (0.040 g, 20% yield) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.11 (s, 1H), 9.09 (s, 1H), 8.89 (s, 1H), 8.52 (s, 2H), 8.03 (s, 1H), 7.62 (d, <i>J</i> = 1.9 Hz, 1H), 7.58 (d, <i>J</i> = 7.8 Hz, 1H), 7.52 (t, <i>J</i> = 7.8 Hz, 1H), 7.45 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 7.32 (d, <i>J</i> = 7.3 Hz, 1H), 7.22 (d, <i>J</i> = 8.2 Hz, 1H), 6.54 (s, 2H), 2.32 (s, 3H). HRMS (C<sub>20</sub>H<sub>18</sub>F<sub>3</sub>N<sub>6</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 431.143 78; found, 431.143 01.</div></div><div id="sec3_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 2-Methyl-<i>N</i>-(2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)-5-((((3-(trifluoromethyl)phenyl)amino)carbonyl)amino)benzamide (<b>23b</b>)</h3><div class="NLM_p last">In a 2 L stainless steel pressure vessel with overhead stirring was charged a mixture of <b>12b</b> (25 g, 55.9 mmol), EtOH (300 mL), EtOAc (200 mL), and Pd/C (15 g, 10% by weight wet). The reactor was charged with 65 psi of H<sub>2</sub> for 72 h. The catalyst was removed by suction filtration and washed with EtOH. The organics were concentrated under reduced pressure and dried under vacuum to obtain 5-amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 418 (MH<sup>+</sup>)], which was used without purification. The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (0.071 g, 0.170 mmol) and 1-isocyanato-3-(trifluoromethyl)benzene (0.026 mL, 0.187 mmol) using the procedure described for the synthesis of <b>23a</b>. Purification via column chromatography on silica gel (gradient elution with 0−100% 90:10:1, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH/NH<sub>4</sub>OH−CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound as a light-yellow solid (0.047 g, 46%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.29 (s, 1H), 9.35 (s, 1H), 9.08 (s, 1H), 8.89 (s, 1H), 8.71 (s, 2H), 8.03 (s, 1H), 7.64 (s, 1H), 7.58−7.44 (m, 5H), 7.31 (d, <i>J</i> = 7.6 Hz, 1H), 7.23 (d, <i>J</i> = 8.3 Hz, 1H), 6.89 (d, <i>J</i> = 8.7 Hz, 2H), 3.05 (br s, 4H), 2.46 (br s, 4H), 2.33 (s, 3H), 2.22 (s, 3H). HRMS (C<sub>31</sub>H<sub>32</sub>F<sub>3</sub>N<sub>8</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 605.259 48; found, 605.260 56.</div></div><div id="sec3_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 2,6-Dichloro-<i>N</i>-(2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)benzamide (<b>27</b>)</h3><div class="NLM_p last">2,6-Dichlorobenzoyl chloride (0.061 mL, 0.43 mmol) was added to a suspension of <i>N</i>2-(4-(4-methylpiperazin-1-yl)phenyl)pyrimidine-2,5-diamine (0.11 g, 0.39 mmol) and CH<sub>2</sub>Cl<sub>2</sub> (2 mL). The solution was stirred at room temperature for 10 min, and then triethylamine (0.070 mL, 0.50 mmol) was added. The suspension was stirred at room temperature overnight. The reaction mixture was filtered through a Buchner apparatus equipped with a micromembrane filter, washed with CH<sub>2</sub>Cl<sub>2</sub>, and dried under vacuum overnight to afford the title compound (0.141 g, 79%) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.78 (s, 1H), 9.44 (s, 1H), 8.68 (s, 2H), 7.93−7.51 (m, 5H), 6.89 (d, <i>J</i> = 8.8 Hz, 2H), 3.06 (m, 4H), 2.45 (m, 4H), 2.22 (s, 3H). HRMS (C<sub>22</sub>H<sub>23</sub>C<sub>l2</sub>N<sub>6</sub>O)<sup>+</sup>: calcd, 457.130 49; found, 457.130 83. Anal. (C<sub>22</sub>H<sub>22</sub>C<sub>l2</sub>N<sub>6</sub>O) C, H, N.</div></div><div id="sec3_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 2,6-Dimethyl-<i>N</i>-(2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)-3-(((3-(trifluoromethyl)phenyl)carbonyl)amino)benzamide (<b>29</b>)</h3><div class="NLM_p last"><b>28</b> was prepared from <b>26</b> (0.300 g, 1.5 mmol) and <b>6b</b> (0.48 g, 1.7 mmol) using the procedure described for the synthesis of <b>12a</b>. Purification via column chromatography on silica gel (gradient elution with 3−10% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) afforded <b>28</b> (0.73 g, 90%) [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 462 (MH<sup>+</sup>)] as a yellow solid. Reduction of <b>28</b> in a manner analogous to the method described for the reduction of <b>12a</b> in the preparation of <b>23a</b> afforded crude 3-aniline, which was purified via preparative reverse-phase HPLC (eluting with 10–90% (0.1% trifluoroacetic acid in CH<sub>3</sub>CN)−water over 15 min). Clean fractions were combined and partitioned between CH<sub>2</sub>Cl<sub>2</sub> and saturated aqueous NaHCO<sub>3</sub>. The aqueous phase was separated and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic phases were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford 3-amino-2,6-dimethyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (0.550 g, 80%) [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 432.1 (MH<sup>+</sup>)] as a light-yellow solid. The title compound was prepared from 3-amino-2,6-dimethyl-<i>N</i>-(2-(4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-5-yl)benzamide (80 mg, 0.2 mmol) and 3-(trifluoromethyl)benzoyl chloride (0.04 mL, 0.2 mmol) using the procedure described for the synthesis of <b>27</b> and purified via preparative reverse-phase HPLC (eluting with 10–90% (0.1% trifluoroacetic acid in CH<sub>3</sub>CN)−water over 15 min). Clean fractions were combined and partitioned between CH<sub>2</sub>Cl<sub>2</sub> and saturated aqueous NaHCO<sub>3</sub>. The aqueous phase was separated and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic phases were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford the title compound (0.023 g, 20%) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.55 (s, 1H), 10.29 (s, 1H), 9.44 (s, 1H), 8.78 (s, 2H), 8.37 (m, 2H), 8.05 (d, <i>J</i> = 8.8 Hz, 1H), 7.86 (t, <i>J</i> = 7.8 Hz, 1H), 7.62 (d, <i>J</i> = 8.8 Hz, 2H), 7.37 (d, <i>J</i> = 8.2 Hz, 1H), 7.24 (d, <i>J</i> = 8.1 Hz, 1H), 6.94 (d, <i>J</i> = 9.0 Hz, 2H), 3.12 (m, 4H), 2.53 (m, 4H), 2.38 (s, 3H), 2.29 (s, 3H), 2.26 (s, 3H). HRMS (C<sub>32</sub>H<sub>33</sub>F<sub>3</sub>N<sub>7</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 604.264 23; found, 604.265 65.</div></div><div id="sec3_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>-(4-Chloro-3-(((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)amino)carbonyl)phenyl)-2,2-difluoro-1,3-benzodioxole-5-carboxamide (<b>32</b>)</h3><div class="NLM_p last"><b>30</b> (0.150 g, 0.874 mmol) was added to a solution of 2,2-difluoro-1,3-benzodioxole-5-carbonyl chloride (0.202 g, 0.918 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (9.0 mL). The mixture was stirred at room temperature for 2.5 h to afford a white suspension, and triethylamine (0.16 mL, 1.14 mmol) was added. The resulting yellow solution was stirred at room temperature for 16 h. The reaction mixture was concentrated to afford an off-white solid. This solid was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and water. The aqueous phase was separated and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic phases were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford <b>31</b> (0.193 g, 62%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.43 (s, 1H), 8.01 (d, <i>J</i> = 1.4 Hz, 1H), 7.97 (s, 1H), 7.90 (dd, <i>J</i> = 8.3, 1.4 Hz, 1H), 7.77−7.84 (m, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 1H), 7.36 (d, <i>J</i> = 8.5 Hz, 1H). MS (ESI, positive ion) <i>m</i>/<i>z</i>: 355.9 (MH<sup>+</sup>). A resealable tube was charged with <b>6b</b> (0.100 g, 0.35 mmol), <b>31</b> (0.16 g, 0.46 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (0.10 g, 0.53 mmol), 1-hydroxy-7-azabenzotriazole (0.048 g, 0.35 mmol), and DMF (2.5 mL). <i>N</i>,<i>N</i>-Diisopropylethylamine (0.214 mL, 1.2 mmol) was added, and the system was flushed with argon. The tube was sealed and the mixture stirred at room temperature for 17 h. The reaction mixture was concentrated to afford an orange-brown oil. This oil was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and water, and saturated aqueous NaHCO<sub>3</sub> was added. The aqueous layer was separated and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic phases were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford an orange-brown oil. This material was purified via column chromatography on silica gel (gradient elution with 0−100% 90:10:1, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH/NH<sub>4</sub>OH−CH<sub>2</sub>Cl<sub>2</sub>) to afford an orange solid. This material was dissolved in 1:1 (DMSO/CH<sub>3</sub>OH) and further purified via preparative reverse-phase HPLC (eluting with 10−90% (0.1% trifluoroacetic acid in CH<sub>3</sub>CN−water over 15 min). Clean fractions were combined and partitioned between EtOAc and saturated aqueous NaHCO<sub>3</sub>. The aqueous phase was separated and extracted with EtOAc. The combined organic phases were washed with brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford the title compound (0.092 g, 42%) as a yellow solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 622 (MH<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.56 (s, 2H), 9.40 (s, 1H), 8.70 (s, 2H), 8.02 (d, <i>J</i> = 12.8 Hz, 2H), 7.90 (d, <i>J</i> = 8.6 Hz, 2H), 7.45−7.72 (m, 4H), 6.88 (d, <i>J</i> = 8.5 Hz, 2H), 3.05 (s, 4H), 2.41−2.48 (m, 4H), 2.22 (s, 3H). HRMS (C<sub>30</sub>H<sub>27</sub>ClF<sub>2</sub>N<sub>7</sub>O<sub>4</sub>)<sup>+</sup>: calcd, 622.177 56; found, 622.176 69.</div></div><div id="sec3_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-(4-Ethyl-3-(((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-pyrimidinyl)amino)carbonyl)phenyl)-2,2-difluoro-1,3-benzodioxole-5-carboxamide (<b>33</b>)</h3><div class="NLM_p last">A resealable tube was charged with <b>32</b> (0.050 g, 0.080 mmol), palladium(II) acetate (0.0018 g, 0.0080 mmol), S-Phos (0.0066 g, 0.016 mmol), potassium phosphate (0.068 g, 0.32 mmol), and THF (1.0 mL). A solution of triethylborane (1 M in THF, 0.12 mL, 0.12 mmol) was added, and the system was flushed with argon. The tube was sealed and the mixture stirred at 60 °C for 18 h. The THF was removed in vacuo, and DMF (2.0 mL) was added. Palladium(II) acetate (0.0018 g, 0.0080 mmol), S-Phos (0.0066 g, 0.016 mmol), potassium phosphate (0.068 g, 0.32 mmol), and triethylborane (0.12 mL, 0.12 mmol) were added, the system was evacuated and purged with argon, and the tube was sealed. The mixture stirred at 100 °C for 6 h. The reaction mixture was filtered through a pad of Celite and concentrated to afford a yellow-green solid. This material was purified via preparative thin layer chromatography TLC (eluting three times with 95:5:0.5, CH<sub>2</sub>Cl<sub>2</sub>/CH<sub>3</sub>OH/NH<sub>4</sub>OH-CH<sub>2</sub>Cl<sub>2</sub>) to afford the title compound (0.010 g, 0.016 mmol, 20%) as an off-white solid. MS (ESI, positive ion) <i>m</i>/<i>z</i>: 616 (MH<sup>+</sup>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.42 (s, 1H), 10.37 (s, 1H), 9.36 (s, 1H), 8.71 (s, 2H), 7.99 (s, 1H), 7.87−7.94 (m, 2H), 7.82 (d, <i>J</i> = 9.3 Hz, 1H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.55 (d, <i>J</i> = 8.2 Hz, 2H), 7.35 (d, <i>J</i> = 8.0 Hz, 1H), 6.88 (d, <i>J</i> = 8.5 Hz, 2H), 3.06 (s, 4H), 2.67−2.78 (m, 2H), 2.42−2.50 (m, 4H), 2.24 (s, 3H), 1.17 (t, <i>J</i> = 7.4 Hz, 3H). HRMS (C<sub>32</sub>H<sub>32</sub>F<sub>2</sub>N<sub>7</sub>O<sub>4</sub>)<sup>+</sup>: calcd, 616.247 84; found, 616.248 29.</div></div><div id="sec3_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 2-Methyl-<i>N</i>-(5-pyrimidinyl)-5-(((3-(trifluoromethyl)phenyl)carbonyl)amino)benzamide (<b>37</b>)</h3><div class="NLM_p last">5-Amino-2-methyl-5-nitro-<i>N</i>-(pyrimidin-5-yl)benzamide was prepared from <b>26</b> and pyrimidin-5-amine according to the procedure used for the synthesis of <b>12b</b>. Reduction of 5-amino-2-methyl-5-nitro-<i>N</i>-(pyrimidin-5-yl)benzamide in a manner analogous to the method described for the reduction of <b>12a</b> in the preparation of <b>23a</b> afforded 5-amino-2-methyl-<i>N</i>-(pyrimidin-5-yl)benzamide [MS (ESI, positive ion) <i>m</i>/<i>z</i>: 228 (M<sup>+</sup>)], which was used without further purification. The title compound was prepared from 5-amino-2-methyl-<i>N</i>-(pyrimidin-5-yl)benzamide (0.087 g, 0.38 mmol) and 3-(trifluoromethyl)benzoyl chloride (0.088 g, 0.42 mmol) according to the procedure described for the synthesis of <b>27</b>. Purification via column chromatography on silica gel (gradient elution with 0−10% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) afforded the title compound (0.083 g, 55% yield) as an off-white amorphous solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.82 (s, 1H), 10.61 (s, 1H), 9.16 (s, 2H), 8.95 (s, 1H), 8.31 (m, 2H), 7.99 (s, 2H), 7.86 (s, 1H), 7.81 (s, 1H), 7.37 (s, 1H), 2.40 (s, 3H). HRMS (C<sub>20</sub>H<sub>16</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub>)<sup>+</sup>: calcd, 401.121 99; found, 401.123 99.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Biological Materials and Methods</h3><div id="sec4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> Lck Kinase Assay</h4><div class="NLM_p">The Lck HTRF kinase assay involves ATP-dependent phosphorylation of a biotinylated substrate peptide of gastrin in the presence or absence of inhibitor compound. The final concentration of gastrin was 1.2 µM. The final concentration of ATP was 0.5 µM (<i>K</i><sub>m(app)</sub> = 0.6 ± 0.1 µM), and the final concentration of Lck (a GST-kinase domain fusion (AA 225–509)) was 250 pM. Buffer conditions were as follows: 50 mM HEPES, pH 7.5, 50 mM NaCl, 20 mM MgCl, 5 mM MnCl, 2 mM DTT, 0.05% BSA. The assay was quenched and stopped with 160 µL of detection reagent. Detection reagents were as follows: buffer made of 50 mM Tris, pH 7.5, 100 mM NaCl, 3 mM EDTA, 0.05% BSA, 0.1% Tween-20. Prior to reading, steptavidin allophycocyanin (SA-APC) was added at a final concentration in the assay of 0.0004 mg/mL, along with europilated antiphosphotyrosine Ab (Eu-anti-PY) at a final concentration of 0.025 nM. The assay plate was read in a Discovery fluorescence plate reader with excitation at 320 nm and emission at 615 and 655 nm. Reported IC<sub>50</sub> values are the mean of two or more separate determinations run in duplicate.</div><div class="NLM_p last">Assays for other kinases were done in a similar way as described above, varying the concentrations of enzyme, peptide substrate, and ATP added to the reaction, depending on the specific activity of the kinase and measured <i>K</i><sub>m</sub> values for the substrates.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> Human Mixed Lymphocyte Reaction (MLR)</h4><div class="NLM_p last">The purpose of this assay is to test the potency of T cell activation inhibitors in an in vitro model of allogeneic T cell stimulation. Human peripheral blood lymphocytes (hPBL, 2 × 10<sup>5</sup>/well) were incubated with mitomycin C treated B lymphoblastoid cells (JY cell line (ATCC, Rockville, MD), 1 × 10<sup>5</sup>/well) as allogeneic stimulators in the presence or absence of dilutions of potential inhibitor compound in 96-well round-bottom tissue culture plates. These cultures were incubated at 37 °C in 5% CO<sub>2</sub> for 6 days total. The proliferative response of the hPBL was measured by <sup>3</sup>H-thymidine incorporation overnight between days 5 and 6 after initiation of culture. Cells were harvested onto glass fiber filters, and <sup>3</sup>H-thymidine incorporation into DNA was analyzed by liquid scintillation counter.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Anti-CD3/CD28-Induced T Cell IL-2 Secretion and Proliferation Assay (IL-2)</h4><div class="NLM_p">The purpose of this assay was to test the potency of T cell receptor (TCR, CD3) and CD28 signaling pathway inhibitors in human T cells. T cells were purified from human peripheral blood lymphocytes (hPBL) and preincubated with or without compound prior to stimulation with a combination of an anti-CD3 and an anti-CD28 antibody in 96-well tissue culture plates (1 × 10<sup>5</sup> T cells/well). Cells were cultured for ∼20 h at 37 °C in 5% CO<sub>2</sub>, then secreted IL-2 in the supernatants was quantified by cytokine ELISA (Pierce/Endogen, St. Louis, MO). The cells remaining in the wells were then pulsed with <sup>3</sup>H-thymidine overnight to assess the T cell proliferative response. Cells were harvested onto glass fiber filters, and <sup>3</sup>H-thymidine incorporation into DNA was analyzed by a liquid scintillation counter. For comparison purposes, phorbol myristic acid (PMA) and calcium ionophore can be used in combination to induce IL-2 secretion from purified T cells. Potential inhibitor compounds can be tested for inhibition of this response as described above for anti-CD3 and -CD28 antibodies.</div><div class="NLM_p last">Human whole-blood anti-CD3/CD28-induced IL-2 secretion assays were run in a similar fashion as described above using whole blood from normal volunteers diluted 50% in tissue culture medium prior to stimulation.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Human Whole-Blood LPS-Induced TNFα</h4><div class="NLM_p last">Compounds were preincubated with heparinized human whole blood diluted in RPMI 1640 with <span class="smallcaps smallerCapital">l</span>-glutamine (GIBCO) supplemented with 10% v/v human serum AB (Gemini BioSciences) and 1% pen/strep at a final whole-blood dilution of 50% in 96-well flat-bottom plates (Falcon) for 1 h at 37 °C. LPS (List Biological Laboratories, 0.1 μg/mL Final) was subsequently added. Plates were then incubated overnight (18 h) at 37 °C. Secreted cytokines were measured by ELISA.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> Pharmacokinetic Studies</h4><div class="NLM_p last">Male Sprague–Dawley rats were administered compound, iv as a solution in DMSO or po as a suspension in 2% hydroxypropyl methylcellulose with 1% Tween-80, at the indicated doses. Samples were taken at various times after dosing and were analyzed for parent compound by the LC−MS method.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Anti-CD3 Induced IL-2 Production in Mice</h4><div class="NLM_p last">Twelve week old (20 g) BALB/c mice were dosed 1 h prior to challenge with compound po (8 per group) at the indicated doses in 2% hydroxypropyl methylcellulose with 1% Tween-80. Mice were then challenged iv with antimouse CD3 monoclonal antibody (145.2C11, BD PharMingen, San Diego, CA; 3 µg/mouse) diluted in PBS. At 90 min after anti-CD3 challenge, blood was collected via cardiac puncture. IL-2 levels were measured in serum by ELISA (BioSource, Camarillo, CA). Data points represent the mean IL-2 levels/group ± the standard error. The <i>p</i> values were determined vs vehicle control by the Mann–Whitney <i>U</i>-test.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> Protein Binding Assay</h4><div class="NLM_p last">An aliquot of test article (DMSO solution) was added to plasma in a well of a 96-deep well plate (Nunc<sup></sup>, Nalge Nunc International, Rochester, NY) to make a 10 µM plasma sample. The DMSO content was 0.1%. The plate was then incubated at 37 °C for 45 min. After incubation aliquots of samples (two aliquots per sample) were transferred to a Millipore MultiScreen Filter Plate incorporating Ultracel-10 membrane with a 10 000 molecular weight cutoff (Millipore Co., Billerica, MA). The filter plate was centrifuged at 3000 rpm for 45 min at 37 °C by Swinging-Bucket Rotor (Allegra 25R, refrigerated benchtop centrifuge, Beckman Coulter, Fullerton, CA). After centrifugation, an aliquot of each filtrate was transferred and mixed with one volume of acetonitrile/water (25:75, v/v, containing 0.1% formic acid and internal standard) to create unbound samples. Another plate was created by spiking the test article (DMSO solution) to plasma filtrate to make 10 µM reference samples. Each well of the reference sample was mixed with one volume of acetonitrile/water (25:75, v/v, containing 0.1% formic acid and internal standard). Reference samples and unbound samples were analyzed by LC−MS. The peak ratio was determined from the MS response of the test article versus the MS response of the internal standard. The percent of binding was calculated as % protein binding = [1 − (mean peak ratios of unbound)/(peak ratio of reference)] × 100.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i59"><a href="/doi/suppl/10.1021/jm7010996">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68077" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68077" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis and HPLC data, X-ray methods and data, exposures for <b>13b</b> in the mouse IL-2, and additional references. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm7010996/suppl_file/jm-2007-010996-si-rev">jm-2007-010996-si-rev (91.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm7010996/suppl_file/jm7010996-file002.pdf">jm7010996-file002.pdf (91.55 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm7010996" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43871" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43871" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erin F. DiMauro</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#acc9c8c5c1cdd9dec3eccdc1cbc9c282cfc3c1"><span class="__cf_email__" data-cfemail="4a2f2e23272b3f38250a2b272d2f2464292527">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Newcomb</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph J. Nunes</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean E. Bemis</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christina Boucher</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lilly Chai</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuart C. Chaffee</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Holly L. Deak</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Linda F. Epstein</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ted Faust</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Gallant</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anu Gore</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Gu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brad Henkle</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Faye Hsieh</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Huang</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph L. Kim</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josie H. Lee</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew W. Martin</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David C. McGowan</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniela Metz</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Deanna Mohn</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kurt A. Morgenstern</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonio Oliveira-dos-Santos</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vinod F. Patel</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Powers</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul E. Rose</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Schneider</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan A. Tomlinson</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan-Yan Tudor</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan M. Turci</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew A. Welcher</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huilin Zhao</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Zhu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaotian Zhu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Department of Molecular Structure, and Department of HTS and Molecular Pharmacology, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Department of HTS and Molecular Pharmacology, Department of Inflammation, Department of Pharmaceutics, and Department of Pharmacokinetics and Drug Metabolism, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32610" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32610" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Perry Novak for the multigram synthesis of <b>6b</b>.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03642" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03642" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 18 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Qian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">T cell antigen receptor signal transduction</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2FS0955-0674%2897%2980064-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=9069257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADyaK2sXisVWms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1997&pages=205-212&author=D.+Qianauthor=A.+Weiss&title=T+cell+antigen+receptor+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">T cell antigen receptor signal transduction</span></div><div class="casAuthors">Qian, Dapeng; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-212</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 71 refs.  The T cell antigen receptor (TCR) initiates signal transduction by activating multiple cytoplasmic protein tyrosine kinases (PTKs).  Considerable progress in the field of TCR signal transduction has been made in three areas recently: first, in understanding the structure and function of the PTK ZAP-70; second, in the elucidation of the function of the substrates and pathways downstream of the PTKs; and third, in the identification of mols. that neg. regulate TCR signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUf6rVmOnRdLVg90H21EOLACvtfcHk0lhPn-6W5lo5Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisVWms7g%253D&md5=20cb19563b966ed37298ebedc6f69c4c</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2897%2980064-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252897%252980064-6%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DD.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DT%2520cell%2520antigen%2520receptor%2520signal%2520transduction%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D1997%26volume%3D9%26spage%3D205%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nel, A. E.</span><span> </span><span class="NLM_article-title">T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1067%2Fmai.2002.124259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=11994696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFSqsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=758-770&author=A.+E.+Nel&title=T-cell+activation+through+the+antigen+receptor.+Part+1%3A+signaling+components%2C+signaling+pathways%2C+and+signal+integration+at+the+T-cell+antigen+receptor+synapse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">T-cell activation through the antigen receptor. Part 1: Signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse</span></div><div class="casAuthors">Nel, Andre E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">758-770</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">A review.  Part 1 of this review will highlight the basic components and signaling pathways by which the T-cell antigen receptor (TCR) activates mature extrathymic T cells.  TCR signaling commences with an early wave of protein tyrosine kinase activation, which is mediated by the Src kinases Lck and Fyn, the 70 kDa ξ-assocd. protein kinase, and members of the Tec kinase family.  This early wave of protein tyrosine phosphorylation leads to the activation of downstream signaling pathways, including an increase in intracellular free calcium, protein kinase C, nuclear factor κB and Ras-mitogen-activated protein kinase activation.  These pathways activate transcription factors, such as activator protein 1, nuclear factor of activated T cells, and Rel proteins, which ultimately lead to the expression of genes that control cellular proliferation, differentiation, anergy, or apoptosis.  This review also describes how costimulatory receptors assist in signal transduction and assembly of macromol. complexes at the TCR contact site with the antigen-presenting cell, also known as the immune synapse.  These basic concepts of TCR signal transduction will be used in part 2 to explain how T-cell function can be altered by therapeutic targeting of TCR signaling components, as well as to explain modification of TCR signaling during TH1/TH2 differentiation, tolerance, and immune senescence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1ul1o3w2DMLVg90H21EOLACvtfcHk0li9zuinvhuRCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFSqsb8%253D&md5=8245cf82d42fdefb908a681a806c5e77</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1067%2Fmai.2002.124259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmai.2002.124259%26sid%3Dliteratum%253Aachs%26aulast%3DNel%26aufirst%3DA.%2BE.%26atitle%3DT-cell%2520activation%2520through%2520the%2520antigen%2520receptor.%2520Part%25201%253A%2520signaling%2520components%252C%2520signaling%2520pathways%252C%2520and%2520signal%2520integration%2520at%2520the%2520T-cell%2520antigen%2520receptor%2520synapse%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2002%26volume%3D109%26spage%3D758%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pitcher, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Oers, N. S. C.</span><span> </span><span class="NLM_article-title">T-cell receptor signal transmission: who gives an ITAM?</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2Fj.it.2003.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=14552840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVKktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=554-560&author=L.+A.+Pitcherauthor=N.+S.+C.+van+Oers&title=T-cell+receptor+signal+transmission%3A+who+gives+an+ITAM%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">T-cell receptor signal transmission: who gives an ITAM?</span></div><div class="casAuthors">Pitcher, Lisa A.; van Oers, Nicolai S. C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">554-560</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  T cells have an amazing ability to discern and differentially respond to MHC-embedded peptides that can differ by only a single amino acid.  This potential involves a combination of the precise ligand-binding specificities of the T-cell receptor (TCR) and the distinct intracellular signaling processes it transmits.  Signaling processes are controlled by the 10 immunoreceptor tyrosine-based activation motifs (ITAMs) present in the invariant chains of the TCR complex (TCR ζ and CD3-γ, -δ and -ε).  Here, the authors discuss recent studies of the functions of TCR invariant chains and the contribution of the 10 ITAMs to T-cell signal transmission.  These results are incorporated into two non-exclusive models of TCR signal transduction: the ITAM multiplicity model, which describes a functional redundancy within the TCR ζ and CD3 ITAMs; and the differential signaling model, which proposes distinct functions for the CD3-γ, -δ and -ε and TCR ζ modules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4KCaKnlUGH7Vg90H21EOLACvtfcHk0li9zuinvhuRCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVKktb0%253D&md5=f3df5898e8c1bd08b4e6bb775980ecc7</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2003.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2003.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DPitcher%26aufirst%3DL.%2BA.%26aulast%3Dvan%2BOers%26aufirst%3DN.%2BS.%2BC.%26atitle%3DT-cell%2520receptor%2520signal%2520transmission%253A%2520who%2520gives%2520an%2520ITAM%253F%26jtitle%3DTrends%2520Immunol.%26date%3D2003%26volume%3D24%26spage%3D554%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Stachlewitz, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettencourt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kebede, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waegell, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span> </span><span class="NLM_article-title">A420983, a novel and selective small-molecule inhibitor of Lck prevents heart allograft rejection</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1124%2Fjpet.105.089169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=16014572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOksrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=36-41&author=R.+F.+Stachlewitzauthor=M.+A.+Hartauthor=B.+Bettencourtauthor=T.+Kebedeauthor=A.+Schwartzauthor=S.+E.+Ratnofskyauthor=D.+J.+Calderwoodauthor=W.+O.+Waegellauthor=G.+C.+Hirst&title=A420983%2C+a+novel+and+selective+small-molecule+inhibitor+of+Lck+prevents+heart+allograft+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A-770041, a novel and selective small-molecule inhibitor of Lck, prevents heart allograft rejection</span></div><div class="casAuthors">Stachlewitz, Robert F.; Hart, Michelle A.; Bettencourt, Brian; Kebede, Tegest; Schwartz, Annette; Ratnofsky, Sheldon E.; Calderwood, David J.; Waegell, Wendy O.; Hirst, Gavin C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-41</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lck, one of eight members of the Src family of tyrosine kinases, is activated after T cell stimulation and is required for T-cell proliferation and interleukin (IL)-2 prodn.  Inhibition of Lck has been a target to prevent lymphocyte activation and acute rejection.  Here, we report the pharmacol. characterization of 1-methyl-1H-indole-2-carboxylic acid (4-{1-[4-(4-acetylpiperazin-l-yl)-cyclohexyl]-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxy-phenyl)-amide (A-770041), an orally bioavailable pyrazolo[3,4-d]pyrimidine with increased selectivity for Lck compared with previously reported compds.  A-770041 is a 147 nM inhibitor of Lck (1 mM ATP) and is 300-fold selective against Fyn, the other Src family kinase involved in T-cell signaling.  Con A-stimulated IL-2 prodn. in whole blood is inhibited by A-770041 with an EC50 of approx. 80 nM.  A-770041 is orally bioavailable (F = 34.1 ± 7.2% at 10 mg/kg) and has a t1/2 of 4.1 ± 0.1 h.  Con A-induced IL-2 prodn. in vivo is inhibited by oral administration of A-770041 (in vivo EC50 = 78 ± 28 nM).  Doses of A-770041 at or above 10 mg/kg/day prevent rejection of hearts transplanted heterotopically in rats from Brown Norway donors to Lewis recipients across a major histocompatibility barrier for least 65 days.  Grafts from animals treated with 20 mg/kg/day A-770041 or 10 mg/day Cyclosporin A had minimal microvascular changes or multifocal mononuclear infiltrates.  However, mineralization in myocytes from the grafts from A-770041-treated animals was less than animals treated with Cyclosporin A.  Lck inhibition is an attractive target to prevent acute rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUGRdbGgdcRbVg90H21EOLACvtfcHk0li9zuinvhuRCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOksrbE&md5=744e6f81abafe3f7573307abbeeddb37</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.089169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.089169%26sid%3Dliteratum%253Aachs%26aulast%3DStachlewitz%26aufirst%3DR.%2BF.%26aulast%3DHart%26aufirst%3DM.%2BA.%26aulast%3DBettencourt%26aufirst%3DB.%26aulast%3DKebede%26aufirst%3DT.%26aulast%3DSchwartz%26aufirst%3DA.%26aulast%3DRatnofsky%26aufirst%3DS.%2BE.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DWaegell%26aufirst%3DW.%2BO.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26atitle%3DA420983%252C%2520a%2520novel%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520Lck%2520prevents%2520heart%2520allograft%2520rejection%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D36%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugge, J. S.</span><span> </span><span class="NLM_article-title">Leukocyte protein tyrosine kinases: potential targets for drug discovery</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1146%2Fannurev.immunol.15.1.371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=9143693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADyaK2sXisVCmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=371-404&author=J.+B.+Bolenauthor=J.+S.+Brugge&title=Leukocyte+protein+tyrosine+kinases%3A+potential+targets+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Leukocyte protein tyrosine kinases: potential targets for drug discovery</span></div><div class="casAuthors">Bolen, Joseph B.; Brugge, Joan S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">371-404</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 222 refs.  Intracellular signal transduction following the extracellular ligation of a wide variety of different types of surface mols. on leukocytes involves the activation of protein tyrosine kinases.  The dependence of successful intracellular signaling on the functions of the nontransmembrane class of protein tyrosine kinases coupled with the cell type-specific expression patterns for several of these enzymes makes them appealing targets for therapeutic intervention.  Development of drugs that can interfere with the catalytic functions of the nontransmembrane protein tyrosine kinases or that can disrupt crit. interactions with regulatory mols. and/or substrates should find clin. applications in the treatment of allergic diseases, autoimmunity, transplantation rejection, and cancer.  Topics discussed include src, lck, lyn, fyn, hck, blk, csk, csk, ctk, tec, btk, itk, tec, bmx, txk, fes, fer, abl, syk, and jak families of kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFmmCM9pk2ebVg90H21EOLACvtfcHk0li9zuinvhuRCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisVCmtrg%253D&md5=077f3fbee0284d0b0f2b744cecc1d5d9</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.15.1.371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.15.1.371%26sid%3Dliteratum%253Aachs%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DBrugge%26aufirst%3DJ.%2BS.%26atitle%3DLeukocyte%2520protein%2520tyrosine%2520kinases%253A%2520potential%2520targets%2520for%2520drug%2520discovery%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1997%26volume%3D15%26spage%3D371%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lowell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, P.</span><span> </span><span class="NLM_article-title">Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1845</span><span class="NLM_x">–</span> <span class="NLM_lpage">1857</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1101%2Fgad.10.15.1845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=8756343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADyaK28XkvFGlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=1845-1857&author=C.+A.+Lowellauthor=P.+Soriano&title=Knockouts+of+Src-family+kinases%3A+stiff+bones%2C+wimpy+T+cells%2C+and+bad+memories"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories</span></div><div class="casAuthors">Lowell, Clifford A.; Soriano, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1845-1857</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review, with 121 refs., on Src-family kinases (SFKs) in bone, neural, lymphocyte, and myeloid cell development and in keratinocyte differentiation, the regulation of SFK activity, and SFKs and tumorigenesis by polyomavirus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Fr3q0woexLVg90H21EOLACvtfcHk0li-zC6xfSl-3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFGlt7s%253D&md5=b8dc93418adea84de69fb4abade22243</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1101%2Fgad.10.15.1845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.10.15.1845%26sid%3Dliteratum%253Aachs%26aulast%3DLowell%26aufirst%3DC.%2BA.%26aulast%3DSoriano%26aufirst%3DP.%26atitle%3DKnockouts%2520of%2520Src-family%2520kinases%253A%2520stiff%2520bones%252C%2520wimpy%2520T%2520cells%252C%2520and%2520bad%2520memories%26jtitle%3DGenes%2520Dev.%26date%3D1996%26volume%3D10%26spage%3D1845%26epage%3D1857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marth, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellins, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gearn, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samelson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, R. M.</span><span> </span><span class="NLM_article-title">Lymphocyte activation provokes modification of a lymphocyte specific protein tyrosine kinase (p56lck)</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">2430</span><span class="NLM_x">–</span> <span class="NLM_lpage">2437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=1989&pages=2430-2437&author=J.+D.+Marthauthor=D.+B.+Lewisauthor=M.+P.+Cookeauthor=E.+D.+Mellinsauthor=M.+E.+Gearnauthor=L.+E.+Samelsonauthor=C.+B.+Wilsonauthor=A.+D.+Millerauthor=R.+M.+Perlmutter&title=Lymphocyte+activation+provokes+modification+of+a+lymphocyte+specific+protein+tyrosine+kinase+%28p56lck%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarth%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DD.%2BB.%26aulast%3DCooke%26aufirst%3DM.%2BP.%26aulast%3DMellins%26aufirst%3DE.%2BD.%26aulast%3DGearn%26aufirst%3DM.%2BE.%26aulast%3DSamelson%26aufirst%3DL.%2BE.%26aulast%3DWilson%26aufirst%3DC.%2BB.%26aulast%3DMiller%26aufirst%3DA.%2BD.%26aulast%3DPerlmutter%26aufirst%3DR.%2BM.%26atitle%3DLymphocyte%2520activation%2520provokes%2520modification%2520of%2520a%2520lymphocyte%2520specific%2520protein%2520tyrosine%2520kinase%2520%2528p56lck%2529%26jtitle%3DJ.%2520Immunol.%26date%3D1989%26volume%3D142%26spage%3D2430%26epage%3D2437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Groves, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidos, C. J.</span><span> </span><span class="NLM_article-title">Fyn can partially substitute for Lck in T lymphocyte development</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1996&pages=417-428&author=T.+Grovesauthor=P.+Smileyauthor=M.+P.+Cookeauthor=K.+Forbushauthor=R.+M.+Perlmutterauthor=C.+J.+Guidos&title=Fyn+can+partially+substitute+for+Lck+in+T+lymphocyte+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGroves%26aufirst%3DT.%26aulast%3DSmiley%26aufirst%3DP.%26aulast%3DCooke%26aufirst%3DM.%2BP.%26aulast%3DForbush%26aufirst%3DK.%26aulast%3DPerlmutter%26aufirst%3DR.%2BM.%26aulast%3DGuidos%26aufirst%3DC.%2BJ.%26atitle%3DFyn%2520can%2520partially%2520substitute%2520for%2520Lck%2520in%2520T%2520lymphocyte%2520development%26jtitle%3DImmunity%26date%3D1996%26volume%3D5%26spage%3D417%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Palacios, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">7990</span><span class="NLM_x">–</span> <span class="NLM_lpage">8000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1038%2Fsj.onc.1208074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15489916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosFyltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=7990-8000&author=E.+H.+Palaciosauthor=A.+Weiss&title=Function+of+the+Src-family+kinases%2C+Lck+and+Fyn%2C+in+T-cell+development+and+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation</span></div><div class="casAuthors">Palacios, Emil H.; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">7990-8000</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The function of the Src-family kinases (SFKs) Lck and Fyn in T cells has been intensively studied over the past 15 yr.  Animal models and cell line studies both indicate a crit. role for Lck and Fyn in proximal T-cell antigen receptor (TCR) signal transduction.  Recruited SFKs phosphorylate TCR ITAMs (immunoreceptor tyrosine-based activation motifs) in the CD3 and ζ chains, which then serve as docking sites for Syk-family kinases.  SFKs then phosphorylate and activate the recruited Syk-family kinase.  Lck and Fyn are spatially segregated in cell membranes due to differential lipid raft localization, and may undergo sequential activation.  In addn. to the CD4 and CD8 coreceptors, a recently described adaptor, Unc119, may link SFKs to the TCR.  CD45 and Csk provide pos. and neg. regulatory control of SFK functions, resp., and Csk is constitutively bound to the transmembrane adapter protein, PAG/Cbp.  TCR-based signaling is required at several stages of T-cell development, including at least pre-TCR signaling, pos. selection, peripheral maintenance of naive T cells, and lymphopenia-induced proliferation.  SFKs are required for each of these TCR-based signals, and Lck seems to be the major contributor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC2s7PGSwBibVg90H21EOLACvtfcHk0li-zC6xfSl-3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosFyltb8%253D&md5=d9d1f2697ef4008ee8c8426ac806bd11</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1208074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1208074%26sid%3Dliteratum%253Aachs%26aulast%3DPalacios%26aufirst%3DE.%2BH.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DFunction%2520of%2520the%2520Src-family%2520kinases%252C%2520Lck%2520and%2520Fyn%252C%2520in%2520T-cell%2520development%2520and%2520activation%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D7990%26epage%3D8000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Molina, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siderovskid, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ewijk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narendran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timms, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, K.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veillette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Profound block in thymocyte development in mice lacking p56<sup>lck</sup></span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=1992&pages=161-164&author=T.+J.+Molinaauthor=K.+Kishiharaauthor=D.+P.+Siderovskidauthor=W.+van+Ewijkauthor=A.+Narendranauthor=E.+Timmsauthor=A.+Wakehamauthor=C.+J.+Paigeauthor=K.-U.+Hartmannauthor=A.+Veilletteauthor=D.+Davidsonauthor=T.+W.+Mak&title=Profound+block+in+thymocyte+development+in+mice+lacking+p56lck"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMolina%26aufirst%3DT.%2BJ.%26aulast%3DKishihara%26aufirst%3DK.%26aulast%3DSiderovskid%26aufirst%3DD.%2BP.%26aulast%3Dvan%2BEwijk%26aufirst%3DW.%26aulast%3DNarendran%26aufirst%3DA.%26aulast%3DTimms%26aufirst%3DE.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DPaige%26aufirst%3DC.%2BJ.%26aulast%3DHartmann%26aufirst%3DK.-U.%26aulast%3DVeillette%26aufirst%3DA.%26aulast%3DDavidson%26aufirst%3DD.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DProfound%2520block%2520in%2520thymocyte%2520development%2520in%2520mice%2520lacking%2520p56lck%26jtitle%3DNature%26date%3D1992%26volume%3D357%26spage%3D161%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Straus, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1992&pages=585-593&author=D.+B.+Strausauthor=A.+Weiss&title=Genetic+evidence+for+the+involvement+of+the+lck+tyrosine+kinase+in+signal+transduction+through+the+T+cell+antigen+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStraus%26aufirst%3DD.%2BB.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DGenetic%2520evidence%2520for%2520the%2520involvement%2520of%2520the%2520lck%2520tyrosine%2520kinase%2520in%2520signal%2520transduction%2520through%2520the%2520T%2520cell%2520antigen%2520receptor%26jtitle%3DCell%26date%3D1992%26volume%3D70%26spage%3D585%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Levin, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbush, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, R. M.</span><span> </span><span class="NLM_article-title">A dominant-negative transgene defines a role for p56lck in thymopoiesis</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1671</span><span class="NLM_x">–</span> <span class="NLM_lpage">1680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1993&pages=1671-1680&author=S.+D.+Levinauthor=S.+J.+Andersonauthor=K.+A.+Forbushauthor=R.+M.+Perlmutter&title=A+dominant-negative+transgene+defines+a+role+for+p56lck+in+thymopoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DS.%2BD.%26aulast%3DAnderson%26aufirst%3DS.%2BJ.%26aulast%3DForbush%26aufirst%3DK.%2BA.%26aulast%3DPerlmutter%26aufirst%3DR.%2BM.%26atitle%3DA%2520dominant-negative%2520transgene%2520defines%2520a%2520role%2520for%2520p56lck%2520in%2520thymopoiesis%26jtitle%3DEMBO%2520J.%26date%3D1993%26volume%3D12%26spage%3D1671%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Goldman, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballas, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutte, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenback, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noraz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, N.</span><span> </span><span class="NLM_article-title">Defective expression of p56lck in an infant with severe combined immunodeficiency</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1172%2FJCI3205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=9664084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADyaK1cXkslOktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=421-429&author=F.+D.+Goldmanauthor=Z.+K.+Ballasauthor=B.+C.+Schutteauthor=J.+Kempauthor=C.+Hollenbackauthor=N.+Norazauthor=N.+Taylor&title=Defective+expression+of+p56lck+in+an+infant+with+severe+combined+immunodeficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Defective expression of p56lck in an infant with severe combined immunodeficiency</span></div><div class="casAuthors">Goldman, Frederick D.; Ballas, Zuhair K.; Schutte, Brian C.; Kemp, John; Hollenback, Clay; Noraz, Nelly; Taylor, Naomi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-429</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Severe combined immune deficiency (SCID) is a heterogeneous disorder characterized by profound defects in cellular and humoral immunity.  The authors report here an infant with clin. and lab. features of SCID and selective CD4 lymphopenia and lack of CD28 expression on CD8+ T cells.  T cells from this patient showed poor blastogenic responses to various mitogens and IL-2.  Other T cell antigen receptor-induced responses, including upregulation of CD69, were similarly inhibited.  However, more proximal T cell antigen receptor signaling events, such as anti-CD3 induced protein tyrosine phosphorylation, phosphorylation of mitogen-assocd. protein kinase, and calcium mobilization were intact.  Although p59fyn and ZAP-70 protein tyrosine kinases were expressed at normal levels, a marked decrease in the level of p56lck was noted.  Furthermore, this decrease was assocd. with the presence of an alternatively spliced lck transcript lacking the exon 7 kinase encoding domain.  These data suggest that a deficiency in p56lck expression can produce a SCID phenotype in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQfR5Dq3U2CbVg90H21EOLACvtfcHk0ljdwpHWV29Lfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkslOktLs%253D&md5=7849911b4ebf15c7c430789267b62d96</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1172%2FJCI3205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI3205%26sid%3Dliteratum%253Aachs%26aulast%3DGoldman%26aufirst%3DF.%2BD.%26aulast%3DBallas%26aufirst%3DZ.%2BK.%26aulast%3DSchutte%26aufirst%3DB.%2BC.%26aulast%3DKemp%26aufirst%3DJ.%26aulast%3DHollenback%26aufirst%3DC.%26aulast%3DNoraz%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DN.%26atitle%3DDefective%2520expression%2520of%2520p56lck%2520in%2520an%2520infant%2520with%2520severe%2520combined%2520immunodeficiency%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1998%26volume%3D102%26spage%3D421%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Hubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seligmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksenhendler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autran, B.</span><span> </span><span class="NLM_article-title">Defective p56<sup>lck</sup> activity in T cells from an adult patient with idiopathic CD4<sup>+</sup> lymphocytopenia</span> <span class="citation_source-journal">Int. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1093%2Fintimm%2F12.4.449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=10744646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisl2hsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=449-457&author=P.+Hubertauthor=F.+Bergeronauthor=V.+Ferreiraauthor=M.+Seligmannauthor=E.+Oksenhendlerauthor=P.+Debreauthor=B.+Autran&title=Defective+p56lck+activity+in+T+cells+from+an+adult+patient+with+idiopathic+CD4%2B+lymphocytopenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia</span></div><div class="casAuthors">Hubert, Pascale; Bergeron, Florence; Ferreira, Valerie; Seligmann, Maxime; Oksenhendler, Eric; Debre, Patrice; Autran, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">449-457</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Idiopathic CD4+ lymphocytopenia (ICL) is defined by a stable loss of CD4+ T cells in the absence of any known cause of immune deficiency.  This syndrome is still of undetd. origin.  It affects adult patients, some of them displaying opportunistic infections similar to HIV-infected subjects.  The hypothesis that the cellular immune defect may be due to biochem. failures of the CD3-TCR pathway is investigated here in a patient assocg. a severe selective CD4+ lymphocytopenia with an increased CD8+ T cell count discovered in the course of a cryptococcal meningitidis.  A 40% redn. of T cell proliferation to CD3-TCR stimulation is obsd. only in the CD4+ subpopulation.  The early CD3-induced protein tyrosine phosphorylations are conserved in both CD4+ and CD8+ subsets, and the levels of the T cell protein tyrosine kinases p56Lck, p59Fyn and ZAP-70 are normal.  However, we find a 50% redn. of p56Lck kinase activity in the patient's T cells compared to a healthy control donor.  P59Fyn activity does not appear to be altered.  Nevertheless, we do not find any genetic abnormality of p56Lck.  These results thus suggest that a defect of an unknown protein regulating p56Lck activity takes place in this patient's T cells.  Taken together, these findings reveal p56Lck alteration in ICL and confirm the crit. role of this kinase in the maintenance of the peripheral CD4+ T cell subpopulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi8OArdolHqbVg90H21EOLACvtfcHk0ljdwpHWV29Lfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisl2hsrY%253D&md5=4db89cbd808adfb34cc71cc9050aa681</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2F12.4.449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252F12.4.449%26sid%3Dliteratum%253Aachs%26aulast%3DHubert%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DF.%26aulast%3DFerreira%26aufirst%3DV.%26aulast%3DSeligmann%26aufirst%3DM.%26aulast%3DOksenhendler%26aufirst%3DE.%26aulast%3DDebre%26aufirst%3DP.%26aulast%3DAutran%26aufirst%3DB.%26atitle%3DDefective%2520p56lck%2520activity%2520in%2520T%2520cells%2520from%2520an%2520adult%2520patient%2520with%2520idiopathic%2520CD4%252B%2520lymphocytopenia%26jtitle%3DInt.%2520Immunol.%26date%3D2000%26volume%3D12%26spage%3D449%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Seddon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamoyska, R.</span><span> </span><span class="NLM_article-title">TCR signals mediated by Src family kinases are essential for the survival of naive T cells</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">2997</span><span class="NLM_x">–</span> <span class="NLM_lpage">3005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2002&pages=2997-3005&author=B.+Seddonauthor=R.+Zamoyska&title=TCR+signals+mediated+by+Src+family+kinases+are+essential+for+the+survival+of+naive+T+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeddon%26aufirst%3DB.%26aulast%3DZamoyska%26aufirst%3DR.%26atitle%3DTCR%2520signals%2520mediated%2520by%2520Src%2520family%2520kinases%2520are%2520essential%2520for%2520the%2520survival%2520of%2520naive%2520T%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D169%26spage%3D2997%26epage%3D3005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hanke, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weringer, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollok, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connelly, P. A.</span><span> </span><span class="NLM_article-title">Discovery of a Novel, Potent, and Src Family-Selective Tyrosine Kinase Inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=695-701&author=J.+H.+Hankeauthor=J.+P.+Gardnerauthor=R.+L.+Dowauthor=P.+S.+Changelianauthor=W.+H.+Brissetteauthor=E.+J.+Weringerauthor=B.+A.+Pollokauthor=P.+A.+Connelly&title=Discovery+of+a+Novel%2C+Potent%2C+and+Src+Family-Selective+Tyrosine+Kinase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanke%26aufirst%3DJ.%2BH.%26aulast%3DGardner%26aufirst%3DJ.%2BP.%26aulast%3DDow%26aufirst%3DR.%2BL.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DWeringer%26aufirst%3DE.%2BJ.%26aulast%3DPollok%26aufirst%3DB.%2BA.%26aulast%3DConnelly%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520Novel%252C%2520Potent%252C%2520and%2520Src%2520Family-Selective%2520Tyrosine%2520Kinase%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D695%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Trevillyan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiou, X. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballaron, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheets, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putnam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubbins, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrior, U. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollison, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faltynek, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djuric, S. W.</span><span> </span><span class="NLM_article-title">Inhibition of p56lck tyrosine kinase by isothiazoles</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=1999&pages=19-29&author=J.+M.+Trevillyanauthor=X.+G.+Chiouauthor=S.+J.+Ballaronauthor=Q.+M.+Tangauthor=A.+Bukoauthor=M.+P.+Sheetsauthor=M.+L.+Smithauthor=B.+Putnamauthor=P.+Wiedemanauthor=N.+Tuauthor=D.+Madarauthor=H.+T.+Smithauthor=E.+J.+Gubbinsauthor=U.+P.+Warriorauthor=Y.-W.+Chenauthor=K.+W.+Mollisonauthor=C.+R.+Faltynekauthor=S.+W.+Djuric&title=Inhibition+of+p56lck+tyrosine+kinase+by+isothiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrevillyan%26aufirst%3DJ.%2BM.%26aulast%3DChiou%26aufirst%3DX.%2BG.%26aulast%3DBallaron%26aufirst%3DS.%2BJ.%26aulast%3DTang%26aufirst%3DQ.%2BM.%26aulast%3DBuko%26aufirst%3DA.%26aulast%3DSheets%26aufirst%3DM.%2BP.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DPutnam%26aufirst%3DB.%26aulast%3DWiedeman%26aufirst%3DP.%26aulast%3DTu%26aufirst%3DN.%26aulast%3DMadar%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DH.%2BT.%26aulast%3DGubbins%26aufirst%3DE.%2BJ.%26aulast%3DWarrior%26aufirst%3DU.%2BP.%26aulast%3DChen%26aufirst%3DY.-W.%26aulast%3DMollison%26aufirst%3DK.%2BW.%26aulast%3DFaltynek%26aufirst%3DC.%2BR.%26aulast%3DDjuric%26aufirst%3DS.%2BW.%26atitle%3DInhibition%2520of%2520p56lck%2520tyrosine%2520kinase%2520by%2520isothiazoles%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1999%26volume%3D364%26spage%3D19%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Arnold, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamens, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munschauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafferty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S. E.</span><span> </span><span class="NLM_article-title">Pyrrolo[2,3-<i>d</i>]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2167</span><span class="NLM_x">–</span> <span class="NLM_lpage">2170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2167-2170&author=L.+D.+Arnoldauthor=D.+J.+Calderwoodauthor=R.+W.+Dixonauthor=D.+N.+Johnstonauthor=J.+S.+Kamensauthor=R.+Munschauerauthor=P.+Raffertyauthor=S.+E.+Ratnofsky&title=Pyrrolo%5B2%2C3-d%5Dpyrimidines+containing+an+extended+5-substituent+as+potent+and+selective+inhibitors+of+lck+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BD.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DDixon%26aufirst%3DR.%2BW.%26aulast%3DJohnston%26aufirst%3DD.%2BN.%26aulast%3DKamens%26aufirst%3DJ.%2BS.%26aulast%3DMunschauer%26aufirst%3DR.%26aulast%3DRafferty%26aufirst%3DP.%26aulast%3DRatnofsky%26aufirst%3DS.%2BE.%26atitle%3DPyrrolo%255B2%252C3-d%255Dpyrimidines%2520containing%2520an%2520extended%25205-substituent%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520lck%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2167%26epage%3D2170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busacca, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckner, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacober, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapadia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzenbeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A. S.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolbert, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschantz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">Discovery of 2-phenylamino-imidazo[4,5-<i>h</i>]isoquinolin-9-ones: a new class of inhibitors of Lck kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3394</span><span class="NLM_x">–</span> <span class="NLM_lpage">3405</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020113o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3394-3405&author=R.+J.+Snowauthor=M.+G.+Cardozoauthor=T.+M.+Morwickauthor=C.+A.+Busaccaauthor=Y.+Dongauthor=R.+J.+Ecknerauthor=S.+Jacoberauthor=S.+Jakesauthor=S.+Kapadiaauthor=S.+Lukasauthor=M.+Panzenbeckauthor=G.+W.+Peetauthor=J.+D.+Petersonauthor=A.+S.+Prokopowiczauthor=R.+Sellatiauthor=R.+M.+Tolbertauthor=M.+A.+Tschantzauthor=N.+Moss&title=Discovery+of+2-phenylamino-imidazo%5B4%2C5-h%5Disoquinolin-9-ones%3A+a+new+class+of+inhibitors+of+Lck+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1021%2Fjm020113o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020113o%26sid%3Dliteratum%253Aachs%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DCardozo%26aufirst%3DM.%2BG.%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26aulast%3DBusacca%26aufirst%3DC.%2BA.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DEckner%26aufirst%3DR.%2BJ.%26aulast%3DJacober%26aufirst%3DS.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKapadia%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DPanzenbeck%26aufirst%3DM.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DPeterson%26aufirst%3DJ.%2BD.%26aulast%3DProkopowicz%26aufirst%3DA.%2BS.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DTolbert%26aufirst%3DR.%2BM.%26aulast%3DTschantz%26aufirst%3DM.%2BA.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25202-phenylamino-imidazo%255B4%252C5-h%255Disoquinolin-9-ones%253A%2520a%2520new%2520class%2520of%2520inhibitors%2520of%2520Lck%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3394%26epage%3D3405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Waegell, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babineau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRae, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span> </span><span class="NLM_article-title">A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection</span> <span class="citation_source-journal">Transplant. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1411</span><span class="NLM_x">–</span> <span class="NLM_lpage">1417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2FS0041-1345%2802%2902909-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=12176420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtlKju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=1411-1417&author=W.+Waegellauthor=M.+Babineauauthor=M.+Hartauthor=K.+Dixonauthor=B.+McRaeauthor=C.+Wallaceauthor=M.+Leachauthor=S.+Ratnofskyauthor=A.+Belangerauthor=G.+Hirstauthor=A.+Rossiniauthor=M.+Appelauthor=J.+Mordesauthor=D.+Greinerauthor=S.+Banerjee&title=A420983%2C+a+novel%2C+small+molecule+inhibitor+of+LCK+prevents+allograft+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection</span></div><div class="casAuthors">Waegell, W.; Babineau, M.; Hart, M.; Dixon, K.; McRae, B.; Wallace, C.; Leach, M.; Ratnofsky, S.; Belanger, A.; Hirst, G.; Rossini, A.; Appel, M.; Mordes, J.; Greiner, D.; Banerjee, S.</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation Proceedings</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1411-1417</span>CODEN:
                <span class="NLM_cas:coden">TRPPA8</span>;
        ISSN:<span class="NLM_cas:issn">0041-1345</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A420983 is a prototypic immunosuppressive agent that selectively targets T cells receiving an activation signal.  Treatment with such an agent may allow long-term allograft survival and avoid harmful non-immune side effects common with other immunosuppressive therapies.  Lck is an attractive target for inhibition of graft rejection because it is involved in this process on several levels.  Signaling through Lck is involved in T cell cytokine prodn. and generation of cytotoxic T lymphocytes (CTL), as well as generation of T cell help required for B-cell alloantibody generation.  The present study demonstrates that the small mol. inhibitor of Lck, A420983, was able to inhibit T-cell responses in several systems.  The authors have shown that A420983 is an effective therapy for prolonging graft survival in three models of transplantation in the mouse.  In two organ transplant models, neonatal cardiac transplantation and skin transplantation.  A420983 was able to significantly prolong graft survival as compared to grafts in vehicle-treated mice.  In the islet transplant model isolated pancreatic islet cells from fully MHC-mismatched donors were protected from rejection by A420983 treatment for the entire test period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkfpFYBF9KrbVg90H21EOLACvtfcHk0lhnJK2-3NCNIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtlKju74%253D&md5=e2e4fbcb2a568bee9df4ad747f09d43c</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1016%2FS0041-1345%2802%2902909-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-1345%252802%252902909-3%26sid%3Dliteratum%253Aachs%26aulast%3DWaegell%26aufirst%3DW.%26aulast%3DBabineau%26aufirst%3DM.%26aulast%3DHart%26aufirst%3DM.%26aulast%3DDixon%26aufirst%3DK.%26aulast%3DMcRae%26aufirst%3DB.%26aulast%3DWallace%26aufirst%3DC.%26aulast%3DLeach%26aufirst%3DM.%26aulast%3DRatnofsky%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DA.%26aulast%3DHirst%26aufirst%3DG.%26aulast%3DRossini%26aufirst%3DA.%26aulast%3DAppel%26aufirst%3DM.%26aulast%3DMordes%26aufirst%3DJ.%26aulast%3DGreiner%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DS.%26atitle%3DA420983%252C%2520a%2520novel%252C%2520small%2520molecule%2520inhibitor%2520of%2520LCK%2520prevents%2520allograft%2520rejection%26jtitle%3DTransplant.%2520Proc.%26date%3D2002%26volume%3D34%26spage%3D1411%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Burchat, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafferty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, B. S.</span><span> </span><span class="NLM_article-title">Pyrazolo[3,4-<i>d</i>]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck—a selectivity insight</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1687</span><span class="NLM_x">–</span> <span class="NLM_lpage">1690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1687-1690&author=A.+F.+Burchatauthor=D.+J.+Calderwoodauthor=M.+M.+Friedmanauthor=G.+C.+Hirstauthor=B.+Liauthor=P.+Raffertyauthor=K.+Ritterauthor=B.+S.+Skinner&title=Pyrazolo%5B3%2C4-d%5Dpyrimidines+containing+an+extended+3-substituent+as+potent+inhibitors+of+Lck%E2%80%94a+selectivity+insight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurchat%26aufirst%3DA.%2BF.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DFriedman%26aufirst%3DM.%2BM.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DRafferty%26aufirst%3DP.%26aulast%3DRitter%26aufirst%3DK.%26aulast%3DSkinner%26aufirst%3DB.%2BS.%26atitle%3DPyrazolo%255B3%252C4-d%255Dpyrimidines%2520containing%2520an%2520extended%25203-substituent%2520as%2520potent%2520inhibitors%2520of%2520Lck%25E2%2580%2594a%2520selectivity%2520insight%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1687%26epage%3D1690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fex, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of novel imidazoquioxaline-based Lck inhibitors: improvement of cell potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3153</span><span class="NLM_x">–</span> <span class="NLM_lpage">3156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3153-3156&author=P.+Chenauthor=E.+J.+Iwanowiczauthor=D.+Norrisauthor=H.+H.+Guauthor=J.+Linauthor=R.+V.+Moquinauthor=J.+Dasauthor=J.+Wityakauthor=S.+H.+Spergelauthor=H.+de+Fexauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Synthesis+and+SAR+of+novel+imidazoquioxaline-based+Lck+inhibitors%3A+improvement+of+cell+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DH.%2BH.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3Dde%2BFex%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520novel%2520imidazoquioxaline-based%2520Lck%2520inhibitors%253A%2520improvement%2520of%2520cell%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3153%26epage%3D3156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFex, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span> </span><span class="NLM_article-title">Discovery of 2-amino-heteroaryl-benzothiazole-6-anilides as potent p56<sup>lck</sup> inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2587</span><span class="NLM_x">–</span> <span class="NLM_lpage">2590</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2587-2590&author=J.+Dasauthor=R.+V.+Moquinauthor=J.+Linauthor=C.+Liuauthor=A.+M.+Doweykoauthor=H.+F.+DeFexauthor=Q.+Fangauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=G.+L.+Schievenauthor=J.+C.+Barrishauthor=J.+Wityak&title=Discovery+of+2-amino-heteroaryl-benzothiazole-6-anilides+as+potent+p56lck+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DDeFex%26aufirst%3DH.%2BF.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DWityak%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%25202-amino-heteroaryl-benzothiazole-6-anilides%2520as%2520potent%2520p56lck%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2587%26epage%3D2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckner, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapadia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzenbeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowics, A. S.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschantz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">Optimization of 2-phenylaminoimidazo[4,5-<i>h</i>]isoquinolin-9-ones: orally active inhibitors of lck kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">–</span> <span class="NLM_lpage">1349</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020446l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1337-1349&author=D.+R.+Goldbergauthor=T.+Butzauthor=M.+G.+Cardozoauthor=R.+J.+Ecknerauthor=A.+Hammachauthor=J.+Huangauthor=S.+Jakesauthor=S.+Kapadiaauthor=M.+Kashemauthor=S.+Lukasauthor=T.+M.+Morwickauthor=M.+Panzenbeckauthor=U.+Patelauthor=S.+Pavauthor=G.+W.+Peetauthor=J.+D.+Petersonauthor=A.+S.+Prokopowicsauthor=R.+J.+Snowauthor=R.+Sellatiauthor=H.+Takahashiauthor=J.+Tanauthor=M.+A.+Tschantzauthor=X-J.+Wangauthor=Y.+Wangauthor=J.+Wolakauthor=P.+Xiongauthor=N.+Moss&title=Optimization+of+2-phenylaminoimidazo%5B4%2C5-h%5Disoquinolin-9-ones%3A+orally+active+inhibitors+of+lck+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6i&amp;dbid=16384&amp;doi=10.1021%2Fjm020446l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020446l%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DButz%26aufirst%3DT.%26aulast%3DCardozo%26aufirst%3DM.%2BG.%26aulast%3DEckner%26aufirst%3DR.%2BJ.%26aulast%3DHammach%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKapadia%26aufirst%3DS.%26aulast%3DKashem%26aufirst%3DM.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26aulast%3DPanzenbeck%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DPeterson%26aufirst%3DJ.%2BD.%26aulast%3DProkopowics%26aufirst%3DA.%2BS.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DTschantz%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DX-J.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWolak%26aufirst%3DJ.%26aulast%3DXiong%26aufirst%3DP.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DOptimization%2520of%25202-phenylaminoimidazo%255B4%252C5-h%255Disoquinolin-9-ones%253A%2520orally%2520active%2520inhibitors%2520of%2520lck%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1337%26epage%3D1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Fex, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56<sup>Lck</sup> inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6061</span><span class="NLM_x">–</span> <span class="NLM_lpage">6066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=6061-6066&author=P.+Chenauthor=D.+Norrisauthor=J.+Dasauthor=S.+H.+Spergelauthor=J.+Wityakauthor=L.+Leithauthor=R.+Zhaoauthor=B.-C.+Chenauthor=S.+Pittauthor=S.+Pangauthor=D.+R.+Shenauthor=R.+Zhangauthor=H.+F.+De+Fexauthor=A.+M.+Doweykoauthor=K.+W.+McIntyreauthor=D.+J.+Shusterauthor=K.+Behniaauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Discovery+of+novel+2-%28aminoheteroaryl%29-thiazole-5-carboxamides+as+potent+and+orally+active+Src-family+kinase+p56Lck+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DLeith%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDe%2BFex%26aufirst%3DH.%2BF.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520novel%25202-%2528aminoheteroaryl%2529-thiazole-5-carboxamides%2520as%2520potent%2520and%2520orally%2520active%2520Src-family%2520kinase%2520p56Lck%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D6061%26epage%3D6066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fex, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thrall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocy, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Imidazoquinoxaline Src-family kinase p56<sup>Lck</sup> inhibitors: SAR, QSAR, and the discovery of (<i>S</i>)-<i>N</i>-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo-[1,5-<i>a</i>]pyrido[3,2-<i>e</i>]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4517</span><span class="NLM_x">–</span> <span class="NLM_lpage">4529</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030217e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4517-4529&author=P.+Chenauthor=A.+M.+Doweykoauthor=D.+Norrisauthor=H.+H.+Guauthor=S.+H.+Spergelauthor=J.+Dasauthor=R.+V.+Moquinauthor=J.+Linauthor=J.+Wityakauthor=E.+J.+Iwanowiczauthor=K.+W.+McIntyreauthor=D.+J.+Shusterauthor=K.+Behniaauthor=S.+Chongauthor=H.+de+Fexauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=S.+Thrallauthor=P.+Stanleyauthor=O.+R.+Kocyauthor=M.+R.+Witmerauthor=S.+B.+Kannerauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Imidazoquinoxaline+Src-family+kinase+p56Lck+inhibitors%3A+SAR%2C+QSAR%2C+and+the+discovery+of+%28S%29-N-%282-chloro-6-methylphenyl%29-2-%283-methyl-1-piperazinyl%29imidazo-%5B1%2C5-a%5Dpyrido%5B3%2C2-e%5Dpyrazin-6-amine+%28BMS-279700%29+as+a+potent+and+orally+active+inhibitor+with+excellent+in+vivo+antiinflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6k&amp;dbid=16384&amp;doi=10.1021%2Fjm030217e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030217e%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DH.%2BH.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DChong%26aufirst%3DS.%26aulast%3Dde%2BFex%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DThrall%26aufirst%3DS.%26aulast%3DStanley%26aufirst%3DP.%26aulast%3DKocy%26aufirst%3DO.%2BR.%26aulast%3DWitmer%26aufirst%3DM.%2BR.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DImidazoquinoxaline%2520Src-family%2520kinase%2520p56Lck%2520inhibitors%253A%2520SAR%252C%2520QSAR%252C%2520and%2520the%2520discovery%2520of%2520%2528S%2529-N-%25282-chloro-6-methylphenyl%2529-2-%25283-methyl-1-piperazinyl%2529imidazo-%255B1%252C5-a%255Dpyrido%255B3%252C2-e%255Dpyrazin-6-amine%2520%2528BMS-279700%2529%2520as%2520a%2520potent%2520and%2520orally%2520active%2520inhibitor%2520with%2520excellent%2520in%2520vivo%2520antiinflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4517%26epage%3D4529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">McRae, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presky, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span> </span><span class="NLM_article-title">Suppression of CD4<sup>+</sup> T cell activation by a novel inhibitor of Src-family kinases</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6l&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2Fj.intimp.2004.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6l&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15710336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6l&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlegtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=667-677&author=B.+L.+McRaeauthor=C.+Wallaceauthor=K.+F.+Dixonauthor=A.+Rouxauthor=S.+Mohanauthor=Y.+Jiaauthor=D.+H.+Preskyauthor=D.+E.+Traceyauthor=G.+C.+Hirst&title=Suppression+of+CD4%2B+T+cell+activation+by+a+novel+inhibitor+of+Src-family+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6lR"><div class="casContent"><span class="casTitleNuber">6l</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases</span></div><div class="casAuthors">McRae, Bradford L.; Wallace, Craig; Dixon, Kathleen Fitzgerald; Roux, Alyson; Mohan, Sukumari; Jia, Yong; Presky, David H.; Tracey, Daniel E.; Hirst, Gavin C.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">667-677</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Src family kinases Lck and Fyn play an important role in T cell development and function.  We have synthesized a novel small mol., A-420983, which inhibits Lck and Fyn, as well as other Src family kinases, but has selectivity with respect to non-Src family kinases.  A-420983 completely inhibited antigen-stimulated prodn. of IFN-γ and IL-4 by mouse Th1 and Th2 cells, resp.  Antigen-induced T cell proliferation was also blocked by treatment with A-420983.  In contrast, IL-15-induced proliferation was unaffected by A-420983, suggesting that TCR-independent pathways of T cell activation were not impaired.  When mice were dosed orally, A-420983 inhibited TCR-mediated c-jun and ZAP-70 phosphorylation in CD4+ T cells and suppressed the disease course of established EAE.  Treatment with A-420983 for 7 days resulted in a block in thymocyte development at the CD4- CD8- stage, consistent with inhibition of Lck and Fyn in vivo.  These results demonstrate that a small mol. inhibitor of Lck and Fyn can block TCR-induced T cell activation in vitro and in vivo.  Furthermore, CNS demyelination mediated by activated encephalitogenic CD4+ T cells is dependent upon the kinase activity of these Src family members.  We conclude that inhibition of Src family kinases may represent a promising strategy for the treatment of T cell-mediated disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBWKvht3SdgrVg90H21EOLACvtfcHk0lh7xQCHOBLj4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlegtbg%253D&md5=7f1ee81f1bb64dd4a2441819e1c25478</span></div><a href="/servlet/linkout?suffix=cit6l&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2004.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2004.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DMcRae%26aufirst%3DB.%2BL.%26aulast%3DWallace%26aufirst%3DC.%26aulast%3DDixon%26aufirst%3DK.%2BF.%26aulast%3DRoux%26aufirst%3DA.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DPresky%26aufirst%3DD.%2BH.%26aulast%3DTracey%26aufirst%3DD.%2BE.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26atitle%3DSuppression%2520of%2520CD4%252B%2520T%2520cell%2520activation%2520by%2520a%2520novel%2520inhibitor%2520of%2520Src-family%2520kinases%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2005%26volume%3D5%26spage%3D667%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Burchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachlewitz, R. F.</span><span> </span><span class="NLM_article-title">Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=118-122&author=A.+Burchatauthor=D.+W.+Borhaniauthor=D.+J.+Calderwoodauthor=G.+C.+Hirstauthor=B.+Liauthor=R.+F.+Stachlewitz&title=Discovery+of+A-770041%2C+a+src-family+selective+orally+active+lck+inhibitor+that+prevents+organ+allograft+rejection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurchat%26aufirst%3DA.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DStachlewitz%26aufirst%3DR.%2BF.%26atitle%3DDiscovery%2520of%2520A-770041%252C%2520a%2520src-family%2520selective%2520orally%2520active%2520lck%2520inhibitor%2520that%2520prevents%2520organ%2520allograft%2520rejection%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D118%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Maier, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugel, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golebiowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufersweiler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanRens, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easwaran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janusz, M. J.</span><span> </span><span class="NLM_article-title">Development of <i>N</i>-4,6-pyrimidine-<i>N</i>-alkyl-<i>N</i>′-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3646</span><span class="NLM_x">–</span> <span class="NLM_lpage">3650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3646-3650&author=J.+A.+Maierauthor=T.+A.+Brugelauthor=M.+Sabatauthor=A.+Golebiowskiauthor=M.+J.+Laufersweilerauthor=J.+C.+VanRensauthor=C.+R.+Hopkinsauthor=B.+Deauthor=L.+C.+Hsiehauthor=K.+K.+Brownauthor=V.+Easwaranauthor=M.+J.+Janusz&title=Development+of+N-4%2C6-pyrimidine-N-alkyl-N%E2%80%B2-phenyl+ureas+as+orally+active+inhibitors+of+lymphocyte+specific+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DJ.%2BA.%26aulast%3DBrugel%26aufirst%3DT.%2BA.%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DGolebiowski%26aufirst%3DA.%26aulast%3DLaufersweiler%26aufirst%3DM.%2BJ.%26aulast%3DVanRens%26aufirst%3DJ.%2BC.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DHsieh%26aufirst%3DL.%2BC.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DEaswaran%26aufirst%3DV.%26aulast%3DJanusz%26aufirst%3DM.%2BJ.%26atitle%3DDevelopment%2520of%2520N-4%252C6-pyrimidine-N-alkyl-N%25E2%2580%25B2-phenyl%2520ureas%2520as%2520orally%2520active%2520inhibitors%2520of%2520lymphocyte%2520specific%2520tyrosine%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3646%26epage%3D3650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armistead, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amouzegh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, E.</span><span> </span><span class="NLM_article-title">Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4981</span><span class="NLM_x">–</span> <span class="NLM_lpage">4991</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060435i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4981-4991&author=M.+W.+Martinauthor=J.+Newcombauthor=J.+J.+Nunesauthor=D.+C.+McGowanauthor=D.+M.+Armisteadauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+Bucknerauthor=L.+Chaiauthor=D.+Elbaumauthor=L.+F.+Epsteinauthor=T.+Faustauthor=S.+Flynnauthor=P.+Gallantauthor=A.+Goreauthor=Y.+Guauthor=F.+Hsiehauthor=X.+Huangauthor=J.+H.+Leeauthor=D.+Metzauthor=S.+Middletonauthor=D.+Mohnauthor=K.+Morgensternauthor=M.+J.+Morrisonauthor=P.+M.+Novakauthor=A.+Oliveira-dos-Santosauthor=D.+Powersauthor=P.+Roseauthor=S.+Schneiderauthor=S.+Sellauthor=Y.+Tudorauthor=S.+M.+Turciauthor=A.+Welcherauthor=R.+D.+Whiteauthor=D.+Zackauthor=H.+Zhaoauthor=L.+Zhuauthor=X.+Zhuauthor=C.+Ghironauthor=P.+Amouzeghauthor=M.+Ermannauthor=J.+Jenkinsauthor=D.+Johnstonauthor=S.+Napierauthor=E.+Power&title=Novel+2-aminopyrimidine+carbamates+as+potent+and+orally+active+inhibitors+of+Lck%3A+synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6o&amp;dbid=16384&amp;doi=10.1021%2Fjm060435i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060435i%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DArmistead%26aufirst%3DD.%2BM.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DElbaum%26aufirst%3DD.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DNovak%26aufirst%3DP.%2BM.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DSell%26aufirst%3DS.%26aulast%3DTudor%26aufirst%3DY.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZack%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DAmouzegh%26aufirst%3DP.%26aulast%3DErmann%26aufirst%3DM.%26aulast%3DJenkins%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DD.%26aulast%3DNapier%26aufirst%3DS.%26aulast%3DPower%26aufirst%3DE.%26atitle%3DNovel%25202-aminopyrimidine%2520carbamates%2520as%2520potent%2520and%2520orally%2520active%2520inhibitors%2520of%2520Lck%253A%2520synthesis%252C%2520SAR%252C%2520and%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4981%26epage%3D4991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cee, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodous, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5671</span><span class="NLM_x">–</span> <span class="NLM_lpage">5686</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0605482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6p&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVChsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5671-5686&author=E.+F.+DiMauroauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+H.+Bucknerauthor=V.+J.+Ceeauthor=L.+Chaiauthor=H.+L.+Deakauthor=L.+F.+Epsteinauthor=T.+Faustauthor=P.+Gallantauthor=S.+D.+Geuns-Meyerauthor=A.+Goreauthor=Y.+Guauthor=B.+Henkleauthor=B.+L.+Hodousauthor=F.+Hsiehauthor=X.+Huangauthor=J.+L.+Kimauthor=J.+H.+Leeauthor=M.+W.+Martinauthor=C.+E.+Masseauthor=D.+C.+McGowanauthor=D.+Metzauthor=D.+Mohnauthor=K.+A.+Morgensternauthor=A.+Oliveira-dos-Santosauthor=V.+F.+Patelauthor=D.+Powersauthor=P.+E.+Roseauthor=S.+Schneiderauthor=S.+A.+Tomlinsonauthor=Y-Y.+Tudorauthor=S.+M.+Turciauthor=A.+A.+Welcherauthor=R.+D.+Whiteauthor=H.+Zhaoauthor=L.+Zhuauthor=X.+Zhu&title=Discovery+of+aminoquinazolines+as+potent%2C+orally+bioavailable+inhibitors+of+Lck%3A+synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6pR"><div class="casContent"><span class="casTitleNuber">6p</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck: Synthesis, SAR, and in Vivo Anti-Inflammatory Activity</span></div><div class="casAuthors">DiMauro, Erin F.; Newcomb, John; Nunes, Joseph J.; Bemis, Jean E.; Boucher, Christina; Buchanan, John L.; Buckner, William H.; Cee, Victor J.; Chai, Lilly; Deak, Holly L.; Epstein, Linda F.; Faust, Ted; Gallant, Paul; Geuns-Meyer, Stephanie D.; Gore, Anu; Gu, Yan; Henkle, Brad; Hodous, Brian L.; Hsieh, Faye; Huang, Xin; Kim, Joseph L.; Lee, Josie H.; Martin, Matthew W.; Masse, Craig E.; McGowan, David C.; Metz, Daniela; Mohn, Deanna; Morgenstern, Kurt A.; Oliveira-dos-Santos, Antonio; Patel, Vinod F.; Powers, David; Rose, Paul E.; Schneider, Stephen; Tomlinson, Susan A.; Tudor, Yan-Yan; Turci, Susan M.; Welcher, Andrew A.; White, Ryan D.; Zhao, Huilin; Zhu, Li; Zhu, Xiaotian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5671-5686</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lymphocyte-specific kinase (Lck) is a cytoplasmic tyrosine kinase of the Src family expressed in T cells and natural killer (NK) cells.  Genetic evidence in both mice and humans demonstrates that Lck kinase activity is crit. for signaling mediated by the T cell receptor (TCR), which leads to normal T cell development and activation.  Selective inhibition of Lck is expected to offer a new therapy for the treatment of T-cell-mediated autoimmune and inflammatory disease.  Screening of our kinase-preferred collection identified aminoquinazoline I as a potent, nonselective inhibitor of Lck and T cell proliferation.  In this report, we describe the synthesis and structure-activity relationships of a series of novel aminoquinazolines possessing in vitro mechanism-based potency.  Two optimized, orally bioavailable compds. exhibit antiinflammatory activity (ED50 of 22 and 11 mg/kg, resp.) in the anti-CD3-induced prodn. of interleukin-2 (IL-2) in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7qaZo8QJ6bVg90H21EOLACvtfcHk0lgYciH64cUonw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVChsLk%253D&md5=3ed1152bf34749755fdd9c2f8f25950c</span></div><a href="/servlet/linkout?suffix=cit6p&amp;dbid=16384&amp;doi=10.1021%2Fjm0605482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605482%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%2BH.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%2BD.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DHodous%26aufirst%3DB.%2BL.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMasse%26aufirst%3DC.%2BE.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DMorgenstern%26aufirst%3DK.%2BA.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTomlinson%26aufirst%3DS.%2BA.%26aulast%3DTudor%26aufirst%3DY-Y.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%2BA.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520aminoquinazolines%2520as%2520potent%252C%2520orally%2520bioavailable%2520inhibitors%2520of%2520Lck%253A%2520synthesis%252C%2520SAR%252C%2520and%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5671%26epage%3D5686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Abbott, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrnciar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morytko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span> </span><span class="NLM_article-title">Discovery of thienopyridines as Src-family selective Lck inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1167</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1167-1171&author=L.+Abbottauthor=P.+Betschmannauthor=A.+Burchatauthor=D.+J.+Calderwoodauthor=H.+Davisauthor=P.+Hrnciarauthor=G.+C.+Hirstauthor=B.+Liauthor=M.+Morytkoauthor=K.+Mullenauthor=B.+Yang&title=Discovery+of+thienopyridines+as+Src-family+selective+Lck+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6q&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DL.%26aulast%3DBetschmann%26aufirst%3DP.%26aulast%3DBurchat%26aufirst%3DA.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DDavis%26aufirst%3DH.%26aulast%3DHrnciar%26aufirst%3DP.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DMorytko%26aufirst%3DM.%26aulast%3DMullen%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520thienopyridines%2520as%2520Src-family%2520selective%2520Lck%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1167%26epage%3D1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hseih, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of novel 2,3-diarylfuro[2,3-<i>b</i>]pyridin-4-amines as potent and selective inhibitors of Lck: synthesis, SAR, and pharmacokinetic properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2209</span><span class="NLM_x">–</span> <span class="NLM_lpage">2304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2209-2304&author=M.+W.+Martinauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=J.+L.+Buchananauthor=E.+F.+DiMauroauthor=D.+C.+McGowanauthor=R.+D.+Whiteauthor=C.+Boucherauthor=T.+Faustauthor=F.+Hseihauthor=J.+H.+Leeauthor=S.+Schneiderauthor=S.+M.+Turciauthor=X.+Zhu&title=Discovery+of+novel+2%2C3-diarylfuro%5B2%2C3-b%5Dpyridin-4-amines+as+potent+and+selective+inhibitors+of+Lck%3A+synthesis%2C+SAR%2C+and+pharmacokinetic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6r&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DHseih%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%25202%252C3-diarylfuro%255B2%252C3-b%255Dpyridin-4-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520synthesis%252C%2520SAR%252C%2520and%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2209%26epage%3D2304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of 4-amino-5,6-biaryl-furo[2,3-<i>d</i>]pyrimidines as inhibitors of Lck: development of an expedient and divergent synthetic route and preliminary SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2305</span><span class="NLM_x">–</span> <span class="NLM_lpage">2309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2305-2309&author=E.+F.+DiMauroauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+H.+Bucknerauthor=T.+Faustauthor=F.+Hsiehauthor=J.+H.+Leeauthor=M.+W.+Martinauthor=D.+C.+McGowanauthor=T.+L.+Marshallauthor=S.+Schneiderauthor=S.+M.+Turciauthor=R.+D.+Whiteauthor=X.+Zhu&title=Discovery+of+4-amino-5%2C6-biaryl-furo%5B2%2C3-d%5Dpyrimidines+as+inhibitors+of+Lck%3A+development+of+an+expedient+and+divergent+synthetic+route+and+preliminary+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6s&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%2BH.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DMarshall%26aufirst%3DT.%2BL.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%25204-amino-5%252C6-biaryl-furo%255B2%252C3-d%255Dpyrimidines%2520as%2520inhibitors%2520of%2520Lck%253A%2520development%2520of%2520an%2520expedient%2520and%2520divergent%2520synthetic%2520route%2520and%2520preliminary%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2305%26epage%3D2309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhamra, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, A. W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hind, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranshaw, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skone, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickerstaff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washington, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-4-Pyrimidinyl-1<i>H</i>-indazol-4-amine inhibitors of Lck: indazoles as phenol isosteres with improved pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4363</span><span class="NLM_x">–</span> <span class="NLM_lpage">4368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4363-4368&author=P.+Bamboroughauthor=R.+M.+Angellauthor=I.+Bhamraauthor=D.+Brownauthor=J.+Bullauthor=J.+A.+Christopherauthor=A.+W.+J.+Cooperauthor=L.+H.+Fazalauthor=I.+Giordanoauthor=L.+Hindauthor=V.+K.+Patelauthor=L.+E.+Ranshawauthor=M.+J.+Simsauthor=P.+A.+Skoneauthor=K.+J.+Smithauthor=E.+Vickerstaffauthor=M.+Washington&title=N-4-Pyrimidinyl-1H-indazol-4-amine+inhibitors+of+Lck%3A+indazoles+as+phenol+isosteres+with+improved+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6t&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DBhamra%26aufirst%3DI.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBull%26aufirst%3DJ.%26aulast%3DChristopher%26aufirst%3DJ.%2BA.%26aulast%3DCooper%26aufirst%3DA.%2BW.%2BJ.%26aulast%3DFazal%26aufirst%3DL.%2BH.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DHind%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DRanshaw%26aufirst%3DL.%2BE.%26aulast%3DSims%26aufirst%3DM.%2BJ.%26aulast%3DSkone%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DVickerstaff%26aufirst%3DE.%26aulast%3DWashington%26aufirst%3DM.%26atitle%3DN-4-Pyrimidinyl-1H-indazol-4-amine%2520inhibitors%2520of%2520Lck%253A%2520indazoles%2520as%2520phenol%2520isosteres%2520with%2520improved%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4363%26epage%3D4368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Martin, M. W.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, S.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A. A.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, D.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiron, C.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermann, M.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saluste, C.-G. P.</span><div class="note"><p class="first last"> “Structure-based design of novel 2-amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity. <i>J. Med. Chem.</i>, in press.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Martin%2C+M.+W.%3B%3B+Newcomb%2C+J.%3B%3B+Nunes%2C+J.+J.%3B%3B+Boucher%2C+C.%3B%3B+Chai%2C+L.%3B%3B+Epstein%2C+L.+F.%3B%3B+Faust%2C+T.%3B%3B+Flores%2C+S.%3B%3B+Gallant%2C+P.%3B%3B+Gore%2C+A.%3B%3B+Gu%2C+Y.%3B%3B+Hsieh%2C+F.%3B%3B+Huang%2C+X.%3B%3B+Kim%2C+J.+L.%3B%3B+Middleton%2C+S.%3B%3B+Morgenstern%2C+K.%3B%3B+Oliveira-dos-Santos%2C+A.%3B%3B+Patel%2C+V.+F.%3B%3B+Powers%2C+D.%3B%3B+Rose%2C+P.%3B%3B+Tudor%2C+Y.%3B%3B+Turci%2C+S.+M.%3B%3B+Welcher%2C+A.+A.%3B%3B+Zack%2C+D.%3B%3B+Zhao%2C+H.%3B%3B+Zhu%2C+L.%3B%3B+Zhu%2C+X.%3B%3B+Ghiron%2C+C.%3B%3B+Ermann%2C+M.%3B%3B+Johnston%2C+D.%3B%3B+Saluste%2C+C.-G.+P.%E2%80%89%E2%80%9CStructure-based+design+of+novel+2-amino-6-phenyl-pyrimido%5B5%E2%80%B2%2C4%E2%80%B2%3A5%2C6%5Dpyrimido%5B1%2C2-a%5Dbenzimidazol-5%286H%29-ones+as+potent+and+orally+active+inhibitors+of+lymphocyte+specific+kinase+%28Lck%29%3A+synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity.+J.+Med.+Chem.%2C+in+press."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6u&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DFlores%26aufirst%3DS.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%26aulast%3DTudor%26aufirst%3DY.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%2BA.%26aulast%3DZack%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DErmann%26aufirst%3DM.%26aulast%3DJohnston%26aufirst%3DD.%26aulast%3DSaluste%26aufirst%3DC.-G.%2BP." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><div class="note"><p class="first last">Selectivity over KDR, Tie-2, and the Janus kinase family is important with respect to establishing an adequate therapeutic index.</p></div><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lanier, L. L.</span><span> </span><span class="NLM_article-title">Natural killer cell receptor signaling</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span>− <span class="NLM_lpage">314</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2FS0952-7915%2803%2900039-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=12787756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Knt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=308-314&author=L.+L.+Lanier&title=Natural+killer+cell+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Natural killer cell receptor signaling</span></div><div class="casAuthors">Lanier, Lewis L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-314</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Natural killer (NK) cell immune responses are regulated by a balance of activating and inhibitory signals transmitted by cell surface receptors.  Immunoreceptor tyrosine-based inhibition motifs in the cytoplasmic domains of inhibitory NK receptors recruit tyrosine or lipid phosphatases, which modulate the activation signals transmitted by receptors linked to the Syk and ZAP70 tyrosine kinases and phosphatidylinositol-3 kinases.  In addn., recent studies of gene-deficient animals, in particular Syk and ZAP70 double-deficient mice, suggest that NK cells possess a robust and potentially redundant receptor system to ensure their development and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTfuH60nipk7Vg90H21EOLACvtfcHk0lgF-YUDPm7bSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Knt70%253D&md5=add9ccc68c130bad752351e143ae854b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2803%2900039-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252803%252900039-6%26sid%3Dliteratum%253Aachs%26aulast%3DLanier%26aufirst%3DL.%2BL.%26atitle%3DNatural%2520killer%2520cell%2520receptor%2520signaling%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2003%26volume%3D15%26spage%3D308%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Thurston, G.</span><span> </span><span class="NLM_article-title">Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis</span> <span class="citation_source-journal">Cell Tissue Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1007%2Fs00441-003-0749-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=12915980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2003&pages=61-68&author=G.+Thurston&title=Role+of+angiopoietins+and+Tie+receptor+tyrosine+kinases+in+angiogenesis+and+lymphangiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis</span></div><div class="casAuthors">Thurston, Gavin</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-68</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  The author focuses on the signaling system involving the angiopoietin1/Tie2 receptor, which appears to be involved in the secondary stages of blood vessel formation.  Although this system is crucial for blood and lymphatic vessel formation, identifying its precise role in embryonic and adult vascular biol. has been a major challenge.  The evidence for the key role of the angiopoietin/Tie system is discussed, and some of the other members of the system (Ang2, Tie1) are mentioned.  A comparison is made with the VEGF signaling system, which seems to provide a complementary, and somewhat more tractable, signaling system.  Some of the basic unanswered questions concerning Tie/angiopoietin biol. and the secondary stages of blood vessel formation are also highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTV22jLj5PybVg90H21EOLACvtfcHk0lgF-YUDPm7bSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmu7s%253D&md5=22a18dfb2e3575b49c009509a6214434</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1007%2Fs00441-003-0749-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-003-0749-6%26sid%3Dliteratum%253Aachs%26aulast%3DThurston%26aufirst%3DG.%26atitle%3DRole%2520of%2520angiopoietins%2520and%2520Tie%2520receptor%2520tyrosine%2520kinases%2520in%2520angiogenesis%2520and%2520lymphangiogenesis%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2003%26volume%3D314%26spage%3D61%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ahmed, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward, W. P.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor (VEGF) inhibition by small molecules</span> <span class="citation_source-journal">J. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15688612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFantb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=59-63&author=S.+I.+Ahmedauthor=A.+L.+Thomasauthor=W.+P.+Steward&title=Vascular+endothelial+growth+factor+%28VEGF%29+inhibition+by+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor (VEGF) inhibition by small molecules</span></div><div class="casAuthors">Ahmed, S. I.; Thomas, A. L.; Steward, W. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemotherapy (Firenze, Italy)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">Suppl. 4</span>),
    <span class="NLM_cas:pages">59-63</span>CODEN:
                <span class="NLM_cas:coden">JCHEEU</span>;
        ISSN:<span class="NLM_cas:issn">1120-009X</span>.
    
            (<span class="NLM_cas:orgname">E.S.I.F.T. srl</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is essential for primary tumors to grow and metastasise, and is driven by the prodn. of pos. angiogenic factors.  The Vascular Endothelial Growth Factor (VEGF) family is central to the process of angiogenesis and comprises 5 mols. designated A, B, C, D and E.  VEGF is overexpressed in several solid malignancies.  The actions of VEGF are mediated through receptors possessing tyrosine kinase activity: VEGFR-1 (Flt-1), VEGFR-2 (Kdr/Flk-1) and VEGFR-3 (Flt-4).  Anti-VEGF strategies include the use of antibodies to VEGF or its receptors, the use of ribozymes to decrease receptor expression, and the use of inhibitors of tyrosine kinase to reduce receptor activation and downstream signalling.  The focus of this review is small mol. inhibitors of VEGF receptors which target their intrinsic tyrosine kinase activity.  The clin. development of the following agents is discussed: SU5416, SU11248, SU6668, PTK/ZK, ZD6474.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvEoRDCaYsR7Vg90H21EOLACvtfcHk0lgF-YUDPm7bSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFantb0%253D&md5=4646b63518c4ff1234ae9771927c1e87</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%2BI.%26aulast%3DThomas%26aufirst%3DA.%2BL.%26aulast%3DSteward%26aufirst%3DW.%2BP.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520%2528VEGF%2529%2520inhibition%2520by%2520small%2520molecules%26jtitle%3DJ.%2520Chemother.%26date%3D2004%26volume%3D16%26spage%3D59%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Paz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span> </span><span class="NLM_article-title">Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.2741%2F1629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15769635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVekurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1415-1439&author=K.+Pazauthor=Z.+Zhu&title=Development+of+angiogenesis+inhibitors+to+vascular+endothelial+growth+factor+receptor+2.+Current+status+and+future+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective</span></div><div class="casAuthors">Paz, Keren; Zhu, Zhenping</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1415-1439</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Angiogenesis, the recruitment of new blood vessels is a crucial mechanism required for both tumor growth and metastasis.  Advances in the understanding of the mol. mechanisms underlying the angiogenesis process have led to the discovery of a variety of pharmaceutical agents with antiangiogenic activity.  The potential application of these angiogenesis inhibitors is currently under intense clin. investigation.  Decades of investigation suggest that vascular endothelial growth factor (VEGF) and its receptors, particularly VEGF receptor 2 (VEGFR2, or kinase insert domain-contg. receptor, KDR), play a crit. role in tumor-assocd. angiogenesis.  KDR, therefore, represents a good target for therapeutic intervention.  A no. of agents designed selectively for targeting KDR are being evaluated in various phases of clin. trials in cancer patients.  This Manuscript reviews briefly the biol. of VEGF family of ligands and receptors and of KDR in particular.  The attempts to develop effective KDR antagonists, including small mols., antibodies and others, for therapeutic purposes are discussed comprehensively with special emphasis on tumor angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWzpjh84lYrVg90H21EOLACvtfcHk0lgF-YUDPm7bSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVekurg%253D&md5=8f8bdb8650b7822f55189835489f4edc</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.2741%2F1629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F1629%26sid%3Dliteratum%253Aachs%26aulast%3DPaz%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DDevelopment%2520of%2520angiogenesis%2520inhibitors%2520to%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%25202.%2520Current%2520status%2520and%2520future%2520perspective%26jtitle%3DFront.%2520Biosci.%26date%3D2005%26volume%3D10%26spage%3D1415%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Eskens, F. A. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verweij, J.</span><span> </span><span class="NLM_article-title">The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3127</span><span class="NLM_x">–</span> <span class="NLM_lpage">3139</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=3127-3139&author=F.+A.+L.+M.+Eskensauthor=J.+Verweij&title=The+clinical+toxicity+profile+of+vascular+endothelial+growth+factor+%28VEGF%29+and+vascular+endothelial+growth+factor+receptor+%28VEGFR%29+targeting+angiogenesis+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEskens%26aufirst%3DF.%2BA.%2BL.%2BM.%26aulast%3DVerweij%26aufirst%3DJ.%26atitle%3DThe%2520clinical%2520toxicity%2520profile%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520%2528VEGF%2529%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528VEGFR%2529%2520targeting%2520angiogenesis%2520inhibitors%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2006%26volume%3D42%26spage%3D3127%26epage%3D3139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Fiedler, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustin, H. G.</span><span> </span><span class="NLM_article-title">Angiopoietins: a link between angiogenesis and inflammation</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2Fj.it.2006.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=17045842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SjsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=552-558&author=U.+Fiedlerauthor=H.+G.+Augustin&title=Angiopoietins%3A+a+link+between+angiogenesis+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7f</span><div class="casTitle"><span class="NLM_cas:atitle">Angiopoietins: a link between angiogenesis and inflammation</span></div><div class="casAuthors">Fiedler, Ulrike; Augustin, Hellmut G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">552-558</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on the angiopoietin (Ang)-Tie ligand-receptor system role in regulating vascular integrity and quiescence and controlling endothelial cell responses during inflammation.  Ang-1-mediated Tie2 activation is required to maintain the quiescent resting state of the endothelium.  Agonistic Ang-1 functions are antagonized by Ang-2, which destabilizes the quiescent endothelium and primes it to respond to exogenous stimuli, thereby facilitating the activities of inflammatory (TNF and IL-1) and angiogenic ( VEGF) cytokines.  Intriguingly, Ang-2 is expressed weakly by the resting endothelium but becomes strongly upregulated following endothelial activation.  Moreover, endothelial cells store Ang-2 in Weibel-Palade bodies from where it can be made available quickly following stimulation, suggesting a role of Ang-2 in controlling rapid vascular adaptive processes.  This suggests that Ang-2 is the dynamic regulator of the Ang-Tie2 axis, thereby functioning as a built-in switch controlling the transition of the resting quiescent endothelium towards the activated responsive endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwYH_Bcsmez7Vg90H21EOLACvtfcHk0lgm0B11sTLDBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SjsrbM&md5=0b299c0063302d43bd28a93a9b8b52a2</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2006.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2006.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DFiedler%26aufirst%3DU.%26aulast%3DAugustin%26aufirst%3DH.%2BG.%26atitle%3DAngiopoietins%253A%2520a%2520link%2520between%2520angiogenesis%2520and%2520inflammation%26jtitle%3DTrends%2520Immunol.%26date%3D2006%26volume%3D27%26spage%3D552%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Tamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, A.</span><span> </span><span class="NLM_article-title">Tyrosine kinases as targets for anti-inflammatory therapy</span> <span class="citation_source-journal">Anti-Inflammatory Anti-Allergy Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.2174%2F187152307779939732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=47-62&author=T.+Tamuraauthor=A.+Koch&title=Tyrosine+kinases+as+targets+for+anti-inflammatory+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7gR"><div class="casContent"><span class="casTitleNuber">7g</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinases as targets for anti-inflammatory therapy</span></div><div class="casAuthors">Tamura, Teruko; Koch, Alexandra</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-60</span>CODEN:
                <span class="NLM_cas:coden">AAAMC6</span>;
        ISSN:<span class="NLM_cas:issn">1871-5230</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tyrosine kinases play key roles in cell proliferation, differentiation, survival, cell migration, tissue development, and cell metabs.  Mutation and /or truncation in tyrosine kinases result in their constitutive activation independent of ligand stimulation.  The constitutively activated tyrosine kinase often triggers cancer development.  Furthermore, it is well documented that overexpression of tyrosine kinases is involved in malignancy.  In inflammatory lesion, tyrosine kinases are also activated via over-prodn. of growth factors and/or cytokines from tissues.  Several recent studies have demonstrated that targeting tyrosine kinases in inflammatory disease may lead to an useful therapy.  In this review, we describe tyrosine kinases that are or may be involved in inflammatory disease such as stem cell factor (SCF) receptor (c-Kit), platelet derived growth factor (PDGF) receptors, macrophage colony stimulating factor (M-CSF) receptor (c-Fms), Trk receptors, vascular endothelial growth factor (VEGF) receptors, fibroblast growth factor (FGF) receptors, epidermal growth factor (EGF) receptors, macrophage stimulating protein receptor (Ron), Janus kinases (Jak), and spleen tyrosine kinase (Syk)/zeta-chain assocd. protein kinase of 70 kDa (ZAP-70).  In addn. we describe potential tools and methods that can be applied for therapy, such as small mol. kinase inhibitors, antibodies, small peptides, or truncated receptors.  Since inflammatory diseases are generally complex host reactions for a long term, and tyrosine kinases are important for maintenance of cell homeostasis, a successful tyrosine kinase targeting therapy will require many further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2v7QF92n9TrVg90H21EOLACvtfcHk0lgm0B11sTLDBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWit74%253D&md5=ce01299b4770f677c8e6622f08a32f5f</span></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.2174%2F187152307779939732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152307779939732%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DKoch%26aufirst%3DA.%26atitle%3DTyrosine%2520kinases%2520as%2520targets%2520for%2520anti-inflammatory%2520therapy%26jtitle%3DAnti-Inflammatory%2520Anti-Allergy%2520Agents%2520Med.%2520Chem.%26date%3D2007%26volume%3D6%26spage%3D47%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">The conformational plasticity of protein kinases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2FS0092-8674%2802%2900741-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=12015977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvV2lsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=275-282&author=M.+Huseauthor=J.+Kuriyan&title=The+conformational+plasticity+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">The conformational plasticity of protein kinases</span></div><div class="casAuthors">Huse, Morgan; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">275-282</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with 48 refs.  Protein kinases operate in a large no. of distinct signaling pathways, where the tight regulation of their catalytic activity is crucial to the development and maintenance of eukaryotic organisms.  The catalytic domains of different kinases adopt strikingly similar structures when they are active.  By contrast, crystal structures of inactive kinases have revealed a marked plasticity in the kinase domain that allows the adoption of distinct conformations in response to interactions with specific regulatory domains or proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJrn7F3h4ej7Vg90H21EOLACvtfcHk0lgm0B11sTLDBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvV2lsLw%253D&md5=cd56edae94ad239f2ce7a5d6c8930cbb</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2900741-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252900741-9%26sid%3Dliteratum%253Aachs%26aulast%3DHuse%26aufirst%3DM.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DThe%2520conformational%2520plasticity%2520of%2520protein%2520kinases%26jtitle%3DCell%26date%3D2002%26volume%3D109%26spage%3D275%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schindler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicena, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1938</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1126%2Fscience.289.5486.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=10988075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1altLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1938-1942&author=T.+Schindlerauthor=W.+Bornmannauthor=P.+Pellicenaauthor=W.+T.+Millerauthor=B.+Clarksonauthor=J.+Kuriyan&title=Structural+mechanism+for+STI-571+inhibition+of+Abelson+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase</span></div><div class="casAuthors">Schindler, Thomas; Bornmann, William; Pellicena, Patricia; Miller, W. Todd; Clarkson, Bayard; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5486</span>),
    <span class="NLM_cas:pages">1938-1942</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The inadvertent activation of the Abelson tyrosine kinase (Abl) causes chronic myelogenous leukemia (CML).  A small-mol. inhibitor of Abl (STI-571) is effective in the treatment of CML.  We report the crystal structure of the catalytic domain of Abl, complexed to a variant of STI-571.  Crit. to the binding of STI-571 is the adoption by the kinase of an inactive conformation, in which a centrally located "activation loop" is not phosphorylated.  The conformation of this loop is distinct from that in active protein kinases, as well as in the inactive form of the closely related Src kinases.  These results suggest that compds. that exploit the distinctive inactivation mechanisms of individual protein kinases can achieve both high affinity and high specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9eAZqIQ1aebVg90H21EOLACvtfcHk0lgFtpU_LQQwyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1altLc%253D&md5=56bb233f010f099d0073020ac6b9db59</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5486.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5486.1938%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DPellicena%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DW.%2BT.%26aulast%3DClarkson%26aufirst%3DB.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DStructural%2520mechanism%2520for%2520STI-571%2520inhibition%2520of%2520Abelson%2520tyrosine%2520kinase%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1938%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mol, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheibe, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. P.</span><span> </span><span class="NLM_article-title">Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">31655</span><span class="NLM_x">–</span> <span class="NLM_lpage">31663</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1074%2Fjbc.M403319200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15123710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslOrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=31655-31663&author=C.+D.+Molauthor=D.+R.+Douganauthor=T.+R.+Schneiderauthor=R.+J.+Skeneauthor=M.+L.+Krausauthor=D.+N.+Scheibeauthor=G.+P.+Snellauthor=H.+Zouauthor=B.-C.+Sangauthor=K.+P.+Wilson&title=Structural+basis+for+the+autoinhibition+and+STI-571+inhibition+of+c-Kit+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase</span></div><div class="casAuthors">Mol, Clifford D.; Dougan, Douglas R.; Schneider, Thomas R.; Skene, Robert J.; Kraus, Michelle L.; Scheibe, Daniel N.; Snell, Gyorgy P.; Zou, Hua; Sang, Bi-Ching; Wilson, Keith P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">31655-31663</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The activity of the c-Kit receptor protein-tyrosine kinase is tightly regulated in normal cells, whereas deregulated c-Kit kinase activity is implicated in the pathogenesis of human cancers.  The c-Kit juxtamembrane region is known to have an autoinhibitory function; however the precise mechanism by which c-Kit is maintained in an autoinhibited state is not known.  We report the 1.9-Å resoln. crystal structure of native c-Kit kinase in an autoinhibited conformation and compare it with active c-Kit kinase.  Autoinhibited c-Kit is stabilized by the juxtamembrane domain, which inserts into the kinase-active site and disrupts formation of the activated structure.  A 1.6-Å crystal structure of c-Kit in complex with STI-571 (Imatinib or Gleevec) demonstrates that inhibitor binding disrupts this natural mechanism for maintaining c-Kit in an autoinhibited state.  Together, these results provide a structural basis for understanding c-Kit kinase autoinhibition and will facilitate the structure-guided design of specific inhibitors that target the activated and autoinhibited conformations of c-Kit kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWJsKx1IzXQbVg90H21EOLACvtfcHk0lgFtpU_LQQwyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslOrtrc%253D&md5=df6065a62b44e4c2e6b020da0f797ab4</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M403319200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M403319200%26sid%3Dliteratum%253Aachs%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DSchneider%26aufirst%3DT.%2BR.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DKraus%26aufirst%3DM.%2BL.%26aulast%3DScheibe%26aufirst%3DD.%2BN.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DSang%26aufirst%3DB.-C.%26aulast%3DWilson%26aufirst%3DK.%2BP.%26atitle%3DStructural%2520basis%2520for%2520the%2520autoinhibition%2520and%2520STI-571%2520inhibition%2520of%2520c-Kit%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D31655%26epage%3D31663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Deak, H. L.; Newcomb, J.; Nunes, J. J.; DiMauro, E. F.; Hodous, B. L.; Patel, V. F.; Boucher, C.; Cheng, A.; Epstein, L.; Gallant, P.; Huang, X.; Lee, J. H.; Schneider, S.; Turci, S. M.; Zhu, X.</span><span> </span><span class="NLM_article-title"><i>N</i>-3-(Phenylcarbamoyl)arylpyrimidine-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><div class="note"><p class="first last"><b>2008</b>, <i>18</i>, 1172–1176.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Deak%2C+H.+L.%3B+Newcomb%2C+J.%3B+Nunes%2C+J.+J.%3B+DiMauro%2C+E.+F.%3B+Hodous%2C+B.+L.%3B+Patel%2C+V.+F.%3B+Boucher%2C+C.%3B+Cheng%2C+A.%3B+Epstein%2C+L.%3B+Gallant%2C+P.%3B+Huang%2C+X.%3B+Lee%2C+J.+H.%3B+Schneider%2C+S.%3B+Turci%2C+S.+M.%3B+Zhu%2C+X.+N-3-%28Phenylcarbamoyl%29arylpyrimidine-5-carboxamides+as+potent+and+selective+inhibitors+of+Lck%3A+structure%2C+synthesis+and+SAR.+Bioorg.+Med.+Chem.+Lett.2008%2C+18%2C+1172%E2%80%931176."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeak%26aufirst%3DH.%2BL.%26atitle%3DN-3-%2528Phenylcarbamoyl%2529arylpyrimidine-5-carboxamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520structure%252C%2520synthesis%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsukura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niijima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotake, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horizoe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaoka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, S.</span><span> </span><span class="NLM_article-title">2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure−activity relationships toward hepatic glucose production induced via agonism of the A<sub>2B</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990499b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=170-179&author=H.+Haradaauthor=O.+Asanoauthor=Y.+Hoshinoauthor=S.+Yoshikawaauthor=M.+Matsukuraauthor=Y.+Kabasawaauthor=J.+Niijimaauthor=Y.+Kotakeauthor=N.+Watanabeauthor=T.+Kawataauthor=T.+Inoueauthor=T.+Horizoeauthor=N.+Yasudaauthor=H.+Minamiauthor=K.+Nagataauthor=M.+Murakamiauthor=J.+Nagaokaauthor=S.+Kobayashiauthor=I.+Tanakaauthor=S.+Abe&title=2-Alkynyl-8-aryl-9-methyladenines+as+novel+adenosine+receptor+antagonists%3A+their+synthesis+and+structure%E2%88%92activity+relationships+toward+hepatic+glucose+production+induced+via+agonism+of+the+A2B+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm990499b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990499b%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DAsano%26aufirst%3DO.%26aulast%3DHoshino%26aufirst%3DY.%26aulast%3DYoshikawa%26aufirst%3DS.%26aulast%3DMatsukura%26aufirst%3DM.%26aulast%3DKabasawa%26aufirst%3DY.%26aulast%3DNiijima%26aufirst%3DJ.%26aulast%3DKotake%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DKawata%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DHorizoe%26aufirst%3DT.%26aulast%3DYasuda%26aufirst%3DN.%26aulast%3DMinami%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DMurakami%26aufirst%3DM.%26aulast%3DNagaoka%26aufirst%3DJ.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DI.%26aulast%3DAbe%26aufirst%3DS.%26atitle%3D2-Alkynyl-8-aryl-9-methyladenines%2520as%2520novel%2520adenosine%2520receptor%2520antagonists%253A%2520their%2520synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520toward%2520hepatic%2520glucose%2520production%2520induced%2520via%2520agonism%2520of%2520the%2520A2B%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D170%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nagar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicena, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veach, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">4236</span><span class="NLM_x">–</span> <span class="NLM_lpage">4243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=12154025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvFeltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=4236-4243&author=B.+Nagarauthor=W.+G.+Bornmannauthor=P.+Pellicenaauthor=T.+Schindlerauthor=D.+R.+Veachauthor=W.+T.+Millerauthor=B.+Clarksonauthor=J.+Kuriyan&title=Crystal+structures+of+the+kinase+domain+of+c-Abl+in+complex+with+the+small+molecule+inhibitors+PD173955+and+imatinib+%28STI-571%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)</span></div><div class="casAuthors">Nagar, Bhushan; Bornmann, William G.; Pellicena, Patricia; Schindler, Thomas; Veach, Darren R.; Miller, W. Todd; Clarkson, Bayard; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4236-4243</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The inadvertent fusion of the bcr gene with the abl gene results in a constitutively active tyrosine kinase (Bcr-Abl) that transforms cells and causes chronic myelogenous leukemia.  Small mol. inhibitors of Bcr-Abl that bind to the kinase domain can be used to treat chronic myelogenous leukemia.  We report crystal structures of the kinase domain of Abl in complex with two such inhibitors, imatinib (also known as STI-571 and Gleevec) and PD173955 (Parke-Davis).  Both compds. bind to the canonical ATP-binding site of the kinase domain, but they do so in different ways.  As shown previously in a crystal structure of Abl bound to a smaller variant of STI-571, STI-571 captures a specific inactive conformation of the activation loop of Abl in which the loop mimics bound peptide substrate.  In contrast, PD173955 binds to a conformation of Abl in which the activation loop resembles that of an active kinase.  The structure suggests that PD173955 would be insensitive to whether the conformation of the activation loop corresponds to active kinases or to that seen in the STI-571 complex.  In vitro kinase assays confirm that this is the case and indicate that PD173955 is at least 10-fold more inhibitory than STI-571.  The structures suggest that PD173955 achieves its greater potency over STI-571 by being able to target multiple forms of Abl (active or inactive), whereas STI-571 requires a specific inactive conformation of Abl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-5qYZHMOZCrVg90H21EOLACvtfcHk0lgofgVDrannew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvFeltLY%253D&md5=843213cd6038ed82a0e43dce56e81a91</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagar%26aufirst%3DB.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DPellicena%26aufirst%3DP.%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DVeach%26aufirst%3DD.%2BR.%26aulast%3DMiller%26aufirst%3DW.%2BT.%26aulast%3DClarkson%26aufirst%3DB.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DCrystal%2520structures%2520of%2520the%2520kinase%2520domain%2520of%2520c-Abl%2520in%2520complex%2520with%2520the%2520small%2520molecule%2520inhibitors%2520PD173955%2520and%2520imatinib%2520%2528STI-571%2529%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D4236%26epage%3D4243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitfelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span> </span><span class="NLM_article-title">Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2994</span><span class="NLM_x">–</span> <span class="NLM_lpage">3008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020057r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2994-3008&author=J.+Reganauthor=S.+Breitfelderauthor=P.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=B.+Klausauthor=J.+Madwedauthor=M.+Moriakauthor=N.+Mossauthor=C.+Pargellisauthor=S.+Pavauthor=A.+Protoauthor=A.+Swinamerauthor=L.+Tongauthor=C.+Torcellini&title=Pyrazole+urea-based+inhibitors+of+p38+MAP+kinase%3A+from+lead+compound+to+clinical+candidate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate</span></div><div class="casAuthors">Regan, John; Breitfelder, Steffen; Cirillo, Pier; Gilmore, Thomas; Graham, Anne G.; Hickey, Eugene; Klaus, Bernhard; Madwed, Jeffrey; Moriak, Monica; Moss, Neil; Pargellis, Chris; Pav, Sue; Proto, Alfred; Swinamer, Alan; Tong, Liang; Torcellini, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2994-3008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on a series of N-pyrazole, N'-aryl ureas and their mode of binding to p38 mitogen activated protein kinase.  Importantly, a key binding domain that is distinct from the ATP (ATP) binding site is exposed when the conserved activation loop, consisting in part of Asp168-Phe169-Gly170, adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein.  We describe the correlation of the structure-activity relationships and crystallog. structures of these inhibitors with p38.  In addn., we incorporated another binding pharmacophore that forms a hydrogen bond at the ATP binding site.  This modification affords significant improvements in binding, cellular, and in vivo potencies resulting in the selection of Compd. 45 (BIRB 796) as a clin. candidate for the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotOOfLV3xRbVg90H21EOLACvtfcHk0lgofgVDrannew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D&md5=e473f514179c8fe24ab3efccc292b6c6</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm020057r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020057r%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DBreitfelder%26aufirst%3DS.%26aulast%3DCirillo%26aufirst%3DP.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKlaus%26aufirst%3DB.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DTorcellini%26aufirst%3DC.%26atitle%3DPyrazole%2520urea-based%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%253A%2520from%2520lead%2520compound%2520to%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2994%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wan, P. T. C.; Garnett, M. J.; Roe, S. M.; Lee, S.; Niculescu-Duvaz, D.; Good, V. M.; Jones, C. M.; Marshall, C. J.; Springer, C. J.; Barford, D.; Marais, R.</span><span> </span><span class="NLM_article-title">Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-Raf</span> (Cancer Genome Project).  <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span>− <span class="NLM_lpage">867</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2FS0092-8674%2804%2900215-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15035987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVyksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=855-867&author=P.+T.+C.+Wan&author=M.+J.+Garnett&author=S.+M.+Roe&author=S.+Lee&author=D.+Niculescu-Duvaz&author=V.+M.+Good&author=C.+M.+Jones&author=C.+J.+Marshall&author=C.+J.+Springer&author=D.+Barford&author=R.+Marais&title=Mechanism+of+activation+of+the+RAF-ERK+signaling+pathway+by+oncogenic+mutations+of+B-Raf"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF</span></div><div class="casAuthors">Wan, Paul T. C.; Garnett, Mathew J.; Roe, S. Mark; Lee, Sharlene; Niculescu-Duvaz, Dan; Good, Valerie M.; Project, Cancer Genome; Jones, C. Michael; Marshall, Christopher J.; Springer, Caroline J.; Barford, David; Marais, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">855-867</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Over 30 mutations of the B-RAF gene assocd. with human cancers have been identified, the majority of which are located within the kinase domain.  Here the authors show that of 22 B-RAF mutants analyzed, 18 have elevated kinase activity and signal to ERK in vivo.  Surprisingly, three mutants have reduced kinase activity towards MEK in vitro but, by activating C-RAF in vivo, signal to ERK in cells.  The structures of wild type and oncogenic V599EB-RAF kinase domains in complex with the RAF inhibitor BAY43-9006 show that the activation segment is held in an inactive conformation by assocn. with the P loop.  The clustering of most mutations to these two regions suggests that disruption of this interaction converts B-RAF into its active conformation.  The high activity mutants signal to ERK by directly phosphorylating MEK, whereas the impaired activity mutants stimulate MEK by activating endogenous C-RAF, possibly via an allosteric or transphosphorylation mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYiQicwc1xVLVg90H21EOLACvtfcHk0lgofgVDrannew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVyksLw%253D&md5=4cc020056c64e514286c000666da1972</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2804%2900215-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252804%252900215-6%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DP.%2BT.%2BC.%26atitle%3DMechanism%2520of%2520activation%2520of%2520the%2520RAF-ERK%2520signaling%2520pathway%2520by%2520oncogenic%2520mutations%2520of%2520B-Raf%26jtitle%3DCell%26date%3D2004%26volume%3D116%26spage%3D855%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Padova, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucklin, G.</span><span> </span><span class="NLM_article-title">SAR of benzopyridines and benzophenones as p38a MAP kinase inhibitors with oral activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3601</span><span class="NLM_x">–</span> <span class="NLM_lpage">3605</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3601-3605&author=L.+Reveszauthor=E.+Blumauthor=F.+E.+Di+Padovaauthor=T.+Buhlauthor=R.+Feifelauthor=H.+Gramauthor=P.+Hiestandauthor=U.+Manningauthor=G.+Rucklin&title=SAR+of+benzopyridines+and+benzophenones+as+p38a+MAP+kinase+inhibitors+with+oral+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DBlum%26aufirst%3DE.%26aulast%3DDi%2BPadova%26aufirst%3DF.%2BE.%26aulast%3DBuhl%26aufirst%3DT.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DGram%26aufirst%3DH.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DManning%26aufirst%3DU.%26aulast%3DRucklin%26aufirst%3DG.%26atitle%3DSAR%2520of%2520benzopyridines%2520and%2520benzophenones%2520as%2520p38a%2520MAP%2520kinase%2520inhibitors%2520with%2520oral%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3601%26epage%3D3605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brüggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrich, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyhack, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J.</span><span> </span><span class="NLM_article-title">Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1697</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1697&publication_year=2004&pages=17-27&author=P.+W.+Manleyauthor=G.+Boldauthor=J.+Br%C3%BCggenauthor=G.+Fendrichauthor=P.+Furetauthor=J.+Mestanauthor=C.+Schnellauthor=B.+Stolzauthor=T.+Meyerauthor=B.+Meyhackauthor=W.+Starkauthor=A.+Straussauthor=J.+Wood&title=Advances+in+the+structural+biology%2C+design+and+clinical+development+of+VEGF-R+kinase+inhibitors+for+the+treatment+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DBr%25C3%25BCggen%26aufirst%3DJ.%26aulast%3DFendrich%26aufirst%3DG.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DStolz%26aufirst%3DB.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DMeyhack%26aufirst%3DB.%26aulast%3DStark%26aufirst%3DW.%26aulast%3DStrauss%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DJ.%26atitle%3DAdvances%2520in%2520the%2520structural%2520biology%252C%2520design%2520and%2520clinical%2520development%2520of%2520VEGF-R%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520angiogenesis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2004%26volume%3D1697%26spage%3D17%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Denni-Dischert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marterer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banziger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusuff, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.-M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taplin, F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Versace, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesarz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, L. B.</span><span> </span><span class="NLM_article-title">The synthesis of a novel B-Raf kinase inhibitor</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/doi/10.1021/op0501601" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11f&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yrs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=70-77&author=D.+Denni-Dischertauthor=W.+Martererauthor=M.+Banzigerauthor=N.+Yusuffauthor=D.+Battauthor=T.+Ramseyauthor=P.+Gengauthor=W.+Michaelauthor=R.-M.+B.+Wangauthor=F.+Taplinauthor=R.+Versaceauthor=D.+Cesarzauthor=L.+B.+Perez&title=The+synthesis+of+a+novel+B-Raf+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11fR"><div class="casContent"><span class="casTitleNuber">11f</span><div class="casTitle"><span class="NLM_cas:atitle">The Synthesis of a Novel Inhibitor of B-Raf Kinase</span></div><div class="casAuthors">Denni-Dischert, Donatienne; Marterer, Wolfgang; Baenziger, Markus; Yusuff, Naeem; Batt, David; Ramsey, Tim; Geng, Peng; Michael, Walter; Wang, Run-Ming B.; Taplin, Francis, Jr.; Versace, Richard; Cesarz, David; Perez, Lawrence B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-77</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A scalable synthetic route to the title compd. [4,7']bis-isoquinolinyl-(2-tert-butyl-5-pyrimidinyl)amine [i.e., N-[(tert-butyl)pyrimidinyl][4,7'-biisoquinolin]-1-amine], an inhibitor of B-Raf kinase is described.  The key step in the synthesis is the Pd-catalyzed Negishi coupling of 4-bromo-1-chloroisoquinoline with trifluoromethanesulfonic acid isoquinoline-7-yl ester to yield 1-chloro-4,7'-biisoquinoline.  This intermediate is transformed to the desired drug substance in one addnl. step, by reaction with 2-tert-butyl-5-aminopyrimidine in the presence of NaH.  A special focus was put on the finally successful removal of traces of Zn and Pd in the drug substance, which came from the Negishi coupling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmtZWYzSm1GrVg90H21EOLACvtfcHk0lhG37k6-V3QMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yrs7fK&md5=86a2ef46630b31506268f64481ecd734</span></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=10.1021%2Fop0501601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop0501601%26sid%3Dliteratum%253Aachs%26aulast%3DDenni-Dischert%26aufirst%3DD.%26aulast%3DMarterer%26aufirst%3DW.%26aulast%3DBanziger%26aufirst%3DM.%26aulast%3DYusuff%26aufirst%3DN.%26aulast%3DBatt%26aufirst%3DD.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DGeng%26aufirst%3DP.%26aulast%3DMichael%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DR.-M.%2BB.%26aulast%3DTaplin%26aufirst%3DF.%26aulast%3DVersace%26aufirst%3DR.%26aulast%3DCesarz%26aufirst%3DD.%26aulast%3DPerez%26aufirst%3DL.%2BB.%26atitle%3DThe%2520synthesis%2520of%2520a%2520novel%2520B-Raf%2520kinase%2520inhibitor%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2006%26volume%3D10%26spage%3D70%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">5-Cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38 MAP kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6261</span><span class="NLM_x">–</span> <span class="NLM_lpage">6270</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503594" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6261-6270&author=C.+Liuauthor=S.+T.+Wrobleskiauthor=J.+Linauthor=G.+Ahmedauthor=A.+Metzgerauthor=J.+Wityakauthor=K.+M.+Gilloolyauthor=D.+J.+Shusterauthor=K.+W.+McIntyreauthor=S.+Pittauthor=D.+R.+Shenauthor=R.+F.+Zhangauthor=H.+Zhangauthor=A.+M.+Doweykoauthor=D.+Dillerauthor=I.+Hendersonauthor=J.+C.+Barrishauthor=J.+H.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=5-Cyanopyrimidine+derivatives+as+a+novel+class+of+potent%2C+selective%2C+and+orally+active+inhibitors+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11g&amp;dbid=16384&amp;doi=10.1021%2Fjm0503594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503594%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DAhmed%26aufirst%3DG.%26aulast%3DMetzger%26aufirst%3DA.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DR.%2BF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DDiller%26aufirst%3DD.%26aulast%3DHenderson%26aufirst%3DI.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3D5-Cyanopyrimidine%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6261%26epage%3D6270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Rational design of inhibitors that bind to inactive conformations</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1038%2Fnchembio799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=16783341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=358-364&author=Y.+Liuauthor=N.+S.+Gray&title=Rational+design+of+inhibitors+that+bind+to+inactive+conformations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11hR"><div class="casContent"><span class="casTitleNuber">11h</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of inhibitors that bind to inactive kinase conformations</span></div><div class="casAuthors">Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The majority of kinase inhibitors, known as type I inhibitors that have been developed so far target the ATP binding site of the kinase in its active conformation, in which the activation loop is phosphorylated.  Recently, crystal structures of inhibitors such as imatinib, BIRB796, and sorafenib (BAY43-9006), known as type II inhibitors, have revealed a new binding mode that exploits an addnl. binding site immediately adjacent to the region occupied by ATP.  This pocket is made accessible by an activation-loop rearrangement that is characteristic of kinases in an inactive conformation.  The examn. of binding features of known type II inhibitors is discussed and a pharmacophore model currently used in the design of a new generation of structurally diverse type II inhibitors is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxahsMPlhgDbVg90H21EOLACvtfcHk0lhG37k6-V3QMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D&md5=4a9347a44a2cf4a412c9741fdcc5696b</span></div><a href="/servlet/linkout?suffix=cit11h&amp;dbid=16384&amp;doi=10.1038%2Fnchembio799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio799%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DRational%2520design%2520of%2520inhibitors%2520that%2520bind%2520to%2520inactive%2520conformations%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Okram, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spraggon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">A general strategy for creating “inactive-conformation” Abl inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11i&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2Fj.chembiol.2006.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11i&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=16873026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11i&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD28XntlGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=779-786&author=B.+Okramauthor=A.+Nagleauthor=F.+J.+Adrianauthor=C.+Leeauthor=P.+Renauthor=X.+Wangauthor=T.+Simauthor=Y.+Xieauthor=X.+Wangauthor=G.+Xiaauthor=G.+Spraggonauthor=M.+Warmuthauthor=Y.+Liuauthor=N.+S.+Gray&title=A+general+strategy+for+creating+%E2%80%9Cinactive-conformation%E2%80%9D+Abl+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11iR"><div class="casContent"><span class="casTitleNuber">11i</span><div class="casTitle"><span class="NLM_cas:atitle">A General Strategy for Creating "Inactive-Conformation" Abl Inhibitors</span></div><div class="casAuthors">Okram, Barun; Nagle, Advait; Adrian, Francisco J.; Lee, Christian; Ren, Pingda; Wang, Xia; Sim, Taebo; Xie, Yongping; Wang, Xing; Xia, Gang; Spraggon, Glen; Warmuth, Markus; Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">779-786</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Kinase inhibitors that bind to the ATP cleft can be broadly classified into two groups: Those that bind exclusively to the ATP site with the kinase assuming a conformation otherwise conducive to phosphotransfer (type I), and those that exploit a hydrophobic site immediately adjacent to the ATP pocket made accessible by a conformational rearrangement of the activation loop (type II).  To date, all type II inhibitors were discovered by using structure-activity-guided optimization strategies.  Here, we describe a general pharmacophore model of type II inhibition that enables a rational "hybrid-design" approach whereby a 3-trifluoromethylbenzamide functionality is appended to four distinct type I scaffolds in order to convert them into their corresponding type II counterparts.  We demonstrate that the designed compds. function as type II inhibitors by using biochem. and cellular kinase assays and by cocrystallog. with Abl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEmN-Rh-LxOLVg90H21EOLACvtfcHk0lhfhECa8K8_3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntlGisL0%253D&md5=84514353c00e20f85225f62d00dc2529</span></div><a href="/servlet/linkout?suffix=cit11i&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2006.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2006.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DOkram%26aufirst%3DB.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DAdrian%26aufirst%3DF.%2BJ.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DA%2520general%2520strategy%2520for%2520creating%2520%25E2%2580%259Cinactive-conformation%25E2%2580%259D%2520Abl%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D779%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">PP1: 4-amino-5-(4-methylphenyl)-7-(<i>tert</i>-butyl)pyrazolo[3,4-<i>d</i>]pyrimidine. PP2: 4-amino-5-(4-chlorophenyl)-7-(<i>tert</i>-butyl)pyrazolo[3,4-<i>d</i>]pyrimidine)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PP1%3A+4-amino-5-%284-methylphenyl%29-7-%28tert-butyl%29pyrazolo%5B3%2C4-d%5Dpyrimidine.+PP2%3A+4-amino-5-%284-chlorophenyl%29-7-%28tert-butyl%29pyrazolo%5B3%2C4-d%5Dpyrimidine%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stover, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K. A.</span><span> </span><span class="NLM_article-title">Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=651-666&author=X.+Zhuauthor=J.+L.+Kimauthor=J.+R.+Newcombauthor=P.+E.+Roseauthor=D.+R.+Stoverauthor=L.+M.+Toledoauthor=H.+Zhaoauthor=K.+A.+Morgenstern&title=Structural+analysis+of+the+lymphocyte-specific+kinase+Lck+in+complex+with+non-selective+and+Src+family+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DNewcomb%26aufirst%3DJ.%2BR.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DStover%26aufirst%3DD.%2BR.%26aulast%3DToledo%26aufirst%3DL.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DMorgenstern%26aufirst%3DK.%2BA.%26atitle%3DStructural%2520analysis%2520of%2520the%2520lymphocyte-specific%2520kinase%2520Lck%2520in%2520complex%2520with%2520non-selective%2520and%2520Src%2520family%2520selective%2520kinase%2520inhibitors%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D651%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fraley, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFall, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span> </span><span class="NLM_article-title">Property-based design of KDR kinase inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.2174%2F0929867043455729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15032725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=709-719&author=M.+A.+Fraleyauthor=W.+F.+Hoffmanauthor=K.+L.+Arringtonauthor=R.+W.+Hungateauthor=G.+D.+Hartmanauthor=R.+C.+McFallauthor=K.+E.+Collauthor=K.+Rickertauthor=K.+A.+Thomasauthor=G.+B.+McGaughey&title=Property-based+design+of+KDR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Property-based design of KDR kinase inhibitors</span></div><div class="casAuthors">Fraley, Mark E.; Hoffman, William F.; Arrington, Kenneth L.; Hungate, Randy W.; Hartman, George D.; McFall, Rosemary C.; Coll, Kathleen E.; Rickert, Keith; Thomas, Kenneth A.; McGaughey, Georgia B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">709-719</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Small mol. inhibitors of KDR kinase activity have typically possessed poor intrinsic phys. properties including low aq. soly. and high lipophilicity.  These features have often conferred limited cell permeability manifested in low levels of cell-based KDR inhibitory activity and oral bioavailability.  Thus, the design of inhibitors with appropriate phys. properties has played a crit. role in the development of clin. candidates.  We present a variety of structural modifications that have afforded improvements in phys. properties and thereby have addressed suboptimal cellular potency and pharmacokinetics for three unique classes of KDR kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_HN0OVe8qrLVg90H21EOLACvtfcHk0lhfhECa8K8_3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7s%253D&md5=e30e4de7e5a106f513e6cf1f83a50a4c</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.2174%2F0929867043455729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043455729%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BA.%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DHungate%26aufirst%3DR.%2BW.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DMcFall%26aufirst%3DR.%2BC.%26aulast%3DColl%26aufirst%3DK.%2BE.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DK.%2BA.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26atitle%3DProperty-based%2520design%2520of%2520KDR%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D709%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Heron, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blowers, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eden, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMiken, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortlock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannifer, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauptit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowsell, S.</span><span> </span><span class="NLM_article-title">SAR and inhibitor complex structure determination of a novel classs of potent and specific Aurora kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1320</span><span class="NLM_x">–</span> <span class="NLM_lpage">1323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1320-1323&author=N.+M.+Heronauthor=M.+Andersonauthor=D.+P.+Blowersauthor=J.+Breedauthor=J.+M.+Edenauthor=S.+Greenauthor=G.+B.+Hillauthor=T.+Johnsonauthor=F.+H.+Jungauthor=H.+H.+McMikenauthor=A.+A.+Mortlockauthor=A.+D.+Panniferauthor=R.+A.+Pauptitauthor=J.+Pinkauthor=N.+J.+Robertsauthor=S.+Rowsell&title=SAR+and+inhibitor+complex+structure+determination+of+a+novel+classs+of+potent+and+specific+Aurora+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeron%26aufirst%3DN.%2BM.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DBlowers%26aufirst%3DD.%2BP.%26aulast%3DBreed%26aufirst%3DJ.%26aulast%3DEden%26aufirst%3DJ.%2BM.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DMcMiken%26aufirst%3DH.%2BH.%26aulast%3DMortlock%26aufirst%3DA.%2BA.%26aulast%3DPannifer%26aufirst%3DA.%2BD.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DPink%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DN.%2BJ.%26aulast%3DRowsell%26aufirst%3DS.%26atitle%3DSAR%2520and%2520inhibitor%2520complex%2520structure%2520determination%2520of%2520a%2520novel%2520classs%2520of%2520potent%2520and%2520specific%2520Aurora%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1320%26epage%3D1323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cherry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. H.</span><span> </span><span class="NLM_article-title">Recent kinase and kinase inhibitor X-ray structures: mechanisms of inhibition and selectivity insights</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.2174%2F0929867043455792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15032722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=663-673&author=M.+Cherryauthor=D.+H.+Williams&title=Recent+kinase+and+kinase+inhibitor+X-ray+structures%3A+mechanisms+of+inhibition+and+selectivity+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent kinase and kinase inhibitor x-ray structures: mechanisms of inhibition and selectivity insights</span></div><div class="casAuthors">Cherry, M.; Williams, D. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">663-673</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent years have seen an explosion in the no. of publicly available x-ray crystal structures of protein kinases.  These structures have provided a wealth of information on the regulatory mechanisms, conformational plasticity and drugability of this important family of enzymes.  Drawing upon structural information, new insights into the development of protein kinase inhibitors are discussed including de-novo design, mol. templates for ATP competitive inhibitors and alternative mechanisms of inhibition.  The highly conserved nature of the ATP binding site is of central concern to drug development and the concept of a selectivity profile has arisen with structure-based design emerging as a key tool for addressing the challenges of specificity.  In addn., protein-ligand complexes, where the enzyme is in an inactive conformation, signify an alternate approach to protein kinase inhibition.  The belief that an inactive kinase presents a less conserved target is reviewed using observations on the structural changes occurring during protein kinase regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB19ovXBL1mrVg90H21EOLACvtfcHk0liQbkCmFiM8xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7w%253D&md5=63c621c012a6e1cc9f795565580d7492</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.2174%2F0929867043455792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043455792%26sid%3Dliteratum%253Aachs%26aulast%3DCherry%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26atitle%3DRecent%2520kinase%2520and%2520kinase%2520inhibitor%2520X-ray%2520structures%253A%2520mechanisms%2520of%2520inhibition%2520and%2520selectivity%2520insights%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D663%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittekind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzillerri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span> </span><span class="NLM_article-title">The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">5790</span><span class="NLM_x">–</span> <span class="NLM_lpage">5797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2006&pages=5790-5797&author=J.+S.+Tokarskiauthor=J.+A.+Newittauthor=C.+Y.+J.+Changauthor=J.+D.+Chengauthor=M.+Wittekindauthor=S.+E.+Kieferauthor=K.+Kishauthor=F.+Y.+F.+Leeauthor=R.+Borzillerriauthor=L.+J.+Lombardoauthor=D.+Xieauthor=Y.+Zhangauthor=H.+E.+Klei&title=The+structure+of+dasatinib+%28BMS-354825%29+bound+to+activated+ABL+kinase+domain+elucidates+its+inhibitory+activity+against+imatinib-resistant+ABL+mutants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DChang%26aufirst%3DC.%2BY.%2BJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DWittekind%26aufirst%3DM.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DF.%2BY.%2BF.%26aulast%3DBorzillerri%26aufirst%3DR.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26atitle%3DThe%2520structure%2520of%2520dasatinib%2520%2528BMS-354825%2529%2520bound%2520to%2520activated%2520ABL%2520kinase%2520domain%2520elucidates%2520its%2520inhibitory%2520activity%2520against%2520imatinib-resistant%2520ABL%2520mutants%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D68%26spage%3D5790%26epage%3D5797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><div class="note"><p class="first last">All kinases were tested at their apparent <i>K</i><sub>m</sub> of ATP with respect to 1 μM peptide substrate.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=All+kinases+were+tested+at+their+apparent+Km+of+ATP+with+respect+to+1+%CE%BCM+peptide+substrate."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hibbs, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarlinton, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grail, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maglitto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacker, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, A. R.</span><span> </span><span class="NLM_article-title">Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1995&pages=301-311&author=M.+L.+Hibbsauthor=D.+M.+Tarlintonauthor=J.+Armesauthor=D.+Grailauthor=G.+Hodgsonauthor=R.+Maglittoauthor=S.+A.+Stackerauthor=A.+R.+Dunn&title=Multiple+defects+in+the+immune+system+of+Lyn-deficient+mice%2C+culminating+in+autoimmune+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHibbs%26aufirst%3DM.%2BL.%26aulast%3DTarlinton%26aufirst%3DD.%2BM.%26aulast%3DArmes%26aufirst%3DJ.%26aulast%3DGrail%26aufirst%3DD.%26aulast%3DHodgson%26aufirst%3DG.%26aulast%3DMaglitto%26aufirst%3DR.%26aulast%3DStacker%26aufirst%3DS.%2BA.%26aulast%3DDunn%26aufirst%3DA.%2BR.%26atitle%3DMultiple%2520defects%2520in%2520the%2520immune%2520system%2520of%2520Lyn-deficient%2520mice%252C%2520culminating%2520in%2520autoimmune%2520disease%26jtitle%3DCell%26date%3D1995%26volume%3D83%26spage%3D301%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nishizumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniuchi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span> </span><span class="NLM_article-title">Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1995&pages=549-560&author=H.+Nishizumiauthor=I.+Taniuchiauthor=Y.+Yamanashiauthor=D.+Kitamuraauthor=D.+Ilicauthor=S.+Moriauthor=T.+Watanabeauthor=T.+Yamamoto&title=Impaired+proliferation+of+peripheral+B+cells+and+indication+of+autoimmune+disease+in+lyn-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNishizumi%26aufirst%3DH.%26aulast%3DTaniuchi%26aufirst%3DI.%26aulast%3DYamanashi%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DD.%26aulast%3DIlic%26aufirst%3DD.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26atitle%3DImpaired%2520proliferation%2520of%2520peripheral%2520B%2520cells%2520and%2520indication%2520of%2520autoimmune%2520disease%2520in%2520lyn-deficient%2520mice%26jtitle%3DImmunity%26date%3D1995%26volume%3D3%26spage%3D549%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><div class="note"><p class="first last">Members of the parent aminoquinazoline class (ref <a onclick="showRef(event, 'cit6p'); return false;" href="javascript:void(0);" class="ref cit6p">6p</a>) demonstrated marginal effects on B cell proliferation. For example, compound <b>49</b> in ref <a onclick="showRef(event, 'cit6p'); return false;" href="javascript:void(0);" class="ref cit6p">6p</a> is a highly potent inhibitor of Lyn (IC<sub>50</sub> = 0.0004 μM) and a weak inhibitor of the anti-IgM F[ab]2-induced BCR-driven mouse B cell proliferation (IC<sub>50</sub> = 3.0 μM).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Members+of+the+parent+aminoquinazoline+class+%28ref+6p%29+demonstrated+marginal+effects+on+B+cell+proliferation.+For+example%2C+compound+49+in+ref+6p+is+a+highly+potent+inhibitor+of+Lyn+%28IC50+%3D+0.0004+%CE%BCM%29+and+a+weak+inhibitor+of+the+anti-IgM+F%5Bab%5D2-induced+BCR-driven+mouse+B+cell+proliferation+%28IC50+%3D+3.0+%CE%BCM%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><div class="note"><p class="first last">EC<sub>50</sub> (fu) = (EC<sub>50</sub>)(mouse fu) = (175 nM)(0.022) = 4 nM.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=EC50+%28fu%29+%3D+%28EC50%29%28mouse+fu%29+%3D+%28175+nM%29%280.022%29+%3D+4+nM."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b','cit1c'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e','cit5f'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e','cit6f','cit6g','cit6h','cit6i','cit6j','cit6k','cit6l','cit6m','cit6n','cit6o','cit6p','cit6q','cit6r','cit6s','cit6t','cit6u'],'ref7':['cit7','cit7b','cit7c','cit7d','cit7e','cit7f','cit7g'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c','cit11d','cit11e','cit11f','cit11g','cit11h','cit11i'],'ref12':['cit12a','cit12b'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 15 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xitao  Li</span>, <span class="hlFld-ContribAuthor ">Yingying  Zuo</span>, <span class="hlFld-ContribAuthor ">Guanghui  Tang</span>, <span class="hlFld-ContribAuthor ">Yan  Wang</span>, <span class="hlFld-ContribAuthor ">Yiqing  Zhou</span>, <span class="hlFld-ContribAuthor ">Xueying  Wang</span>, <span class="hlFld-ContribAuthor ">Tianlin  Guo</span>, <span class="hlFld-ContribAuthor ">Mengying  Xia</span>, <span class="hlFld-ContribAuthor ">Ning  Ding</span>, and <span class="hlFld-ContribAuthor ">Zhengying  Pan</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Series of 2,5-Diaminopyrimidine Covalent Irreversible Inhibitors of Bruton’s Tyrosine Kinase with in Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5112-5128. <a href="https://doi.org/10.1021/jm4017762" title="DOI URL">https://doi.org/10.1021/jm4017762</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4017762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4017762%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BSeries%252Bof%252B2%25252C5-Diaminopyrimidine%252BCovalent%252BIrreversible%252BInhibitors%252Bof%252BBruton%2525E2%252580%252599s%252BTyrosine%252BKinase%252Bwith%252Bin%252BVivo%252BAntitumor%252BActivity%26aulast%3DLi%26aufirst%3DXitao%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D16112013%26date%3D10062014%26date%3D26062014%26volume%3D57%26issue%3D12%26spage%3D5112%26epage%3D5128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yohan  Malki</span>, <span class="hlFld-ContribAuthor ">Jean  Martinez</span>, <span class="hlFld-ContribAuthor ">Nicolas  Masurier</span>. </span><span class="cited-content_cbyCitation_article-title">1,3‐Diazepine: A privileged scaffold in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2021,</strong> <em>41 </em>
                                    (4)
                                     , 2247-2315. <a href="https://doi.org/10.1002/med.21795" title="DOI URL">https://doi.org/10.1002/med.21795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21795%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3D1%25252C3%2525E2%252580%252590Diazepine%25253A%252BA%252Bprivileged%252Bscaffold%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DMalki%26aufirst%3DYohan%26date%3D2021%26date%3D2021%26volume%3D41%26issue%3D4%26spage%3D2247%26epage%3D2315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ji-Quan  Zhang</span>, <span class="hlFld-ContribAuthor ">Shu-Min  Li</span>, <span class="hlFld-ContribAuthor ">Chun-Feng  Wu</span>, <span class="hlFld-ContribAuthor ">Xing-Lan  Wang</span>, <span class="hlFld-ContribAuthor ">Ting-Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Yao  Du</span>, <span class="hlFld-ContribAuthor ">Yuan-Yong  Yang</span>, <span class="hlFld-ContribAuthor ">Ling-Ling  Fan</span>, <span class="hlFld-ContribAuthor ">Yong-Xi  Dong</span>, <span class="hlFld-ContribAuthor ">Jian-Ta  Wang</span>, <span class="hlFld-ContribAuthor ">Lei  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">The synthesis of symmetrical 3,3-Disubstituted oxindoles by phosphine-catalyzed γ/γ-addition of oxindoles with allenoates. </span><span class="cited-content_cbyCitation_journal-name">Catalysis Communications</span><span> <strong>2020,</strong> <em>138 </em>, 105838. <a href="https://doi.org/10.1016/j.catcom.2019.105838" title="DOI URL">https://doi.org/10.1016/j.catcom.2019.105838</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.catcom.2019.105838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.catcom.2019.105838%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysis%2520Communications%26atitle%3DThe%252Bsynthesis%252Bof%252Bsymmetrical%252B3%25252C3-Disubstituted%252Boxindoles%252Bby%252Bphosphine-catalyzed%252B%2525CE%2525B3%25252F%2525CE%2525B3-addition%252Bof%252Boxindoles%252Bwith%252Ballenoates%26aulast%3DZhang%26aufirst%3DJi-Quan%26date%3D2020%26volume%3D138%26spage%3D105838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alix  Tröster</span>, <span class="hlFld-ContribAuthor ">Stephanie  Heinzlmeir</span>, <span class="hlFld-ContribAuthor ">Benedict-Tilman  Berger</span>, <span class="hlFld-ContribAuthor ">Santosh L.  Gande</span>, <span class="hlFld-ContribAuthor ">Krishna  Saxena</span>, <span class="hlFld-ContribAuthor ">Sridhar  Sreeramulu</span>, <span class="hlFld-ContribAuthor ">Verena  Linhard</span>, <span class="hlFld-ContribAuthor ">Amir H.  Nasiri</span>, <span class="hlFld-ContribAuthor ">Michael  Bolte</span>, <span class="hlFld-ContribAuthor ">Susanne  Müller</span>, <span class="hlFld-ContribAuthor ">Bernhard  Kuster</span>, <span class="hlFld-ContribAuthor ">Guillaume  Médard</span>, <span class="hlFld-ContribAuthor ">Denis  Kudlinzki</span>, <span class="hlFld-ContribAuthor ">Harald  Schwalbe</span>. </span><span class="cited-content_cbyCitation_article-title">NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (16)
                                     , 1629-1633. <a href="https://doi.org/10.1002/cmdc.201800398" title="DOI URL">https://doi.org/10.1002/cmdc.201800398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800398%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DNVP-BHG712%25253A%252BEffects%252Bof%252BRegioisomers%252Bon%252Bthe%252BAffinity%252Band%252BSelectivity%252Btoward%252Bthe%252BEPHrin%252BFamily%26aulast%3DTr%25C3%25B6ster%26aufirst%3DAlix%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D16%26spage%3D1629%26epage%3D1633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Daoguang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Dezhi  Yang</span>, <span class="hlFld-ContribAuthor ">Fansheng  Ran</span>, <span class="hlFld-ContribAuthor ">Michael L.  Wang</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2018,</strong> <em>351 </em>
                                    (7)
                                     , 1700369. <a href="https://doi.org/10.1002/ardp.201700369" title="DOI URL">https://doi.org/10.1002/ardp.201700369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201700369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201700369%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DTargeting%252BBruton%252527s%252Btyrosine%252Bkinase%252Bfor%252Bthe%252Btreatment%252Bof%252BB%252Bcell%252Bassociated%252Bmalignancies%252Band%252Bautoimmune%252Bdiseases%25253A%252BPreclinical%252Band%252Bclinical%252Bdevelopments%252Bof%252Bsmall%252Bmolecule%252Binhibitors%26aulast%3DZhang%26aufirst%3DZhen%26date%3D2018%26date%3D2018%26volume%3D351%26issue%3D7%26spage%3D1700369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmed Karam  Farag</span>, <span class="hlFld-ContribAuthor ">Ahmed  Elkamhawy</span>, <span class="hlFld-ContribAuthor ">Ashwini M.  Londhe</span>, <span class="hlFld-ContribAuthor ">Kyung-Tae  Lee</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Eun Joo  Roh</span>. </span><span class="cited-content_cbyCitation_article-title">Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>141 </em>, 657-675. <a href="https://doi.org/10.1016/j.ejmech.2017.10.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BLCK%25252FFMS%252Binhibitors%252Bbased%252Bon%252Bphenoxypyrimidine%252Bscaffold%252Bas%252Bpotential%252Btreatment%252Bfor%252Binflammatory%252Bdisorders%26aulast%3DFarag%26aufirst%3DAhmed%2BKaram%26date%3D2017%26volume%3D141%26spage%3D657%26epage%3D675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hermann AM  Mucke</span>. </span><span class="cited-content_cbyCitation_article-title">Patent highlights August–September 2016. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2017,</strong> <em>6 </em>
                                    (1)
                                     , 17-24. <a href="https://doi.org/10.4155/ppa-2016-0037" title="DOI URL">https://doi.org/10.4155/ppa-2016-0037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa-2016-0037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa-2016-0037%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DPatent%252Bhighlights%252BAugust%2525E2%252580%252593September%252B2016%26aulast%3DMucke%26aufirst%3DHermann%2BAM%26date%3D2017%26volume%3D6%26issue%3D1%26spage%3D17%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua  Chen</span>, <span class="hlFld-ContribAuthor ">Shun-Kai  Xing</span>, <span class="hlFld-ContribAuthor ">Fang  Gao</span>, <span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Xiao-Liu  Li</span>, <span class="hlFld-ContribAuthor ">Ming  Meng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and immunomodulating activity of C - pseudo nucleosides containing thiazolidin-4-one and phenyl connected by acetamide bond. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2016,</strong> <em>27 </em>
                                    (6)
                                     , 938-942. <a href="https://doi.org/10.1016/j.cclet.2016.01.041" title="DOI URL">https://doi.org/10.1016/j.cclet.2016.01.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2016.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2016.01.041%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bimmunomodulating%252Bactivity%252Bof%252BC%252B-%252Bpseudo%252Bnucleosides%252Bcontaining%252Bthiazolidin-4-one%252Band%252Bphenyl%252Bconnected%252Bby%252Bacetamide%252Bbond%26aulast%3DChen%26aufirst%3DHua%26date%3D2016%26volume%3D27%26issue%3D6%26spage%3D938%26epage%3D942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. V.  Koroleva</span>, <span class="hlFld-ContribAuthor ">Zh. I.  Ignatovich</span>, <span class="hlFld-ContribAuthor ">Yu. V.  Sinyutich</span>, <span class="hlFld-ContribAuthor ">K. N.  Gusak</span>. </span><span class="cited-content_cbyCitation_article-title">Aminopyrimidine derivatives as protein kinases inhibitors. Molecular design, synthesis, and biologic activity. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>52 </em>
                                    (2)
                                     , 139-177. <a href="https://doi.org/10.1134/S1070428016020019" title="DOI URL">https://doi.org/10.1134/S1070428016020019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428016020019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428016020019%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAminopyrimidine%252Bderivatives%252Bas%252Bprotein%252Bkinases%252Binhibitors.%252BMolecular%252Bdesign%25252C%252Bsynthesis%25252C%252Band%252Bbiologic%252Bactivity%26aulast%3DKoroleva%26aufirst%3DE.%2BV.%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D2%26spage%3D139%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. V.  Koroleva</span>, <span class="hlFld-ContribAuthor ">Zh. V.  Ignatovich</span>, <span class="hlFld-ContribAuthor ">K. N.  Gusak</span>, <span class="hlFld-ContribAuthor ">A. L.  Ermolinskaya</span>, <span class="hlFld-ContribAuthor ">Yu. V.  Sinyutich</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of N-aryl benzamides containing pharmacophoric tyrosine kinase inhibitor fragments. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>51 </em>
                                    (1)
                                     , 101-109. <a href="https://doi.org/10.1134/S1070428015010182" title="DOI URL">https://doi.org/10.1134/S1070428015010182</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428015010182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428015010182%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BN-aryl%252Bbenzamides%252Bcontaining%252Bpharmacophoric%252Btyrosine%252Bkinase%252Binhibitor%252Bfragments%26aulast%3DKoroleva%26aufirst%3DE.%2BV.%26date%3D2015%26date%3D2015%26volume%3D51%26issue%3D1%26spage%3D101%26epage%3D109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingyi  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Bai</span>, <span class="hlFld-ContribAuthor ">Rui  Xie</span>, <span class="hlFld-ContribAuthor ">Liping  Sun</span>, <span class="hlFld-ContribAuthor ">Kejiang  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Development and strategies of VEGFR-2/KDR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (14)
                                     , 1839-1852. <a href="https://doi.org/10.4155/fmc.12.121" title="DOI URL">https://doi.org/10.4155/fmc.12.121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.121%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252Bstrategies%252Bof%252BVEGFR-2%25252FKDR%252Binhibitors%26aulast%3DHuang%26aufirst%3DLingyi%26date%3D2012%26volume%3D4%26issue%3D14%26spage%3D1839%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew W  Martin</span>, <span class="hlFld-ContribAuthor ">Michelle R  Machacek</span>. </span><span class="cited-content_cbyCitation_article-title">Update on lymphocyte specific kinase inhibitors: a patent survey. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2010,</strong> <em>20 </em>
                                    (11)
                                     , 1573-1593. <a href="https://doi.org/10.1517/13543776.2010.517749" title="DOI URL">https://doi.org/10.1517/13543776.2010.517749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2010.517749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2010.517749%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DUpdate%252Bon%252Blymphocyte%252Bspecific%252Bkinase%252Binhibitors%25253A%252Ba%252Bpatent%252Bsurvey%26aulast%3DMartin%26aufirst%3DMatthew%2BW%26date%3D2010%26date%3D2010%26volume%3D20%26issue%3D11%26spage%3D1573%26epage%3D1593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tetsuo  Takayama</span>, <span class="hlFld-ContribAuthor ">Hiroki  Umemiya</span>, <span class="hlFld-ContribAuthor ">Hideaki  Amada</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Yabuuchi</span>, <span class="hlFld-ContribAuthor ">Takeshi  Koami</span>, <span class="hlFld-ContribAuthor ">Fumiyasu  Shiozawa</span>, <span class="hlFld-ContribAuthor ">Yusuke  Oka</span>, <span class="hlFld-ContribAuthor ">Akiko  Takaoka</span>, <span class="hlFld-ContribAuthor ">Akie  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Mayumi  Endo</span>, <span class="hlFld-ContribAuthor ">Masakazu  Sato</span>. </span><span class="cited-content_cbyCitation_article-title">Ring-fused pyrazole derivatives as potent inhibitors of lymphocyte-specific kinase (Lck): Structure, synthesis, and SAR. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (1)
                                     , 112-116. <a href="https://doi.org/10.1016/j.bmcl.2009.11.013" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.013%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DRing-fused%252Bpyrazole%252Bderivatives%252Bas%252Bpotent%252Binhibitors%252Bof%252Blymphocyte-specific%252Bkinase%252B%252528Lck%252529%25253A%252BStructure%25252C%252Bsynthesis%25252C%252Band%252BSAR%26aulast%3DTakayama%26aufirst%3DTetsuo%26date%3D2010%26volume%3D20%26issue%3D1%26spage%3D112%26epage%3D116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tetsuo  Takayama</span>, <span class="hlFld-ContribAuthor ">Hiroki  Umemiya</span>, <span class="hlFld-ContribAuthor ">Hideaki  Amada</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Yabuuchi</span>, <span class="hlFld-ContribAuthor ">Fumiyasu  Shiozawa</span>, <span class="hlFld-ContribAuthor ">Hironori  Katakai</span>, <span class="hlFld-ContribAuthor ">Akiko  Takaoka</span>, <span class="hlFld-ContribAuthor ">Akie  Yamaguchi</span>, <span class="hlFld-ContribAuthor ">Mayumi  Endo</span>, <span class="hlFld-ContribAuthor ">Masakazu  Sato</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrrole derivatives as potent inhibitors of lymphocyte-specific kinase: Structure, synthesis, and SAR. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2010,</strong> <em>20 </em>
                                    (1)
                                     , 108-111. <a href="https://doi.org/10.1016/j.bmcl.2009.11.014" title="DOI URL">https://doi.org/10.1016/j.bmcl.2009.11.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2009.11.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2009.11.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPyrrole%252Bderivatives%252Bas%252Bpotent%252Binhibitors%252Bof%252Blymphocyte-specific%252Bkinase%25253A%252BStructure%25252C%252Bsynthesis%25252C%252Band%252BSAR%26aulast%3DTakayama%26aufirst%3DTetsuo%26date%3D2010%26volume%3D20%26issue%3D1%26spage%3D108%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. A.  Kovalskiy</span>, <span class="hlFld-ContribAuthor ">V. P.  Perevalov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 3-(3-piperidyl)-isoquinoline and 3-(4-piperidyl)-isoquinoline. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2009,</strong> <em>45 </em>
                                    (8)
                                     , 957-964. <a href="https://doi.org/10.1007/s10593-009-0368-6" title="DOI URL">https://doi.org/10.1007/s10593-009-0368-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-009-0368-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-009-0368-6%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DSynthesis%252Bof%252B3-%2525283-piperidyl%252529-isoquinoline%252Band%252B3-%2525284-piperidyl%252529-isoquinoline%26aulast%3DKovalskiy%26aufirst%3DD.%2BA.%26date%3D2009%26date%3D2009%26volume%3D45%26issue%3D8%26spage%3D957%26epage%3D964" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7010996&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Design of aminopyrimidine amides <b>2</b> and <b>3</b> from aminoquinazolines <b>1</b>: −L− = −CONH−, −NHCO−, or −NHCONH−.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7010996&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0011.jpeg" id="rightTab-gs1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Aminopyrimidine Amides, Reverse Amides, and Ureas<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7010996&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 4-(4-methylpiperazino)aniline, TFA, IPA, 80 °C (<b>5b</b>, 88%); (b) 3-morpholinopropan-1-amine, DIPEA, IPA, 70 °C (<b>5c</b>, 100%); (c) 1-methylpiperidin-4-amine, NaH, THF (<b>5d</b>, 100%); (d) 10% Pd/C, H<sub>2</sub>, CH<sub>3</sub>OH/EtOAc; (e) 3-(trifluoromethyl)aniline, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub> (84%); (f) CO(g), CH<sub>3</sub>OH, Pd(OAc)<sub>2</sub>, dppp, NEt<sub>3</sub>, 70−100 °C (85%); (g) LiOH, THF/H<sub>2</sub>O (92%); (h) EDC−HCl, HATU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub> (<b>10a</b>, 65%; <b>10b</b>, 91%); (i) (i) acid, SOCl<sub>2</sub>, 80 °C, (ii) aniline, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (j) 1-isocyanato-3-(trifluoromethyl)benzene, benzene, 75 °C (<b>23a</b>, 20%; <b>23b</b>, 46%).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0012.jpeg" id="rightTab-gs2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Aminopyrimidine Reverse Amides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7010996&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) isoamyl nitrite, CuI, CH<sub>2</sub>I<sub>2</sub>, THF, 70 °C (21%); (b) 2-morpholinoethanamine, DIPEA, IPA, 70 °C (100%); (c) 10% Pd/C, H<sub>2</sub>, CH<sub>3</sub>OH/EtOAc; (d) 3-(trifluoromethyl)benzoyl chloride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub> (63%); (e) (i) acid, SOCl<sub>2</sub>, 80 °C, (ii) aniline, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (f) EDC−HCl, HATU, DIPEA, DMF (42%); (g) BEt<sub>3</sub>, Pd(OAc)<sub>2</sub>, S-Phos, K<sub>3</sub>PO<sub>4</sub>, THF, 60 °C (20%).</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0009.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Cocrystal structures: (a) Lck and aminopyrimidine amide <b>10b</b>; (b) Lck and aminopyrimidine reverse amide <b>19</b>; (c) overlay of aminopyrimidine amide <b>10b</b> (green) with quinazoline <b>34</b> (blue) in Lck.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7010996&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/medium/jm-2007-010996_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of <b>13b</b> on Anti-CD3 induced IL-2 production in BALB/c mice. The 12 week old female BALB/c mice were pretreated (po) with <b>13b</b> at 10, 30, or 100 mg/kg. After 1.0 h the mice were challenged (iv) with anti-mouse CD3 monoclonal antibody (3 mg/mouse). After 90 min of anti-CD3 challenge, blood was collected via cardiac puncture. IL-2 was measured in serum using the BioSource ELISA kit. Data points represent the mean ± SE; <i>n</i> = 5 animals per group: (∗) <i>p</i> ≤ 0.05 vs vehicle control by Mann–Whitney <i>U</i>-test. Mean plasma concentrations for each dose are expressed in parentheses.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2008/jmcmar.2008.51.issue-6/jm7010996/production/images/large/jm-2007-010996_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm7010996&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 18 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Qian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">T cell antigen receptor signal transduction</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2FS0955-0674%2897%2980064-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=9069257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADyaK2sXisVWms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1997&pages=205-212&author=D.+Qianauthor=A.+Weiss&title=T+cell+antigen+receptor+signal+transduction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">T cell antigen receptor signal transduction</span></div><div class="casAuthors">Qian, Dapeng; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">205-212</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">A review with 71 refs.  The T cell antigen receptor (TCR) initiates signal transduction by activating multiple cytoplasmic protein tyrosine kinases (PTKs).  Considerable progress in the field of TCR signal transduction has been made in three areas recently: first, in understanding the structure and function of the PTK ZAP-70; second, in the elucidation of the function of the substrates and pathways downstream of the PTKs; and third, in the identification of mols. that neg. regulate TCR signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUf6rVmOnRdLVg90H21EOLACvtfcHk0lj3HHCUmrfXaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisVWms7g%253D&md5=20cb19563b966ed37298ebedc6f69c4c</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS0955-0674%2897%2980064-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0955-0674%252897%252980064-6%26sid%3Dliteratum%253Aachs%26aulast%3DQian%26aufirst%3DD.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DT%2520cell%2520antigen%2520receptor%2520signal%2520transduction%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D1997%26volume%3D9%26spage%3D205%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nel, A. E.</span><span> </span><span class="NLM_article-title">T-cell activation through the antigen receptor. Part 1: signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse</span> <span class="citation_source-journal">J. Allergy Clin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">758</span><span class="NLM_x">–</span> <span class="NLM_lpage">770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1067%2Fmai.2002.124259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=11994696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD38XksFSqsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=758-770&author=A.+E.+Nel&title=T-cell+activation+through+the+antigen+receptor.+Part+1%3A+signaling+components%2C+signaling+pathways%2C+and+signal+integration+at+the+T-cell+antigen+receptor+synapse"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">T-cell activation through the antigen receptor. Part 1: Signaling components, signaling pathways, and signal integration at the T-cell antigen receptor synapse</span></div><div class="casAuthors">Nel, Andre E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Allergy and Clinical Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">758-770</span>CODEN:
                <span class="NLM_cas:coden">JACIBY</span>;
        ISSN:<span class="NLM_cas:issn">0091-6749</span>.
    
            (<span class="NLM_cas:orgname">Mosby, Inc.</span>)
        </div><div class="casAbstract">A review.  Part 1 of this review will highlight the basic components and signaling pathways by which the T-cell antigen receptor (TCR) activates mature extrathymic T cells.  TCR signaling commences with an early wave of protein tyrosine kinase activation, which is mediated by the Src kinases Lck and Fyn, the 70 kDa ξ-assocd. protein kinase, and members of the Tec kinase family.  This early wave of protein tyrosine phosphorylation leads to the activation of downstream signaling pathways, including an increase in intracellular free calcium, protein kinase C, nuclear factor κB and Ras-mitogen-activated protein kinase activation.  These pathways activate transcription factors, such as activator protein 1, nuclear factor of activated T cells, and Rel proteins, which ultimately lead to the expression of genes that control cellular proliferation, differentiation, anergy, or apoptosis.  This review also describes how costimulatory receptors assist in signal transduction and assembly of macromol. complexes at the TCR contact site with the antigen-presenting cell, also known as the immune synapse.  These basic concepts of TCR signal transduction will be used in part 2 to explain how T-cell function can be altered by therapeutic targeting of TCR signaling components, as well as to explain modification of TCR signaling during TH1/TH2 differentiation, tolerance, and immune senescence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1ul1o3w2DMLVg90H21EOLACvtfcHk0lj3HHCUmrfXaw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XksFSqsb8%253D&md5=8245cf82d42fdefb908a681a806c5e77</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1067%2Fmai.2002.124259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmai.2002.124259%26sid%3Dliteratum%253Aachs%26aulast%3DNel%26aufirst%3DA.%2BE.%26atitle%3DT-cell%2520activation%2520through%2520the%2520antigen%2520receptor.%2520Part%25201%253A%2520signaling%2520components%252C%2520signaling%2520pathways%252C%2520and%2520signal%2520integration%2520at%2520the%2520T-cell%2520antigen%2520receptor%2520synapse%26jtitle%3DJ.%2520Allergy%2520Clin.%2520Immunol.%26date%3D2002%26volume%3D109%26spage%3D758%26epage%3D770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Pitcher, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Oers, N. S. C.</span><span> </span><span class="NLM_article-title">T-cell receptor signal transmission: who gives an ITAM?</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2Fj.it.2003.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=14552840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1c&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVKktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2003&pages=554-560&author=L.+A.+Pitcherauthor=N.+S.+C.+van+Oers&title=T-cell+receptor+signal+transmission%3A+who+gives+an+ITAM%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1cR"><div class="casContent"><span class="casTitleNuber">1c</span><div class="casTitle"><span class="NLM_cas:atitle">T-cell receptor signal transmission: who gives an ITAM?</span></div><div class="casAuthors">Pitcher, Lisa A.; van Oers, Nicolai S. C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">554-560</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  T cells have an amazing ability to discern and differentially respond to MHC-embedded peptides that can differ by only a single amino acid.  This potential involves a combination of the precise ligand-binding specificities of the T-cell receptor (TCR) and the distinct intracellular signaling processes it transmits.  Signaling processes are controlled by the 10 immunoreceptor tyrosine-based activation motifs (ITAMs) present in the invariant chains of the TCR complex (TCR ζ and CD3-γ, -δ and -ε).  Here, the authors discuss recent studies of the functions of TCR invariant chains and the contribution of the 10 ITAMs to T-cell signal transmission.  These results are incorporated into two non-exclusive models of TCR signal transduction: the ITAM multiplicity model, which describes a functional redundancy within the TCR ζ and CD3 ITAMs; and the differential signaling model, which proposes distinct functions for the CD3-γ, -δ and -ε and TCR ζ modules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4KCaKnlUGH7Vg90H21EOLACvtfcHk0lgMW1BQJqG8Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVKktb0%253D&md5=f3df5898e8c1bd08b4e6bb775980ecc7</span></div><a href="/servlet/linkout?suffix=cit1c&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2003.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2003.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DPitcher%26aufirst%3DL.%2BA.%26aulast%3Dvan%2BOers%26aufirst%3DN.%2BS.%2BC.%26atitle%3DT-cell%2520receptor%2520signal%2520transmission%253A%2520who%2520gives%2520an%2520ITAM%253F%26jtitle%3DTrends%2520Immunol.%26date%3D2003%26volume%3D24%26spage%3D554%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Stachlewitz, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettencourt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kebede, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waegell, W. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span> </span><span class="NLM_article-title">A420983, a novel and selective small-molecule inhibitor of Lck prevents heart allograft rejection</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1124%2Fjpet.105.089169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=16014572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOksrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2005&pages=36-41&author=R.+F.+Stachlewitzauthor=M.+A.+Hartauthor=B.+Bettencourtauthor=T.+Kebedeauthor=A.+Schwartzauthor=S.+E.+Ratnofskyauthor=D.+J.+Calderwoodauthor=W.+O.+Waegellauthor=G.+C.+Hirst&title=A420983%2C+a+novel+and+selective+small-molecule+inhibitor+of+Lck+prevents+heart+allograft+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">A-770041, a novel and selective small-molecule inhibitor of Lck, prevents heart allograft rejection</span></div><div class="casAuthors">Stachlewitz, Robert F.; Hart, Michelle A.; Bettencourt, Brian; Kebede, Tegest; Schwartz, Annette; Ratnofsky, Sheldon E.; Calderwood, David J.; Waegell, Wendy O.; Hirst, Gavin C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-41</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lck, one of eight members of the Src family of tyrosine kinases, is activated after T cell stimulation and is required for T-cell proliferation and interleukin (IL)-2 prodn.  Inhibition of Lck has been a target to prevent lymphocyte activation and acute rejection.  Here, we report the pharmacol. characterization of 1-methyl-1H-indole-2-carboxylic acid (4-{1-[4-(4-acetylpiperazin-l-yl)-cyclohexyl]-4-amino-1H-pyrazolo[3,4-d]pyrimidin-3-yl}-2-methoxy-phenyl)-amide (A-770041), an orally bioavailable pyrazolo[3,4-d]pyrimidine with increased selectivity for Lck compared with previously reported compds.  A-770041 is a 147 nM inhibitor of Lck (1 mM ATP) and is 300-fold selective against Fyn, the other Src family kinase involved in T-cell signaling.  Con A-stimulated IL-2 prodn. in whole blood is inhibited by A-770041 with an EC50 of approx. 80 nM.  A-770041 is orally bioavailable (F = 34.1 ± 7.2% at 10 mg/kg) and has a t1/2 of 4.1 ± 0.1 h.  Con A-induced IL-2 prodn. in vivo is inhibited by oral administration of A-770041 (in vivo EC50 = 78 ± 28 nM).  Doses of A-770041 at or above 10 mg/kg/day prevent rejection of hearts transplanted heterotopically in rats from Brown Norway donors to Lewis recipients across a major histocompatibility barrier for least 65 days.  Grafts from animals treated with 20 mg/kg/day A-770041 or 10 mg/day Cyclosporin A had minimal microvascular changes or multifocal mononuclear infiltrates.  However, mineralization in myocytes from the grafts from A-770041-treated animals was less than animals treated with Cyclosporin A.  Lck inhibition is an attractive target to prevent acute rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUGRdbGgdcRbVg90H21EOLACvtfcHk0lgMW1BQJqG8Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOksrbE&md5=744e6f81abafe3f7573307abbeeddb37</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1124%2Fjpet.105.089169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.105.089169%26sid%3Dliteratum%253Aachs%26aulast%3DStachlewitz%26aufirst%3DR.%2BF.%26aulast%3DHart%26aufirst%3DM.%2BA.%26aulast%3DBettencourt%26aufirst%3DB.%26aulast%3DKebede%26aufirst%3DT.%26aulast%3DSchwartz%26aufirst%3DA.%26aulast%3DRatnofsky%26aufirst%3DS.%2BE.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DWaegell%26aufirst%3DW.%2BO.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26atitle%3DA420983%252C%2520a%2520novel%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520Lck%2520prevents%2520heart%2520allograft%2520rejection%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D315%26spage%3D36%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bolen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugge, J. S.</span><span> </span><span class="NLM_article-title">Leukocyte protein tyrosine kinases: potential targets for drug discovery</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1146%2Fannurev.immunol.15.1.371" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=9143693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADyaK2sXisVCmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1997&pages=371-404&author=J.+B.+Bolenauthor=J.+S.+Brugge&title=Leukocyte+protein+tyrosine+kinases%3A+potential+targets+for+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Leukocyte protein tyrosine kinases: potential targets for drug discovery</span></div><div class="casAuthors">Bolen, Joseph B.; Brugge, Joan S.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">371-404</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews</span>)
        </div><div class="casAbstract">A review with 222 refs.  Intracellular signal transduction following the extracellular ligation of a wide variety of different types of surface mols. on leukocytes involves the activation of protein tyrosine kinases.  The dependence of successful intracellular signaling on the functions of the nontransmembrane class of protein tyrosine kinases coupled with the cell type-specific expression patterns for several of these enzymes makes them appealing targets for therapeutic intervention.  Development of drugs that can interfere with the catalytic functions of the nontransmembrane protein tyrosine kinases or that can disrupt crit. interactions with regulatory mols. and/or substrates should find clin. applications in the treatment of allergic diseases, autoimmunity, transplantation rejection, and cancer.  Topics discussed include src, lck, lyn, fyn, hck, blk, csk, csk, ctk, tec, btk, itk, tec, bmx, txk, fes, fer, abl, syk, and jak families of kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFmmCM9pk2ebVg90H21EOLACvtfcHk0lgMW1BQJqG8Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXisVCmtrg%253D&md5=077f3fbee0284d0b0f2b744cecc1d5d9</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.15.1.371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.15.1.371%26sid%3Dliteratum%253Aachs%26aulast%3DBolen%26aufirst%3DJ.%2BB.%26aulast%3DBrugge%26aufirst%3DJ.%2BS.%26atitle%3DLeukocyte%2520protein%2520tyrosine%2520kinases%253A%2520potential%2520targets%2520for%2520drug%2520discovery%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D1997%26volume%3D15%26spage%3D371%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lowell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soriano, P.</span><span> </span><span class="NLM_article-title">Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1845</span><span class="NLM_x">–</span> <span class="NLM_lpage">1857</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1101%2Fgad.10.15.1845" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=8756343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADyaK28XkvFGlt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1996&pages=1845-1857&author=C.+A.+Lowellauthor=P.+Soriano&title=Knockouts+of+Src-family+kinases%3A+stiff+bones%2C+wimpy+T+cells%2C+and+bad+memories"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories</span></div><div class="casAuthors">Lowell, Clifford A.; Soriano, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1845-1857</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review, with 121 refs., on Src-family kinases (SFKs) in bone, neural, lymphocyte, and myeloid cell development and in keratinocyte differentiation, the regulation of SFK activity, and SFKs and tumorigenesis by polyomavirus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4Fr3q0woexLVg90H21EOLACvtfcHk0ljrQZ33uRFc0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFGlt7s%253D&md5=b8dc93418adea84de69fb4abade22243</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1101%2Fgad.10.15.1845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.10.15.1845%26sid%3Dliteratum%253Aachs%26aulast%3DLowell%26aufirst%3DC.%2BA.%26aulast%3DSoriano%26aufirst%3DP.%26atitle%3DKnockouts%2520of%2520Src-family%2520kinases%253A%2520stiff%2520bones%252C%2520wimpy%2520T%2520cells%252C%2520and%2520bad%2520memories%26jtitle%3DGenes%2520Dev.%26date%3D1996%26volume%3D10%26spage%3D1845%26epage%3D1857" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Marth, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellins, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gearn, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samelson, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, R. M.</span><span> </span><span class="NLM_article-title">Lymphocyte activation provokes modification of a lymphocyte specific protein tyrosine kinase (p56lck)</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">142</span><span class="NLM_x">, </span> <span class="NLM_fpage">2430</span><span class="NLM_x">–</span> <span class="NLM_lpage">2437</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=142&publication_year=1989&pages=2430-2437&author=J.+D.+Marthauthor=D.+B.+Lewisauthor=M.+P.+Cookeauthor=E.+D.+Mellinsauthor=M.+E.+Gearnauthor=L.+E.+Samelsonauthor=C.+B.+Wilsonauthor=A.+D.+Millerauthor=R.+M.+Perlmutter&title=Lymphocyte+activation+provokes+modification+of+a+lymphocyte+specific+protein+tyrosine+kinase+%28p56lck%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMarth%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DD.%2BB.%26aulast%3DCooke%26aufirst%3DM.%2BP.%26aulast%3DMellins%26aufirst%3DE.%2BD.%26aulast%3DGearn%26aufirst%3DM.%2BE.%26aulast%3DSamelson%26aufirst%3DL.%2BE.%26aulast%3DWilson%26aufirst%3DC.%2BB.%26aulast%3DMiller%26aufirst%3DA.%2BD.%26aulast%3DPerlmutter%26aufirst%3DR.%2BM.%26atitle%3DLymphocyte%2520activation%2520provokes%2520modification%2520of%2520a%2520lymphocyte%2520specific%2520protein%2520tyrosine%2520kinase%2520%2528p56lck%2529%26jtitle%3DJ.%2520Immunol.%26date%3D1989%26volume%3D142%26spage%3D2430%26epage%3D2437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Groves, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smiley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbush, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guidos, C. J.</span><span> </span><span class="NLM_article-title">Fyn can partially substitute for Lck in T lymphocyte development</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1996&pages=417-428&author=T.+Grovesauthor=P.+Smileyauthor=M.+P.+Cookeauthor=K.+Forbushauthor=R.+M.+Perlmutterauthor=C.+J.+Guidos&title=Fyn+can+partially+substitute+for+Lck+in+T+lymphocyte+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGroves%26aufirst%3DT.%26aulast%3DSmiley%26aufirst%3DP.%26aulast%3DCooke%26aufirst%3DM.%2BP.%26aulast%3DForbush%26aufirst%3DK.%26aulast%3DPerlmutter%26aufirst%3DR.%2BM.%26aulast%3DGuidos%26aufirst%3DC.%2BJ.%26atitle%3DFyn%2520can%2520partially%2520substitute%2520for%2520Lck%2520in%2520T%2520lymphocyte%2520development%26jtitle%3DImmunity%26date%3D1996%26volume%3D5%26spage%3D417%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Palacios, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">7990</span><span class="NLM_x">–</span> <span class="NLM_lpage">8000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1038%2Fsj.onc.1208074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15489916" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2cXosFyltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2004&pages=7990-8000&author=E.+H.+Palaciosauthor=A.+Weiss&title=Function+of+the+Src-family+kinases%2C+Lck+and+Fyn%2C+in+T-cell+development+and+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation</span></div><div class="casAuthors">Palacios, Emil H.; Weiss, Arthur</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">7990-8000</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The function of the Src-family kinases (SFKs) Lck and Fyn in T cells has been intensively studied over the past 15 yr.  Animal models and cell line studies both indicate a crit. role for Lck and Fyn in proximal T-cell antigen receptor (TCR) signal transduction.  Recruited SFKs phosphorylate TCR ITAMs (immunoreceptor tyrosine-based activation motifs) in the CD3 and ζ chains, which then serve as docking sites for Syk-family kinases.  SFKs then phosphorylate and activate the recruited Syk-family kinase.  Lck and Fyn are spatially segregated in cell membranes due to differential lipid raft localization, and may undergo sequential activation.  In addn. to the CD4 and CD8 coreceptors, a recently described adaptor, Unc119, may link SFKs to the TCR.  CD45 and Csk provide pos. and neg. regulatory control of SFK functions, resp., and Csk is constitutively bound to the transmembrane adapter protein, PAG/Cbp.  TCR-based signaling is required at several stages of T-cell development, including at least pre-TCR signaling, pos. selection, peripheral maintenance of naive T cells, and lymphopenia-induced proliferation.  SFKs are required for each of these TCR-based signals, and Lck seems to be the major contributor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC2s7PGSwBibVg90H21EOLACvtfcHk0ljrQZ33uRFc0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXosFyltb8%253D&md5=d9d1f2697ef4008ee8c8426ac806bd11</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1208074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1208074%26sid%3Dliteratum%253Aachs%26aulast%3DPalacios%26aufirst%3DE.%2BH.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DFunction%2520of%2520the%2520Src-family%2520kinases%252C%2520Lck%2520and%2520Fyn%252C%2520in%2520T-cell%2520development%2520and%2520activation%26jtitle%3DOncogene%26date%3D2004%26volume%3D23%26spage%3D7990%26epage%3D8000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Molina, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siderovskid, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Ewijk, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narendran, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timms, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakeham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paige, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartmann, K.-U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veillette, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Profound block in thymocyte development in mice lacking p56<sup>lck</sup></span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">164</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=1992&pages=161-164&author=T.+J.+Molinaauthor=K.+Kishiharaauthor=D.+P.+Siderovskidauthor=W.+van+Ewijkauthor=A.+Narendranauthor=E.+Timmsauthor=A.+Wakehamauthor=C.+J.+Paigeauthor=K.-U.+Hartmannauthor=A.+Veilletteauthor=D.+Davidsonauthor=T.+W.+Mak&title=Profound+block+in+thymocyte+development+in+mice+lacking+p56lck"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMolina%26aufirst%3DT.%2BJ.%26aulast%3DKishihara%26aufirst%3DK.%26aulast%3DSiderovskid%26aufirst%3DD.%2BP.%26aulast%3Dvan%2BEwijk%26aufirst%3DW.%26aulast%3DNarendran%26aufirst%3DA.%26aulast%3DTimms%26aufirst%3DE.%26aulast%3DWakeham%26aufirst%3DA.%26aulast%3DPaige%26aufirst%3DC.%2BJ.%26aulast%3DHartmann%26aufirst%3DK.-U.%26aulast%3DVeillette%26aufirst%3DA.%26aulast%3DDavidson%26aufirst%3DD.%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DProfound%2520block%2520in%2520thymocyte%2520development%2520in%2520mice%2520lacking%2520p56lck%26jtitle%3DNature%26date%3D1992%26volume%3D357%26spage%3D161%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Straus, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, A.</span><span> </span><span class="NLM_article-title">Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1992&pages=585-593&author=D.+B.+Strausauthor=A.+Weiss&title=Genetic+evidence+for+the+involvement+of+the+lck+tyrosine+kinase+in+signal+transduction+through+the+T+cell+antigen+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStraus%26aufirst%3DD.%2BB.%26aulast%3DWeiss%26aufirst%3DA.%26atitle%3DGenetic%2520evidence%2520for%2520the%2520involvement%2520of%2520the%2520lck%2520tyrosine%2520kinase%2520in%2520signal%2520transduction%2520through%2520the%2520T%2520cell%2520antigen%2520receptor%26jtitle%3DCell%26date%3D1992%26volume%3D70%26spage%3D585%26epage%3D593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Levin, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbush, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, R. M.</span><span> </span><span class="NLM_article-title">A dominant-negative transgene defines a role for p56lck in thymopoiesis</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1671</span><span class="NLM_x">–</span> <span class="NLM_lpage">1680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1993&pages=1671-1680&author=S.+D.+Levinauthor=S.+J.+Andersonauthor=K.+A.+Forbushauthor=R.+M.+Perlmutter&title=A+dominant-negative+transgene+defines+a+role+for+p56lck+in+thymopoiesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevin%26aufirst%3DS.%2BD.%26aulast%3DAnderson%26aufirst%3DS.%2BJ.%26aulast%3DForbush%26aufirst%3DK.%2BA.%26aulast%3DPerlmutter%26aufirst%3DR.%2BM.%26atitle%3DA%2520dominant-negative%2520transgene%2520defines%2520a%2520role%2520for%2520p56lck%2520in%2520thymopoiesis%26jtitle%3DEMBO%2520J.%26date%3D1993%26volume%3D12%26spage%3D1671%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Goldman, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballas, Z. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schutte, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenback, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noraz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, N.</span><span> </span><span class="NLM_article-title">Defective expression of p56lck in an infant with severe combined immunodeficiency</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">429</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1172%2FJCI3205" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=9664084" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADyaK1cXkslOktLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=421-429&author=F.+D.+Goldmanauthor=Z.+K.+Ballasauthor=B.+C.+Schutteauthor=J.+Kempauthor=C.+Hollenbackauthor=N.+Norazauthor=N.+Taylor&title=Defective+expression+of+p56lck+in+an+infant+with+severe+combined+immunodeficiency"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">Defective expression of p56lck in an infant with severe combined immunodeficiency</span></div><div class="casAuthors">Goldman, Frederick D.; Ballas, Zuhair K.; Schutte, Brian C.; Kemp, John; Hollenback, Clay; Noraz, Nelly; Taylor, Naomi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">421-429</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Severe combined immune deficiency (SCID) is a heterogeneous disorder characterized by profound defects in cellular and humoral immunity.  The authors report here an infant with clin. and lab. features of SCID and selective CD4 lymphopenia and lack of CD28 expression on CD8+ T cells.  T cells from this patient showed poor blastogenic responses to various mitogens and IL-2.  Other T cell antigen receptor-induced responses, including upregulation of CD69, were similarly inhibited.  However, more proximal T cell antigen receptor signaling events, such as anti-CD3 induced protein tyrosine phosphorylation, phosphorylation of mitogen-assocd. protein kinase, and calcium mobilization were intact.  Although p59fyn and ZAP-70 protein tyrosine kinases were expressed at normal levels, a marked decrease in the level of p56lck was noted.  Furthermore, this decrease was assocd. with the presence of an alternatively spliced lck transcript lacking the exon 7 kinase encoding domain.  These data suggest that a deficiency in p56lck expression can produce a SCID phenotype in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQfR5Dq3U2CbVg90H21EOLACvtfcHk0ljZ1hnB7h44gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkslOktLs%253D&md5=7849911b4ebf15c7c430789267b62d96</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1172%2FJCI3205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI3205%26sid%3Dliteratum%253Aachs%26aulast%3DGoldman%26aufirst%3DF.%2BD.%26aulast%3DBallas%26aufirst%3DZ.%2BK.%26aulast%3DSchutte%26aufirst%3DB.%2BC.%26aulast%3DKemp%26aufirst%3DJ.%26aulast%3DHollenback%26aufirst%3DC.%26aulast%3DNoraz%26aufirst%3DN.%26aulast%3DTaylor%26aufirst%3DN.%26atitle%3DDefective%2520expression%2520of%2520p56lck%2520in%2520an%2520infant%2520with%2520severe%2520combined%2520immunodeficiency%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1998%26volume%3D102%26spage%3D421%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Hubert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferreira, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seligmann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oksenhendler, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debre, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Autran, B.</span><span> </span><span class="NLM_article-title">Defective p56<sup>lck</sup> activity in T cells from an adult patient with idiopathic CD4<sup>+</sup> lymphocytopenia</span> <span class="citation_source-journal">Int. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">449</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1093%2Fintimm%2F12.4.449" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=10744646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisl2hsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=449-457&author=P.+Hubertauthor=F.+Bergeronauthor=V.+Ferreiraauthor=M.+Seligmannauthor=E.+Oksenhendlerauthor=P.+Debreauthor=B.+Autran&title=Defective+p56lck+activity+in+T+cells+from+an+adult+patient+with+idiopathic+CD4%2B+lymphocytopenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Defective p56Lck activity in T cells from an adult patient with idiopathic CD4+ lymphocytopenia</span></div><div class="casAuthors">Hubert, Pascale; Bergeron, Florence; Ferreira, Valerie; Seligmann, Maxime; Oksenhendler, Eric; Debre, Patrice; Autran, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">International Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">449-457</span>CODEN:
                <span class="NLM_cas:coden">INIMEN</span>;
        ISSN:<span class="NLM_cas:issn">0953-8178</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Idiopathic CD4+ lymphocytopenia (ICL) is defined by a stable loss of CD4+ T cells in the absence of any known cause of immune deficiency.  This syndrome is still of undetd. origin.  It affects adult patients, some of them displaying opportunistic infections similar to HIV-infected subjects.  The hypothesis that the cellular immune defect may be due to biochem. failures of the CD3-TCR pathway is investigated here in a patient assocg. a severe selective CD4+ lymphocytopenia with an increased CD8+ T cell count discovered in the course of a cryptococcal meningitidis.  A 40% redn. of T cell proliferation to CD3-TCR stimulation is obsd. only in the CD4+ subpopulation.  The early CD3-induced protein tyrosine phosphorylations are conserved in both CD4+ and CD8+ subsets, and the levels of the T cell protein tyrosine kinases p56Lck, p59Fyn and ZAP-70 are normal.  However, we find a 50% redn. of p56Lck kinase activity in the patient's T cells compared to a healthy control donor.  P59Fyn activity does not appear to be altered.  Nevertheless, we do not find any genetic abnormality of p56Lck.  These results thus suggest that a defect of an unknown protein regulating p56Lck activity takes place in this patient's T cells.  Taken together, these findings reveal p56Lck alteration in ICL and confirm the crit. role of this kinase in the maintenance of the peripheral CD4+ T cell subpopulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqi8OArdolHqbVg90H21EOLACvtfcHk0ljZ1hnB7h44gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisl2hsrY%253D&md5=4db89cbd808adfb34cc71cc9050aa681</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.1093%2Fintimm%2F12.4.449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fintimm%252F12.4.449%26sid%3Dliteratum%253Aachs%26aulast%3DHubert%26aufirst%3DP.%26aulast%3DBergeron%26aufirst%3DF.%26aulast%3DFerreira%26aufirst%3DV.%26aulast%3DSeligmann%26aufirst%3DM.%26aulast%3DOksenhendler%26aufirst%3DE.%26aulast%3DDebre%26aufirst%3DP.%26aulast%3DAutran%26aufirst%3DB.%26atitle%3DDefective%2520p56lck%2520activity%2520in%2520T%2520cells%2520from%2520an%2520adult%2520patient%2520with%2520idiopathic%2520CD4%252B%2520lymphocytopenia%26jtitle%3DInt.%2520Immunol.%26date%3D2000%26volume%3D12%26spage%3D449%26epage%3D457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Seddon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zamoyska, R.</span><span> </span><span class="NLM_article-title">TCR signals mediated by Src family kinases are essential for the survival of naive T cells</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">2997</span><span class="NLM_x">–</span> <span class="NLM_lpage">3005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2002&pages=2997-3005&author=B.+Seddonauthor=R.+Zamoyska&title=TCR+signals+mediated+by+Src+family+kinases+are+essential+for+the+survival+of+naive+T+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeddon%26aufirst%3DB.%26aulast%3DZamoyska%26aufirst%3DR.%26atitle%3DTCR%2520signals%2520mediated%2520by%2520Src%2520family%2520kinases%2520are%2520essential%2520for%2520the%2520survival%2520of%2520naive%2520T%2520cells%26jtitle%3DJ.%2520Immunol.%26date%3D2002%26volume%3D169%26spage%3D2997%26epage%3D3005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hanke, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dow, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weringer, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollok, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connelly, P. A.</span><span> </span><span class="NLM_article-title">Discovery of a Novel, Potent, and Src Family-Selective Tyrosine Kinase Inhibitor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">271</span><span class="NLM_x">, </span> <span class="NLM_fpage">695</span><span class="NLM_x">–</span> <span class="NLM_lpage">701</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=271&publication_year=1996&pages=695-701&author=J.+H.+Hankeauthor=J.+P.+Gardnerauthor=R.+L.+Dowauthor=P.+S.+Changelianauthor=W.+H.+Brissetteauthor=E.+J.+Weringerauthor=B.+A.+Pollokauthor=P.+A.+Connelly&title=Discovery+of+a+Novel%2C+Potent%2C+and+Src+Family-Selective+Tyrosine+Kinase+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHanke%26aufirst%3DJ.%2BH.%26aulast%3DGardner%26aufirst%3DJ.%2BP.%26aulast%3DDow%26aufirst%3DR.%2BL.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DWeringer%26aufirst%3DE.%2BJ.%26aulast%3DPollok%26aufirst%3DB.%2BA.%26aulast%3DConnelly%26aufirst%3DP.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520Novel%252C%2520Potent%252C%2520and%2520Src%2520Family-Selective%2520Tyrosine%2520Kinase%2520Inhibitor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1996%26volume%3D271%26spage%3D695%26epage%3D701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Trevillyan, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiou, X. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballaron, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Q. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheets, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putnam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiedeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gubbins, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warrior, U. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mollison, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faltynek, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Djuric, S. W.</span><span> </span><span class="NLM_article-title">Inhibition of p56lck tyrosine kinase by isothiazoles</span> <span class="citation_source-journal">Arch. Biochem. Biophys.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">364</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=364&publication_year=1999&pages=19-29&author=J.+M.+Trevillyanauthor=X.+G.+Chiouauthor=S.+J.+Ballaronauthor=Q.+M.+Tangauthor=A.+Bukoauthor=M.+P.+Sheetsauthor=M.+L.+Smithauthor=B.+Putnamauthor=P.+Wiedemanauthor=N.+Tuauthor=D.+Madarauthor=H.+T.+Smithauthor=E.+J.+Gubbinsauthor=U.+P.+Warriorauthor=Y.-W.+Chenauthor=K.+W.+Mollisonauthor=C.+R.+Faltynekauthor=S.+W.+Djuric&title=Inhibition+of+p56lck+tyrosine+kinase+by+isothiazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrevillyan%26aufirst%3DJ.%2BM.%26aulast%3DChiou%26aufirst%3DX.%2BG.%26aulast%3DBallaron%26aufirst%3DS.%2BJ.%26aulast%3DTang%26aufirst%3DQ.%2BM.%26aulast%3DBuko%26aufirst%3DA.%26aulast%3DSheets%26aufirst%3DM.%2BP.%26aulast%3DSmith%26aufirst%3DM.%2BL.%26aulast%3DPutnam%26aufirst%3DB.%26aulast%3DWiedeman%26aufirst%3DP.%26aulast%3DTu%26aufirst%3DN.%26aulast%3DMadar%26aufirst%3DD.%26aulast%3DSmith%26aufirst%3DH.%2BT.%26aulast%3DGubbins%26aufirst%3DE.%2BJ.%26aulast%3DWarrior%26aufirst%3DU.%2BP.%26aulast%3DChen%26aufirst%3DY.-W.%26aulast%3DMollison%26aufirst%3DK.%2BW.%26aulast%3DFaltynek%26aufirst%3DC.%2BR.%26aulast%3DDjuric%26aufirst%3DS.%2BW.%26atitle%3DInhibition%2520of%2520p56lck%2520tyrosine%2520kinase%2520by%2520isothiazoles%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1999%26volume%3D364%26spage%3D19%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Arnold, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamens, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munschauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafferty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S. E.</span><span> </span><span class="NLM_article-title">Pyrrolo[2,3-<i>d</i>]pyrimidines containing an extended 5-substituent as potent and selective inhibitors of lck I</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2167</span><span class="NLM_x">–</span> <span class="NLM_lpage">2170</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2000&pages=2167-2170&author=L.+D.+Arnoldauthor=D.+J.+Calderwoodauthor=R.+W.+Dixonauthor=D.+N.+Johnstonauthor=J.+S.+Kamensauthor=R.+Munschauerauthor=P.+Raffertyauthor=S.+E.+Ratnofsky&title=Pyrrolo%5B2%2C3-d%5Dpyrimidines+containing+an+extended+5-substituent+as+potent+and+selective+inhibitors+of+lck+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArnold%26aufirst%3DL.%2BD.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DDixon%26aufirst%3DR.%2BW.%26aulast%3DJohnston%26aufirst%3DD.%2BN.%26aulast%3DKamens%26aufirst%3DJ.%2BS.%26aulast%3DMunschauer%26aufirst%3DR.%26aulast%3DRafferty%26aufirst%3DP.%26aulast%3DRatnofsky%26aufirst%3DS.%2BE.%26atitle%3DPyrrolo%255B2%252C3-d%255Dpyrimidines%2520containing%2520an%2520extended%25205-substituent%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520lck%2520I%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2000%26volume%3D10%26spage%3D2167%26epage%3D2170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Busacca, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckner, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacober, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapadia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzenbeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowicz, A. S.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolbert, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschantz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">Discovery of 2-phenylamino-imidazo[4,5-<i>h</i>]isoquinolin-9-ones: a new class of inhibitors of Lck kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3394</span><span class="NLM_x">–</span> <span class="NLM_lpage">3405</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020113o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3394-3405&author=R.+J.+Snowauthor=M.+G.+Cardozoauthor=T.+M.+Morwickauthor=C.+A.+Busaccaauthor=Y.+Dongauthor=R.+J.+Ecknerauthor=S.+Jacoberauthor=S.+Jakesauthor=S.+Kapadiaauthor=S.+Lukasauthor=M.+Panzenbeckauthor=G.+W.+Peetauthor=J.+D.+Petersonauthor=A.+S.+Prokopowiczauthor=R.+Sellatiauthor=R.+M.+Tolbertauthor=M.+A.+Tschantzauthor=N.+Moss&title=Discovery+of+2-phenylamino-imidazo%5B4%2C5-h%5Disoquinolin-9-ones%3A+a+new+class+of+inhibitors+of+Lck+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1021%2Fjm020113o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020113o%26sid%3Dliteratum%253Aachs%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DCardozo%26aufirst%3DM.%2BG.%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26aulast%3DBusacca%26aufirst%3DC.%2BA.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DEckner%26aufirst%3DR.%2BJ.%26aulast%3DJacober%26aufirst%3DS.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKapadia%26aufirst%3DS.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DPanzenbeck%26aufirst%3DM.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DPeterson%26aufirst%3DJ.%2BD.%26aulast%3DProkopowicz%26aufirst%3DA.%2BS.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DTolbert%26aufirst%3DR.%2BM.%26aulast%3DTschantz%26aufirst%3DM.%2BA.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DDiscovery%2520of%25202-phenylamino-imidazo%255B4%252C5-h%255Disoquinolin-9-ones%253A%2520a%2520new%2520class%2520of%2520inhibitors%2520of%2520Lck%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3394%26epage%3D3405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Waegell, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babineau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McRae, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratnofsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Appel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greiner, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span> </span><span class="NLM_article-title">A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection</span> <span class="citation_source-journal">Transplant. Proc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1411</span><span class="NLM_x">–</span> <span class="NLM_lpage">1417</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2FS0041-1345%2802%2902909-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=12176420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtlKju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2002&pages=1411-1417&author=W.+Waegellauthor=M.+Babineauauthor=M.+Hartauthor=K.+Dixonauthor=B.+McRaeauthor=C.+Wallaceauthor=M.+Leachauthor=S.+Ratnofskyauthor=A.+Belangerauthor=G.+Hirstauthor=A.+Rossiniauthor=M.+Appelauthor=J.+Mordesauthor=D.+Greinerauthor=S.+Banerjee&title=A420983%2C+a+novel%2C+small+molecule+inhibitor+of+LCK+prevents+allograft+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection</span></div><div class="casAuthors">Waegell, W.; Babineau, M.; Hart, M.; Dixon, K.; McRae, B.; Wallace, C.; Leach, M.; Ratnofsky, S.; Belanger, A.; Hirst, G.; Rossini, A.; Appel, M.; Mordes, J.; Greiner, D.; Banerjee, S.</div><div class="citationInfo"><span class="NLM_cas:title">Transplantation Proceedings</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1411-1417</span>CODEN:
                <span class="NLM_cas:coden">TRPPA8</span>;
        ISSN:<span class="NLM_cas:issn">0041-1345</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A420983 is a prototypic immunosuppressive agent that selectively targets T cells receiving an activation signal.  Treatment with such an agent may allow long-term allograft survival and avoid harmful non-immune side effects common with other immunosuppressive therapies.  Lck is an attractive target for inhibition of graft rejection because it is involved in this process on several levels.  Signaling through Lck is involved in T cell cytokine prodn. and generation of cytotoxic T lymphocytes (CTL), as well as generation of T cell help required for B-cell alloantibody generation.  The present study demonstrates that the small mol. inhibitor of Lck, A420983, was able to inhibit T-cell responses in several systems.  The authors have shown that A420983 is an effective therapy for prolonging graft survival in three models of transplantation in the mouse.  In two organ transplant models, neonatal cardiac transplantation and skin transplantation.  A420983 was able to significantly prolong graft survival as compared to grafts in vehicle-treated mice.  In the islet transplant model isolated pancreatic islet cells from fully MHC-mismatched donors were protected from rejection by A420983 treatment for the entire test period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkfpFYBF9KrbVg90H21EOLACvtfcHk0lgOawblxG7Zdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtlKju74%253D&md5=e2e4fbcb2a568bee9df4ad747f09d43c</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1016%2FS0041-1345%2802%2902909-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0041-1345%252802%252902909-3%26sid%3Dliteratum%253Aachs%26aulast%3DWaegell%26aufirst%3DW.%26aulast%3DBabineau%26aufirst%3DM.%26aulast%3DHart%26aufirst%3DM.%26aulast%3DDixon%26aufirst%3DK.%26aulast%3DMcRae%26aufirst%3DB.%26aulast%3DWallace%26aufirst%3DC.%26aulast%3DLeach%26aufirst%3DM.%26aulast%3DRatnofsky%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DA.%26aulast%3DHirst%26aufirst%3DG.%26aulast%3DRossini%26aufirst%3DA.%26aulast%3DAppel%26aufirst%3DM.%26aulast%3DMordes%26aufirst%3DJ.%26aulast%3DGreiner%26aufirst%3DD.%26aulast%3DBanerjee%26aufirst%3DS.%26atitle%3DA420983%252C%2520a%2520novel%252C%2520small%2520molecule%2520inhibitor%2520of%2520LCK%2520prevents%2520allograft%2520rejection%26jtitle%3DTransplant.%2520Proc.%26date%3D2002%26volume%3D34%26spage%3D1411%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Burchat, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedman, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafferty, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skinner, B. S.</span><span> </span><span class="NLM_article-title">Pyrazolo[3,4-<i>d</i>]pyrimidines containing an extended 3-substituent as potent inhibitors of Lck—a selectivity insight</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1687</span><span class="NLM_x">–</span> <span class="NLM_lpage">1690</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1687-1690&author=A.+F.+Burchatauthor=D.+J.+Calderwoodauthor=M.+M.+Friedmanauthor=G.+C.+Hirstauthor=B.+Liauthor=P.+Raffertyauthor=K.+Ritterauthor=B.+S.+Skinner&title=Pyrazolo%5B3%2C4-d%5Dpyrimidines+containing+an+extended+3-substituent+as+potent+inhibitors+of+Lck%E2%80%94a+selectivity+insight"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurchat%26aufirst%3DA.%2BF.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DFriedman%26aufirst%3DM.%2BM.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DRafferty%26aufirst%3DP.%26aulast%3DRitter%26aufirst%3DK.%26aulast%3DSkinner%26aufirst%3DB.%2BS.%26atitle%3DPyrazolo%255B3%252C4-d%255Dpyrimidines%2520containing%2520an%2520extended%25203-substituent%2520as%2520potent%2520inhibitors%2520of%2520Lck%25E2%2580%2594a%2520selectivity%2520insight%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1687%26epage%3D1690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fex, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of novel imidazoquioxaline-based Lck inhibitors: improvement of cell potency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">3153</span><span class="NLM_x">–</span> <span class="NLM_lpage">3156</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=3153-3156&author=P.+Chenauthor=E.+J.+Iwanowiczauthor=D.+Norrisauthor=H.+H.+Guauthor=J.+Linauthor=R.+V.+Moquinauthor=J.+Dasauthor=J.+Wityakauthor=S.+H.+Spergelauthor=H.+de+Fexauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Synthesis+and+SAR+of+novel+imidazoquioxaline-based+Lck+inhibitors%3A+improvement+of+cell+potency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DH.%2BH.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3Dde%2BFex%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520novel%2520imidazoquioxaline-based%2520Lck%2520inhibitors%253A%2520improvement%2520of%2520cell%2520potency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D3153%26epage%3D3156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeFex, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span> </span><span class="NLM_article-title">Discovery of 2-amino-heteroaryl-benzothiazole-6-anilides as potent p56<sup>lck</sup> inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">2587</span><span class="NLM_x">–</span> <span class="NLM_lpage">2590</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=2587-2590&author=J.+Dasauthor=R.+V.+Moquinauthor=J.+Linauthor=C.+Liuauthor=A.+M.+Doweykoauthor=H.+F.+DeFexauthor=Q.+Fangauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=G.+L.+Schievenauthor=J.+C.+Barrishauthor=J.+Wityak&title=Discovery+of+2-amino-heteroaryl-benzothiazole-6-anilides+as+potent+p56lck+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DDeFex%26aufirst%3DH.%2BF.%26aulast%3DFang%26aufirst%3DQ.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DWityak%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%25202-amino-heteroaryl-benzothiazole-6-anilides%2520as%2520potent%2520p56lck%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D2587%26epage%3D2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Goldberg, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cardozo, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckner, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammach, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakes, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapadia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lukas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morwick, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panzenbeck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopowics, A. S.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snow, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellati, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschantz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">Optimization of 2-phenylaminoimidazo[4,5-<i>h</i>]isoquinolin-9-ones: orally active inhibitors of lck kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">1337</span><span class="NLM_x">–</span> <span class="NLM_lpage">1349</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020446l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=1337-1349&author=D.+R.+Goldbergauthor=T.+Butzauthor=M.+G.+Cardozoauthor=R.+J.+Ecknerauthor=A.+Hammachauthor=J.+Huangauthor=S.+Jakesauthor=S.+Kapadiaauthor=M.+Kashemauthor=S.+Lukasauthor=T.+M.+Morwickauthor=M.+Panzenbeckauthor=U.+Patelauthor=S.+Pavauthor=G.+W.+Peetauthor=J.+D.+Petersonauthor=A.+S.+Prokopowicsauthor=R.+J.+Snowauthor=R.+Sellatiauthor=H.+Takahashiauthor=J.+Tanauthor=M.+A.+Tschantzauthor=X-J.+Wangauthor=Y.+Wangauthor=J.+Wolakauthor=P.+Xiongauthor=N.+Moss&title=Optimization+of+2-phenylaminoimidazo%5B4%2C5-h%5Disoquinolin-9-ones%3A+orally+active+inhibitors+of+lck+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6i&amp;dbid=16384&amp;doi=10.1021%2Fjm020446l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020446l%26sid%3Dliteratum%253Aachs%26aulast%3DGoldberg%26aufirst%3DD.%2BR.%26aulast%3DButz%26aufirst%3DT.%26aulast%3DCardozo%26aufirst%3DM.%2BG.%26aulast%3DEckner%26aufirst%3DR.%2BJ.%26aulast%3DHammach%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DJakes%26aufirst%3DS.%26aulast%3DKapadia%26aufirst%3DS.%26aulast%3DKashem%26aufirst%3DM.%26aulast%3DLukas%26aufirst%3DS.%26aulast%3DMorwick%26aufirst%3DT.%2BM.%26aulast%3DPanzenbeck%26aufirst%3DM.%26aulast%3DPatel%26aufirst%3DU.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DPeterson%26aufirst%3DJ.%2BD.%26aulast%3DProkopowics%26aufirst%3DA.%2BS.%26aulast%3DSnow%26aufirst%3DR.%2BJ.%26aulast%3DSellati%26aufirst%3DR.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DJ.%26aulast%3DTschantz%26aufirst%3DM.%2BA.%26aulast%3DWang%26aufirst%3DX-J.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWolak%26aufirst%3DJ.%26aulast%3DXiong%26aufirst%3DP.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DOptimization%2520of%25202-phenylaminoimidazo%255B4%252C5-h%255Disoquinolin-9-ones%253A%2520orally%2520active%2520inhibitors%2520of%2520lck%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D1337%26epage%3D1349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leith, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Fex, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56<sup>Lck</sup> inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">6061</span><span class="NLM_x">–</span> <span class="NLM_lpage">6066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=6061-6066&author=P.+Chenauthor=D.+Norrisauthor=J.+Dasauthor=S.+H.+Spergelauthor=J.+Wityakauthor=L.+Leithauthor=R.+Zhaoauthor=B.-C.+Chenauthor=S.+Pittauthor=S.+Pangauthor=D.+R.+Shenauthor=R.+Zhangauthor=H.+F.+De+Fexauthor=A.+M.+Doweykoauthor=K.+W.+McIntyreauthor=D.+J.+Shusterauthor=K.+Behniaauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Discovery+of+novel+2-%28aminoheteroaryl%29-thiazole-5-carboxamides+as+potent+and+orally+active+Src-family+kinase+p56Lck+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6j&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DLeith%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DDe%2BFex%26aufirst%3DH.%2BF.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520novel%25202-%2528aminoheteroaryl%2529-thiazole-5-carboxamides%2520as%2520potent%2520and%2520orally%2520active%2520Src-family%2520kinase%2520p56Lck%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D6061%26epage%3D6066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Norris, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spergel, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moquin, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwanowicz, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behnia, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Fex, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thrall, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocy, O. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witmer, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanner, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span> </span><span class="NLM_article-title">Imidazoquinoxaline Src-family kinase p56<sup>Lck</sup> inhibitors: SAR, QSAR, and the discovery of (<i>S</i>)-<i>N</i>-(2-chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo-[1,5-<i>a</i>]pyrido[3,2-<i>e</i>]pyrazin-6-amine (BMS-279700) as a potent and orally active inhibitor with excellent in vivo antiinflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4517</span><span class="NLM_x">–</span> <span class="NLM_lpage">4529</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030217e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4517-4529&author=P.+Chenauthor=A.+M.+Doweykoauthor=D.+Norrisauthor=H.+H.+Guauthor=S.+H.+Spergelauthor=J.+Dasauthor=R.+V.+Moquinauthor=J.+Linauthor=J.+Wityakauthor=E.+J.+Iwanowiczauthor=K.+W.+McIntyreauthor=D.+J.+Shusterauthor=K.+Behniaauthor=S.+Chongauthor=H.+de+Fexauthor=S.+Pangauthor=S.+Pittauthor=D.+R.+Shenauthor=S.+Thrallauthor=P.+Stanleyauthor=O.+R.+Kocyauthor=M.+R.+Witmerauthor=S.+B.+Kannerauthor=G.+L.+Schievenauthor=J.+C.+Barrish&title=Imidazoquinoxaline+Src-family+kinase+p56Lck+inhibitors%3A+SAR%2C+QSAR%2C+and+the+discovery+of+%28S%29-N-%282-chloro-6-methylphenyl%29-2-%283-methyl-1-piperazinyl%29imidazo-%5B1%2C5-a%5Dpyrido%5B3%2C2-e%5Dpyrazin-6-amine+%28BMS-279700%29+as+a+potent+and+orally+active+inhibitor+with+excellent+in+vivo+antiinflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6k&amp;dbid=16384&amp;doi=10.1021%2Fjm030217e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030217e%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DNorris%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DH.%2BH.%26aulast%3DSpergel%26aufirst%3DS.%2BH.%26aulast%3DDas%26aufirst%3DJ.%26aulast%3DMoquin%26aufirst%3DR.%2BV.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DIwanowicz%26aufirst%3DE.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DBehnia%26aufirst%3DK.%26aulast%3DChong%26aufirst%3DS.%26aulast%3Dde%2BFex%26aufirst%3DH.%26aulast%3DPang%26aufirst%3DS.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DThrall%26aufirst%3DS.%26aulast%3DStanley%26aufirst%3DP.%26aulast%3DKocy%26aufirst%3DO.%2BR.%26aulast%3DWitmer%26aufirst%3DM.%2BR.%26aulast%3DKanner%26aufirst%3DS.%2BB.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26atitle%3DImidazoquinoxaline%2520Src-family%2520kinase%2520p56Lck%2520inhibitors%253A%2520SAR%252C%2520QSAR%252C%2520and%2520the%2520discovery%2520of%2520%2528S%2529-N-%25282-chloro-6-methylphenyl%2529-2-%25283-methyl-1-piperazinyl%2529imidazo-%255B1%252C5-a%255Dpyrido%255B3%252C2-e%255Dpyrazin-6-amine%2520%2528BMS-279700%2529%2520as%2520a%2520potent%2520and%2520orally%2520active%2520inhibitor%2520with%2520excellent%2520in%2520vivo%2520antiinflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4517%26epage%3D4529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">McRae, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roux, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Presky, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tracey, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span> </span><span class="NLM_article-title">Suppression of CD4<sup>+</sup> T cell activation by a novel inhibitor of Src-family kinases</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6l&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2Fj.intimp.2004.11.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6l&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15710336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6l&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlegtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=667-677&author=B.+L.+McRaeauthor=C.+Wallaceauthor=K.+F.+Dixonauthor=A.+Rouxauthor=S.+Mohanauthor=Y.+Jiaauthor=D.+H.+Preskyauthor=D.+E.+Traceyauthor=G.+C.+Hirst&title=Suppression+of+CD4%2B+T+cell+activation+by+a+novel+inhibitor+of+Src-family+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6lR"><div class="casContent"><span class="casTitleNuber">6l</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of CD4+ T cell activation by a novel inhibitor of Src family kinases</span></div><div class="casAuthors">McRae, Bradford L.; Wallace, Craig; Dixon, Kathleen Fitzgerald; Roux, Alyson; Mohan, Sukumari; Jia, Yong; Presky, David H.; Tracey, Daniel E.; Hirst, Gavin C.</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">667-677</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The Src family kinases Lck and Fyn play an important role in T cell development and function.  We have synthesized a novel small mol., A-420983, which inhibits Lck and Fyn, as well as other Src family kinases, but has selectivity with respect to non-Src family kinases.  A-420983 completely inhibited antigen-stimulated prodn. of IFN-γ and IL-4 by mouse Th1 and Th2 cells, resp.  Antigen-induced T cell proliferation was also blocked by treatment with A-420983.  In contrast, IL-15-induced proliferation was unaffected by A-420983, suggesting that TCR-independent pathways of T cell activation were not impaired.  When mice were dosed orally, A-420983 inhibited TCR-mediated c-jun and ZAP-70 phosphorylation in CD4+ T cells and suppressed the disease course of established EAE.  Treatment with A-420983 for 7 days resulted in a block in thymocyte development at the CD4- CD8- stage, consistent with inhibition of Lck and Fyn in vivo.  These results demonstrate that a small mol. inhibitor of Lck and Fyn can block TCR-induced T cell activation in vitro and in vivo.  Furthermore, CNS demyelination mediated by activated encephalitogenic CD4+ T cells is dependent upon the kinase activity of these Src family members.  We conclude that inhibition of Src family kinases may represent a promising strategy for the treatment of T cell-mediated disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBWKvht3SdgrVg90H21EOLACvtfcHk0liJNknPh7U93g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlegtbg%253D&md5=7f1ee81f1bb64dd4a2441819e1c25478</span></div><a href="/servlet/linkout?suffix=cit6l&amp;dbid=16384&amp;doi=10.1016%2Fj.intimp.2004.11.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.intimp.2004.11.012%26sid%3Dliteratum%253Aachs%26aulast%3DMcRae%26aufirst%3DB.%2BL.%26aulast%3DWallace%26aufirst%3DC.%26aulast%3DDixon%26aufirst%3DK.%2BF.%26aulast%3DRoux%26aufirst%3DA.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DPresky%26aufirst%3DD.%2BH.%26aulast%3DTracey%26aufirst%3DD.%2BE.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26atitle%3DSuppression%2520of%2520CD4%252B%2520T%2520cell%2520activation%2520by%2520a%2520novel%2520inhibitor%2520of%2520Src-family%2520kinases%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2005%26volume%3D5%26spage%3D667%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Burchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borhani, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stachlewitz, R. F.</span><span> </span><span class="NLM_article-title">Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejection</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">118</span><span class="NLM_x">–</span> <span class="NLM_lpage">122</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=118-122&author=A.+Burchatauthor=D.+W.+Borhaniauthor=D.+J.+Calderwoodauthor=G.+C.+Hirstauthor=B.+Liauthor=R.+F.+Stachlewitz&title=Discovery+of+A-770041%2C+a+src-family+selective+orally+active+lck+inhibitor+that+prevents+organ+allograft+rejection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurchat%26aufirst%3DA.%26aulast%3DBorhani%26aufirst%3DD.%2BW.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DStachlewitz%26aufirst%3DR.%2BF.%26atitle%3DDiscovery%2520of%2520A-770041%252C%2520a%2520src-family%2520selective%2520orally%2520active%2520lck%2520inhibitor%2520that%2520prevents%2520organ%2520allograft%2520rejection%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D118%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Maier, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brugel, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golebiowski, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laufersweiler, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanRens, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hopkins, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Easwaran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janusz, M. J.</span><span> </span><span class="NLM_article-title">Development of <i>N</i>-4,6-pyrimidine-<i>N</i>-alkyl-<i>N</i>′-phenyl ureas as orally active inhibitors of lymphocyte specific tyrosine kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">3646</span><span class="NLM_x">–</span> <span class="NLM_lpage">3650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=3646-3650&author=J.+A.+Maierauthor=T.+A.+Brugelauthor=M.+Sabatauthor=A.+Golebiowskiauthor=M.+J.+Laufersweilerauthor=J.+C.+VanRensauthor=C.+R.+Hopkinsauthor=B.+Deauthor=L.+C.+Hsiehauthor=K.+K.+Brownauthor=V.+Easwaranauthor=M.+J.+Janusz&title=Development+of+N-4%2C6-pyrimidine-N-alkyl-N%E2%80%B2-phenyl+ureas+as+orally+active+inhibitors+of+lymphocyte+specific+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaier%26aufirst%3DJ.%2BA.%26aulast%3DBrugel%26aufirst%3DT.%2BA.%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DGolebiowski%26aufirst%3DA.%26aulast%3DLaufersweiler%26aufirst%3DM.%2BJ.%26aulast%3DVanRens%26aufirst%3DJ.%2BC.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DDe%26aufirst%3DB.%26aulast%3DHsieh%26aufirst%3DL.%2BC.%26aulast%3DBrown%26aufirst%3DK.%2BK.%26aulast%3DEaswaran%26aufirst%3DV.%26aulast%3DJanusz%26aufirst%3DM.%2BJ.%26atitle%3DDevelopment%2520of%2520N-4%252C6-pyrimidine-N-alkyl-N%25E2%2580%25B2-phenyl%2520ureas%2520as%2520orally%2520active%2520inhibitors%2520of%2520lymphocyte%2520specific%2520tyrosine%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D3646%26epage%3D3650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armistead, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elbaum, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiron, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amouzegh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Napier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Power, E.</span><span> </span><span class="NLM_article-title">Novel 2-aminopyrimidine carbamates as potent and orally active inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">4981</span><span class="NLM_x">–</span> <span class="NLM_lpage">4991</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060435i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=4981-4991&author=M.+W.+Martinauthor=J.+Newcombauthor=J.+J.+Nunesauthor=D.+C.+McGowanauthor=D.+M.+Armisteadauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+Bucknerauthor=L.+Chaiauthor=D.+Elbaumauthor=L.+F.+Epsteinauthor=T.+Faustauthor=S.+Flynnauthor=P.+Gallantauthor=A.+Goreauthor=Y.+Guauthor=F.+Hsiehauthor=X.+Huangauthor=J.+H.+Leeauthor=D.+Metzauthor=S.+Middletonauthor=D.+Mohnauthor=K.+Morgensternauthor=M.+J.+Morrisonauthor=P.+M.+Novakauthor=A.+Oliveira-dos-Santosauthor=D.+Powersauthor=P.+Roseauthor=S.+Schneiderauthor=S.+Sellauthor=Y.+Tudorauthor=S.+M.+Turciauthor=A.+Welcherauthor=R.+D.+Whiteauthor=D.+Zackauthor=H.+Zhaoauthor=L.+Zhuauthor=X.+Zhuauthor=C.+Ghironauthor=P.+Amouzeghauthor=M.+Ermannauthor=J.+Jenkinsauthor=D.+Johnstonauthor=S.+Napierauthor=E.+Power&title=Novel+2-aminopyrimidine+carbamates+as+potent+and+orally+active+inhibitors+of+Lck%3A+synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6o&amp;dbid=16384&amp;doi=10.1021%2Fjm060435i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060435i%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DArmistead%26aufirst%3DD.%2BM.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DElbaum%26aufirst%3DD.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DMorrison%26aufirst%3DM.%2BJ.%26aulast%3DNovak%26aufirst%3DP.%2BM.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DSell%26aufirst%3DS.%26aulast%3DTudor%26aufirst%3DY.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZack%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DAmouzegh%26aufirst%3DP.%26aulast%3DErmann%26aufirst%3DM.%26aulast%3DJenkins%26aufirst%3DJ.%26aulast%3DJohnston%26aufirst%3DD.%26aulast%3DNapier%26aufirst%3DS.%26aulast%3DPower%26aufirst%3DE.%26atitle%3DNovel%25202-aminopyrimidine%2520carbamates%2520as%2520potent%2520and%2520orally%2520active%2520inhibitors%2520of%2520Lck%253A%2520synthesis%252C%2520SAR%252C%2520and%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D4981%26epage%3D4991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cee, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkle, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodous, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masse, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohn, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomlinson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5671</span><span class="NLM_x">–</span> <span class="NLM_lpage">5686</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0605482" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6p&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVChsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5671-5686&author=E.+F.+DiMauroauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+H.+Bucknerauthor=V.+J.+Ceeauthor=L.+Chaiauthor=H.+L.+Deakauthor=L.+F.+Epsteinauthor=T.+Faustauthor=P.+Gallantauthor=S.+D.+Geuns-Meyerauthor=A.+Goreauthor=Y.+Guauthor=B.+Henkleauthor=B.+L.+Hodousauthor=F.+Hsiehauthor=X.+Huangauthor=J.+L.+Kimauthor=J.+H.+Leeauthor=M.+W.+Martinauthor=C.+E.+Masseauthor=D.+C.+McGowanauthor=D.+Metzauthor=D.+Mohnauthor=K.+A.+Morgensternauthor=A.+Oliveira-dos-Santosauthor=V.+F.+Patelauthor=D.+Powersauthor=P.+E.+Roseauthor=S.+Schneiderauthor=S.+A.+Tomlinsonauthor=Y-Y.+Tudorauthor=S.+M.+Turciauthor=A.+A.+Welcherauthor=R.+D.+Whiteauthor=H.+Zhaoauthor=L.+Zhuauthor=X.+Zhu&title=Discovery+of+aminoquinazolines+as+potent%2C+orally+bioavailable+inhibitors+of+Lck%3A+synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6pR"><div class="casContent"><span class="casTitleNuber">6p</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck: Synthesis, SAR, and in Vivo Anti-Inflammatory Activity</span></div><div class="casAuthors">DiMauro, Erin F.; Newcomb, John; Nunes, Joseph J.; Bemis, Jean E.; Boucher, Christina; Buchanan, John L.; Buckner, William H.; Cee, Victor J.; Chai, Lilly; Deak, Holly L.; Epstein, Linda F.; Faust, Ted; Gallant, Paul; Geuns-Meyer, Stephanie D.; Gore, Anu; Gu, Yan; Henkle, Brad; Hodous, Brian L.; Hsieh, Faye; Huang, Xin; Kim, Joseph L.; Lee, Josie H.; Martin, Matthew W.; Masse, Craig E.; McGowan, David C.; Metz, Daniela; Mohn, Deanna; Morgenstern, Kurt A.; Oliveira-dos-Santos, Antonio; Patel, Vinod F.; Powers, David; Rose, Paul E.; Schneider, Stephen; Tomlinson, Susan A.; Tudor, Yan-Yan; Turci, Susan M.; Welcher, Andrew A.; White, Ryan D.; Zhao, Huilin; Zhu, Li; Zhu, Xiaotian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">5671-5686</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The lymphocyte-specific kinase (Lck) is a cytoplasmic tyrosine kinase of the Src family expressed in T cells and natural killer (NK) cells.  Genetic evidence in both mice and humans demonstrates that Lck kinase activity is crit. for signaling mediated by the T cell receptor (TCR), which leads to normal T cell development and activation.  Selective inhibition of Lck is expected to offer a new therapy for the treatment of T-cell-mediated autoimmune and inflammatory disease.  Screening of our kinase-preferred collection identified aminoquinazoline I as a potent, nonselective inhibitor of Lck and T cell proliferation.  In this report, we describe the synthesis and structure-activity relationships of a series of novel aminoquinazolines possessing in vitro mechanism-based potency.  Two optimized, orally bioavailable compds. exhibit antiinflammatory activity (ED50 of 22 and 11 mg/kg, resp.) in the anti-CD3-induced prodn. of interleukin-2 (IL-2) in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm7qaZo8QJ6bVg90H21EOLACvtfcHk0lg4n-E8S4DVrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVChsLk%253D&md5=3ed1152bf34749755fdd9c2f8f25950c</span></div><a href="/servlet/linkout?suffix=cit6p&amp;dbid=16384&amp;doi=10.1021%2Fjm0605482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0605482%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%2BH.%26aulast%3DCee%26aufirst%3DV.%2BJ.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%2BD.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHenkle%26aufirst%3DB.%26aulast%3DHodous%26aufirst%3DB.%2BL.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMasse%26aufirst%3DC.%2BE.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DMetz%26aufirst%3DD.%26aulast%3DMohn%26aufirst%3DD.%26aulast%3DMorgenstern%26aufirst%3DK.%2BA.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTomlinson%26aufirst%3DS.%2BA.%26aulast%3DTudor%26aufirst%3DY-Y.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%2BA.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520aminoquinazolines%2520as%2520potent%252C%2520orally%2520bioavailable%2520inhibitors%2520of%2520Lck%253A%2520synthesis%252C%2520SAR%252C%2520and%2520in%2520vivo%2520anti-inflammatory%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5671%26epage%3D5686" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6q"><span><span class="NLM_label">(q) </span><span class="NLM_contrib-group">Abbott, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betschmann, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burchat, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderwood, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hrnciar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirst, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morytko, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B.</span><span> </span><span class="NLM_article-title">Discovery of thienopyridines as Src-family selective Lck inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1167</span><span class="NLM_x">–</span> <span class="NLM_lpage">1171</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1167-1171&author=L.+Abbottauthor=P.+Betschmannauthor=A.+Burchatauthor=D.+J.+Calderwoodauthor=H.+Davisauthor=P.+Hrnciarauthor=G.+C.+Hirstauthor=B.+Liauthor=M.+Morytkoauthor=K.+Mullenauthor=B.+Yang&title=Discovery+of+thienopyridines+as+Src-family+selective+Lck+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6q&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott%26aufirst%3DL.%26aulast%3DBetschmann%26aufirst%3DP.%26aulast%3DBurchat%26aufirst%3DA.%26aulast%3DCalderwood%26aufirst%3DD.%2BJ.%26aulast%3DDavis%26aufirst%3DH.%26aulast%3DHrnciar%26aufirst%3DP.%26aulast%3DHirst%26aufirst%3DG.%2BC.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DMorytko%26aufirst%3DM.%26aulast%3DMullen%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520thienopyridines%2520as%2520Src-family%2520selective%2520Lck%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D1167%26epage%3D1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6r"><span><span class="NLM_label">(r) </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hseih, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of novel 2,3-diarylfuro[2,3-<i>b</i>]pyridin-4-amines as potent and selective inhibitors of Lck: synthesis, SAR, and pharmacokinetic properties</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2209</span><span class="NLM_x">–</span> <span class="NLM_lpage">2304</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2209-2304&author=M.+W.+Martinauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=J.+L.+Buchananauthor=E.+F.+DiMauroauthor=D.+C.+McGowanauthor=R.+D.+Whiteauthor=C.+Boucherauthor=T.+Faustauthor=F.+Hseihauthor=J.+H.+Leeauthor=S.+Schneiderauthor=S.+M.+Turciauthor=X.+Zhu&title=Discovery+of+novel+2%2C3-diarylfuro%5B2%2C3-b%5Dpyridin-4-amines+as+potent+and+selective+inhibitors+of+Lck%3A+synthesis%2C+SAR%2C+and+pharmacokinetic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6r&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DHseih%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520novel%25202%252C3-diarylfuro%255B2%252C3-b%255Dpyridin-4-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520synthesis%252C%2520SAR%252C%2520and%2520pharmacokinetic%2520properties%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2209%26epage%3D2304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6s"><span><span class="NLM_label">(s) </span><span class="NLM_contrib-group">DiMauro, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bemis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchanan, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckner, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.</span><span> </span><span class="NLM_article-title">Discovery of 4-amino-5,6-biaryl-furo[2,3-<i>d</i>]pyrimidines as inhibitors of Lck: development of an expedient and divergent synthetic route and preliminary SAR</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2305</span><span class="NLM_x">–</span> <span class="NLM_lpage">2309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2305-2309&author=E.+F.+DiMauroauthor=J.+Newcombauthor=J.+J.+Nunesauthor=J.+E.+Bemisauthor=C.+Boucherauthor=J.+L.+Buchananauthor=W.+H.+Bucknerauthor=T.+Faustauthor=F.+Hsiehauthor=J.+H.+Leeauthor=M.+W.+Martinauthor=D.+C.+McGowanauthor=T.+L.+Marshallauthor=S.+Schneiderauthor=S.+M.+Turciauthor=R.+D.+Whiteauthor=X.+Zhu&title=Discovery+of+4-amino-5%2C6-biaryl-furo%5B2%2C3-d%5Dpyrimidines+as+inhibitors+of+Lck%3A+development+of+an+expedient+and+divergent+synthetic+route+and+preliminary+SAR"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6s&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiMauro%26aufirst%3DE.%2BF.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBemis%26aufirst%3DJ.%2BE.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DBuchanan%26aufirst%3DJ.%2BL.%26aulast%3DBuckner%26aufirst%3DW.%2BH.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DJ.%2BH.%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DMcGowan%26aufirst%3DD.%2BC.%26aulast%3DMarshall%26aufirst%3DT.%2BL.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DZhu%26aufirst%3DX.%26atitle%3DDiscovery%2520of%25204-amino-5%252C6-biaryl-furo%255B2%252C3-d%255Dpyrimidines%2520as%2520inhibitors%2520of%2520Lck%253A%2520development%2520of%2520an%2520expedient%2520and%2520divergent%2520synthetic%2520route%2520and%2520preliminary%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2305%26epage%3D2309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6t"><span><span class="NLM_label">(t) </span><span class="NLM_contrib-group">Bamborough, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhamra, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christopher, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooper, A. W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hind, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ranshaw, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skone, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vickerstaff, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Washington, M.</span><span> </span><span class="NLM_article-title"><i>N</i>-4-Pyrimidinyl-1<i>H</i>-indazol-4-amine inhibitors of Lck: indazoles as phenol isosteres with improved pharmacokinetics</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">4363</span><span class="NLM_x">–</span> <span class="NLM_lpage">4368</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=4363-4368&author=P.+Bamboroughauthor=R.+M.+Angellauthor=I.+Bhamraauthor=D.+Brownauthor=J.+Bullauthor=J.+A.+Christopherauthor=A.+W.+J.+Cooperauthor=L.+H.+Fazalauthor=I.+Giordanoauthor=L.+Hindauthor=V.+K.+Patelauthor=L.+E.+Ranshawauthor=M.+J.+Simsauthor=P.+A.+Skoneauthor=K.+J.+Smithauthor=E.+Vickerstaffauthor=M.+Washington&title=N-4-Pyrimidinyl-1H-indazol-4-amine+inhibitors+of+Lck%3A+indazoles+as+phenol+isosteres+with+improved+pharmacokinetics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6t&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBamborough%26aufirst%3DP.%26aulast%3DAngell%26aufirst%3DR.%2BM.%26aulast%3DBhamra%26aufirst%3DI.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBull%26aufirst%3DJ.%26aulast%3DChristopher%26aufirst%3DJ.%2BA.%26aulast%3DCooper%26aufirst%3DA.%2BW.%2BJ.%26aulast%3DFazal%26aufirst%3DL.%2BH.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DHind%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DRanshaw%26aufirst%3DL.%2BE.%26aulast%3DSims%26aufirst%3DM.%2BJ.%26aulast%3DSkone%26aufirst%3DP.%2BA.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DVickerstaff%26aufirst%3DE.%26aulast%3DWashington%26aufirst%3DM.%26atitle%3DN-4-Pyrimidinyl-1H-indazol-4-amine%2520inhibitors%2520of%2520Lck%253A%2520indazoles%2520as%2520phenol%2520isosteres%2520with%2520improved%2520pharmacokinetics%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D4363%26epage%3D4368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6u"><span><span class="NLM_label">(u) </span><span class="NLM_contrib-group">Martin, M. W.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nunes, J. J.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, L.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, L. F.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faust, T.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, S.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallant, P.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gore, A.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, F.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Middleton, S.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliveira-dos-Santos, A.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, Y.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turci, S. M.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welcher, A. A.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zack, D.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, L.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, X.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiron, C.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermann, M.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnston, D.;</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saluste, C.-G. P.</span><div class="note"><p class="first last"> “Structure-based design of novel 2-amino-6-phenyl-pyrimido[5′,4′:5,6]pyrimido[1,2-<i>a</i>]benzimidazol-5(6<i>H</i>)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity. <i>J. Med. Chem.</i>, in press.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Martin%2C+M.+W.%3B%3B+Newcomb%2C+J.%3B%3B+Nunes%2C+J.+J.%3B%3B+Boucher%2C+C.%3B%3B+Chai%2C+L.%3B%3B+Epstein%2C+L.+F.%3B%3B+Faust%2C+T.%3B%3B+Flores%2C+S.%3B%3B+Gallant%2C+P.%3B%3B+Gore%2C+A.%3B%3B+Gu%2C+Y.%3B%3B+Hsieh%2C+F.%3B%3B+Huang%2C+X.%3B%3B+Kim%2C+J.+L.%3B%3B+Middleton%2C+S.%3B%3B+Morgenstern%2C+K.%3B%3B+Oliveira-dos-Santos%2C+A.%3B%3B+Patel%2C+V.+F.%3B%3B+Powers%2C+D.%3B%3B+Rose%2C+P.%3B%3B+Tudor%2C+Y.%3B%3B+Turci%2C+S.+M.%3B%3B+Welcher%2C+A.+A.%3B%3B+Zack%2C+D.%3B%3B+Zhao%2C+H.%3B%3B+Zhu%2C+L.%3B%3B+Zhu%2C+X.%3B%3B+Ghiron%2C+C.%3B%3B+Ermann%2C+M.%3B%3B+Johnston%2C+D.%3B%3B+Saluste%2C+C.-G.+P.%E2%80%89%E2%80%9CStructure-based+design+of+novel+2-amino-6-phenyl-pyrimido%5B5%E2%80%B2%2C4%E2%80%B2%3A5%2C6%5Dpyrimido%5B1%2C2-a%5Dbenzimidazol-5%286H%29-ones+as+potent+and+orally+active+inhibitors+of+lymphocyte+specific+kinase+%28Lck%29%3A+synthesis%2C+SAR%2C+and+in+vivo+anti-inflammatory+activity.+J.+Med.+Chem.%2C+in+press."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6u&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DM.%2BW.%26aulast%3DNewcomb%26aufirst%3DJ.%26aulast%3DNunes%26aufirst%3DJ.%2BJ.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DChai%26aufirst%3DL.%26aulast%3DEpstein%26aufirst%3DL.%2BF.%26aulast%3DFaust%26aufirst%3DT.%26aulast%3DFlores%26aufirst%3DS.%26aulast%3DGallant%26aufirst%3DP.%26aulast%3DGore%26aufirst%3DA.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DHsieh%26aufirst%3DF.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DMiddleton%26aufirst%3DS.%26aulast%3DMorgenstern%26aufirst%3DK.%26aulast%3DOliveira-dos-Santos%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DPowers%26aufirst%3DD.%26aulast%3DRose%26aufirst%3DP.%26aulast%3DTudor%26aufirst%3DY.%26aulast%3DTurci%26aufirst%3DS.%2BM.%26aulast%3DWelcher%26aufirst%3DA.%2BA.%26aulast%3DZack%26aufirst%3DD.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DGhiron%26aufirst%3DC.%26aulast%3DErmann%26aufirst%3DM.%26aulast%3DJohnston%26aufirst%3DD.%26aulast%3DSaluste%26aufirst%3DC.-G.%2BP." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><div class="note"><p class="first last">Selectivity over KDR, Tie-2, and the Janus kinase family is important with respect to establishing an adequate therapeutic index.</p></div><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lanier, L. L.</span><span> </span><span class="NLM_article-title">Natural killer cell receptor signaling</span> <span class="citation_source-journal">Curr. Opin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span>− <span class="NLM_lpage">314</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2FS0952-7915%2803%2900039-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=12787756" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkt1Knt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2003&pages=308-314&author=L.+L.+Lanier&title=Natural+killer+cell+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Natural killer cell receptor signaling</span></div><div class="casAuthors">Lanier, Lewis L.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">308-314</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Natural killer (NK) cell immune responses are regulated by a balance of activating and inhibitory signals transmitted by cell surface receptors.  Immunoreceptor tyrosine-based inhibition motifs in the cytoplasmic domains of inhibitory NK receptors recruit tyrosine or lipid phosphatases, which modulate the activation signals transmitted by receptors linked to the Syk and ZAP70 tyrosine kinases and phosphatidylinositol-3 kinases.  In addn., recent studies of gene-deficient animals, in particular Syk and ZAP70 double-deficient mice, suggest that NK cells possess a robust and potentially redundant receptor system to ensure their development and function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTfuH60nipk7Vg90H21EOLACvtfcHk0lheAPuGR2bZIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkt1Knt70%253D&md5=add9ccc68c130bad752351e143ae854b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2803%2900039-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252803%252900039-6%26sid%3Dliteratum%253Aachs%26aulast%3DLanier%26aufirst%3DL.%2BL.%26atitle%3DNatural%2520killer%2520cell%2520receptor%2520signaling%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2003%26volume%3D15%26spage%3D308%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Thurston, G.</span><span> </span><span class="NLM_article-title">Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis</span> <span class="citation_source-journal">Cell Tissue Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">61</span><span class="NLM_x">–</span> <span class="NLM_lpage">68</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1007%2Fs00441-003-0749-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=12915980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2003&pages=61-68&author=G.+Thurston&title=Role+of+angiopoietins+and+Tie+receptor+tyrosine+kinases+in+angiogenesis+and+lymphangiogenesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis</span></div><div class="casAuthors">Thurston, Gavin</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-68</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review.  The author focuses on the signaling system involving the angiopoietin1/Tie2 receptor, which appears to be involved in the secondary stages of blood vessel formation.  Although this system is crucial for blood and lymphatic vessel formation, identifying its precise role in embryonic and adult vascular biol. has been a major challenge.  The evidence for the key role of the angiopoietin/Tie system is discussed, and some of the other members of the system (Ang2, Tie1) are mentioned.  A comparison is made with the VEGF signaling system, which seems to provide a complementary, and somewhat more tractable, signaling system.  Some of the basic unanswered questions concerning Tie/angiopoietin biol. and the secondary stages of blood vessel formation are also highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTV22jLj5PybVg90H21EOLACvtfcHk0lib60ROHE1RpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmu7s%253D&md5=22a18dfb2e3575b49c009509a6214434</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1007%2Fs00441-003-0749-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-003-0749-6%26sid%3Dliteratum%253Aachs%26aulast%3DThurston%26aufirst%3DG.%26atitle%3DRole%2520of%2520angiopoietins%2520and%2520Tie%2520receptor%2520tyrosine%2520kinases%2520in%2520angiogenesis%2520and%2520lymphangiogenesis%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2003%26volume%3D314%26spage%3D61%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ahmed, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward, W. P.</span><span> </span><span class="NLM_article-title">Vascular endothelial growth factor (VEGF) inhibition by small molecules</span> <span class="citation_source-journal">J. Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15688612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsFantb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=59-63&author=S.+I.+Ahmedauthor=A.+L.+Thomasauthor=W.+P.+Steward&title=Vascular+endothelial+growth+factor+%28VEGF%29+inhibition+by+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Vascular endothelial growth factor (VEGF) inhibition by small molecules</span></div><div class="casAuthors">Ahmed, S. I.; Thomas, A. L.; Steward, W. P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemotherapy (Firenze, Italy)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">Suppl. 4</span>),
    <span class="NLM_cas:pages">59-63</span>CODEN:
                <span class="NLM_cas:coden">JCHEEU</span>;
        ISSN:<span class="NLM_cas:issn">1120-009X</span>.
    
            (<span class="NLM_cas:orgname">E.S.I.F.T. srl</span>)
        </div><div class="casAbstract">A review.  Angiogenesis is essential for primary tumors to grow and metastasise, and is driven by the prodn. of pos. angiogenic factors.  The Vascular Endothelial Growth Factor (VEGF) family is central to the process of angiogenesis and comprises 5 mols. designated A, B, C, D and E.  VEGF is overexpressed in several solid malignancies.  The actions of VEGF are mediated through receptors possessing tyrosine kinase activity: VEGFR-1 (Flt-1), VEGFR-2 (Kdr/Flk-1) and VEGFR-3 (Flt-4).  Anti-VEGF strategies include the use of antibodies to VEGF or its receptors, the use of ribozymes to decrease receptor expression, and the use of inhibitors of tyrosine kinase to reduce receptor activation and downstream signalling.  The focus of this review is small mol. inhibitors of VEGF receptors which target their intrinsic tyrosine kinase activity.  The clin. development of the following agents is discussed: SU5416, SU11248, SU6668, PTK/ZK, ZD6474.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvEoRDCaYsR7Vg90H21EOLACvtfcHk0lib60ROHE1RpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsFantb0%253D&md5=4646b63518c4ff1234ae9771927c1e87</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DS.%2BI.%26aulast%3DThomas%26aufirst%3DA.%2BL.%26aulast%3DSteward%26aufirst%3DW.%2BP.%26atitle%3DVascular%2520endothelial%2520growth%2520factor%2520%2528VEGF%2529%2520inhibition%2520by%2520small%2520molecules%26jtitle%3DJ.%2520Chemother.%26date%3D2004%26volume%3D16%26spage%3D59%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Paz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span> </span><span class="NLM_article-title">Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective</span> <span class="citation_source-journal">Front. Biosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1415</span><span class="NLM_x">–</span> <span class="NLM_lpage">1439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.2741%2F1629" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15769635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2MXisVekurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2005&pages=1415-1439&author=K.+Pazauthor=Z.+Zhu&title=Development+of+angiogenesis+inhibitors+to+vascular+endothelial+growth+factor+receptor+2.+Current+status+and+future+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Development of angiogenesis inhibitors to vascular endothelial growth factor receptor 2. Current status and future perspective</span></div><div class="casAuthors">Paz, Keren; Zhu, Zhenping</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1415-1439</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review.  Angiogenesis, the recruitment of new blood vessels is a crucial mechanism required for both tumor growth and metastasis.  Advances in the understanding of the mol. mechanisms underlying the angiogenesis process have led to the discovery of a variety of pharmaceutical agents with antiangiogenic activity.  The potential application of these angiogenesis inhibitors is currently under intense clin. investigation.  Decades of investigation suggest that vascular endothelial growth factor (VEGF) and its receptors, particularly VEGF receptor 2 (VEGFR2, or kinase insert domain-contg. receptor, KDR), play a crit. role in tumor-assocd. angiogenesis.  KDR, therefore, represents a good target for therapeutic intervention.  A no. of agents designed selectively for targeting KDR are being evaluated in various phases of clin. trials in cancer patients.  This Manuscript reviews briefly the biol. of VEGF family of ligands and receptors and of KDR in particular.  The attempts to develop effective KDR antagonists, including small mols., antibodies and others, for therapeutic purposes are discussed comprehensively with special emphasis on tumor angiogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrnWzpjh84lYrVg90H21EOLACvtfcHk0lib60ROHE1RpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXisVekurg%253D&md5=8f8bdb8650b7822f55189835489f4edc</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.2741%2F1629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252F1629%26sid%3Dliteratum%253Aachs%26aulast%3DPaz%26aufirst%3DK.%26aulast%3DZhu%26aufirst%3DZ.%26atitle%3DDevelopment%2520of%2520angiogenesis%2520inhibitors%2520to%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%25202.%2520Current%2520status%2520and%2520future%2520perspective%26jtitle%3DFront.%2520Biosci.%26date%3D2005%26volume%3D10%26spage%3D1415%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Eskens, F. A. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verweij, J.</span><span> </span><span class="NLM_article-title">The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">3127</span><span class="NLM_x">–</span> <span class="NLM_lpage">3139</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=3127-3139&author=F.+A.+L.+M.+Eskensauthor=J.+Verweij&title=The+clinical+toxicity+profile+of+vascular+endothelial+growth+factor+%28VEGF%29+and+vascular+endothelial+growth+factor+receptor+%28VEGFR%29+targeting+angiogenesis+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEskens%26aufirst%3DF.%2BA.%2BL.%2BM.%26aulast%3DVerweij%26aufirst%3DJ.%26atitle%3DThe%2520clinical%2520toxicity%2520profile%2520of%2520vascular%2520endothelial%2520growth%2520factor%2520%2528VEGF%2529%2520and%2520vascular%2520endothelial%2520growth%2520factor%2520receptor%2520%2528VEGFR%2529%2520targeting%2520angiogenesis%2520inhibitors%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2006%26volume%3D42%26spage%3D3127%26epage%3D3139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Fiedler, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustin, H. G.</span><span> </span><span class="NLM_article-title">Angiopoietins: a link between angiogenesis and inflammation</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">552</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2Fj.it.2006.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=17045842" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1SjsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=552-558&author=U.+Fiedlerauthor=H.+G.+Augustin&title=Angiopoietins%3A+a+link+between+angiogenesis+and+inflammation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7f</span><div class="casTitle"><span class="NLM_cas:atitle">Angiopoietins: a link between angiogenesis and inflammation</span></div><div class="casAuthors">Fiedler, Ulrike; Augustin, Hellmut G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">552-558</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review on the angiopoietin (Ang)-Tie ligand-receptor system role in regulating vascular integrity and quiescence and controlling endothelial cell responses during inflammation.  Ang-1-mediated Tie2 activation is required to maintain the quiescent resting state of the endothelium.  Agonistic Ang-1 functions are antagonized by Ang-2, which destabilizes the quiescent endothelium and primes it to respond to exogenous stimuli, thereby facilitating the activities of inflammatory (TNF and IL-1) and angiogenic ( VEGF) cytokines.  Intriguingly, Ang-2 is expressed weakly by the resting endothelium but becomes strongly upregulated following endothelial activation.  Moreover, endothelial cells store Ang-2 in Weibel-Palade bodies from where it can be made available quickly following stimulation, suggesting a role of Ang-2 in controlling rapid vascular adaptive processes.  This suggests that Ang-2 is the dynamic regulator of the Ang-Tie2 axis, thereby functioning as a built-in switch controlling the transition of the resting quiescent endothelium towards the activated responsive endothelium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwYH_Bcsmez7Vg90H21EOLACvtfcHk0lib60ROHE1RpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1SjsrbM&md5=0b299c0063302d43bd28a93a9b8b52a2</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2006.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2006.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DFiedler%26aufirst%3DU.%26aulast%3DAugustin%26aufirst%3DH.%2BG.%26atitle%3DAngiopoietins%253A%2520a%2520link%2520between%2520angiogenesis%2520and%2520inflammation%26jtitle%3DTrends%2520Immunol.%26date%3D2006%26volume%3D27%26spage%3D552%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Tamura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, A.</span><span> </span><span class="NLM_article-title">Tyrosine kinases as targets for anti-inflammatory therapy</span> <span class="citation_source-journal">Anti-Inflammatory Anti-Allergy Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.2174%2F187152307779939732" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVWit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=47-62&author=T.+Tamuraauthor=A.+Koch&title=Tyrosine+kinases+as+targets+for+anti-inflammatory+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7gR"><div class="casContent"><span class="casTitleNuber">7g</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine kinases as targets for anti-inflammatory therapy</span></div><div class="casAuthors">Tamura, Teruko; Koch, Alexandra</div><div class="citationInfo"><span class="NLM_cas:title">Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-60</span>CODEN:
                <span class="NLM_cas:coden">AAAMC6</span>;
        ISSN:<span class="NLM_cas:issn">1871-5230</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tyrosine kinases play key roles in cell proliferation, differentiation, survival, cell migration, tissue development, and cell metabs.  Mutation and /or truncation in tyrosine kinases result in their constitutive activation independent of ligand stimulation.  The constitutively activated tyrosine kinase often triggers cancer development.  Furthermore, it is well documented that overexpression of tyrosine kinases is involved in malignancy.  In inflammatory lesion, tyrosine kinases are also activated via over-prodn. of growth factors and/or cytokines from tissues.  Several recent studies have demonstrated that targeting tyrosine kinases in inflammatory disease may lead to an useful therapy.  In this review, we describe tyrosine kinases that are or may be involved in inflammatory disease such as stem cell factor (SCF) receptor (c-Kit), platelet derived growth factor (PDGF) receptors, macrophage colony stimulating factor (M-CSF) receptor (c-Fms), Trk receptors, vascular endothelial growth factor (VEGF) receptors, fibroblast growth factor (FGF) receptors, epidermal growth factor (EGF) receptors, macrophage stimulating protein receptor (Ron), Janus kinases (Jak), and spleen tyrosine kinase (Syk)/zeta-chain assocd. protein kinase of 70 kDa (ZAP-70).  In addn. we describe potential tools and methods that can be applied for therapy, such as small mol. kinase inhibitors, antibodies, small peptides, or truncated receptors.  Since inflammatory diseases are generally complex host reactions for a long term, and tyrosine kinases are important for maintenance of cell homeostasis, a successful tyrosine kinase targeting therapy will require many further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2v7QF92n9TrVg90H21EOLACvtfcHk0liSj8d0aZ_WGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVWit74%253D&md5=ce01299b4770f677c8e6622f08a32f5f</span></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.2174%2F187152307779939732&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152307779939732%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DKoch%26aufirst%3DA.%26atitle%3DTyrosine%2520kinases%2520as%2520targets%2520for%2520anti-inflammatory%2520therapy%26jtitle%3DAnti-Inflammatory%2520Anti-Allergy%2520Agents%2520Med.%2520Chem.%26date%3D2007%26volume%3D6%26spage%3D47%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Huse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">The conformational plasticity of protein kinases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2FS0092-8674%2802%2900741-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=12015977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvV2lsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=275-282&author=M.+Huseauthor=J.+Kuriyan&title=The+conformational+plasticity+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">The conformational plasticity of protein kinases</span></div><div class="casAuthors">Huse, Morgan; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">275-282</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with 48 refs.  Protein kinases operate in a large no. of distinct signaling pathways, where the tight regulation of their catalytic activity is crucial to the development and maintenance of eukaryotic organisms.  The catalytic domains of different kinases adopt strikingly similar structures when they are active.  By contrast, crystal structures of inactive kinases have revealed a marked plasticity in the kinase domain that allows the adoption of distinct conformations in response to interactions with specific regulatory domains or proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJrn7F3h4ej7Vg90H21EOLACvtfcHk0liSj8d0aZ_WGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvV2lsLw%253D&md5=cd56edae94ad239f2ce7a5d6c8930cbb</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2900741-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252900741-9%26sid%3Dliteratum%253Aachs%26aulast%3DHuse%26aufirst%3DM.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DThe%2520conformational%2520plasticity%2520of%2520protein%2520kinases%26jtitle%3DCell%26date%3D2002%26volume%3D109%26spage%3D275%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Schindler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicena, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1938</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1126%2Fscience.289.5486.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=10988075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1altLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1938-1942&author=T.+Schindlerauthor=W.+Bornmannauthor=P.+Pellicenaauthor=W.+T.+Millerauthor=B.+Clarksonauthor=J.+Kuriyan&title=Structural+mechanism+for+STI-571+inhibition+of+Abelson+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase</span></div><div class="casAuthors">Schindler, Thomas; Bornmann, William; Pellicena, Patricia; Miller, W. Todd; Clarkson, Bayard; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5486</span>),
    <span class="NLM_cas:pages">1938-1942</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The inadvertent activation of the Abelson tyrosine kinase (Abl) causes chronic myelogenous leukemia (CML).  A small-mol. inhibitor of Abl (STI-571) is effective in the treatment of CML.  We report the crystal structure of the catalytic domain of Abl, complexed to a variant of STI-571.  Crit. to the binding of STI-571 is the adoption by the kinase of an inactive conformation, in which a centrally located "activation loop" is not phosphorylated.  The conformation of this loop is distinct from that in active protein kinases, as well as in the inactive form of the closely related Src kinases.  These results suggest that compds. that exploit the distinctive inactivation mechanisms of individual protein kinases can achieve both high affinity and high specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9eAZqIQ1aebVg90H21EOLACvtfcHk0liSj8d0aZ_WGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1altLc%253D&md5=56bb233f010f099d0073020ac6b9db59</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5486.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5486.1938%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DPellicena%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DW.%2BT.%26aulast%3DClarkson%26aufirst%3DB.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DStructural%2520mechanism%2520for%2520STI-571%2520inhibition%2520of%2520Abelson%2520tyrosine%2520kinase%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1938%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Mol, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dougan, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skene, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheibe, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snell, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sang, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. P.</span><span> </span><span class="NLM_article-title">Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">31655</span><span class="NLM_x">–</span> <span class="NLM_lpage">31663</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1074%2Fjbc.M403319200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15123710" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlslOrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=31655-31663&author=C.+D.+Molauthor=D.+R.+Douganauthor=T.+R.+Schneiderauthor=R.+J.+Skeneauthor=M.+L.+Krausauthor=D.+N.+Scheibeauthor=G.+P.+Snellauthor=H.+Zouauthor=B.-C.+Sangauthor=K.+P.+Wilson&title=Structural+basis+for+the+autoinhibition+and+STI-571+inhibition+of+c-Kit+tyrosine+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase</span></div><div class="casAuthors">Mol, Clifford D.; Dougan, Douglas R.; Schneider, Thomas R.; Skene, Robert J.; Kraus, Michelle L.; Scheibe, Daniel N.; Snell, Gyorgy P.; Zou, Hua; Sang, Bi-Ching; Wilson, Keith P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">31655-31663</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The activity of the c-Kit receptor protein-tyrosine kinase is tightly regulated in normal cells, whereas deregulated c-Kit kinase activity is implicated in the pathogenesis of human cancers.  The c-Kit juxtamembrane region is known to have an autoinhibitory function; however the precise mechanism by which c-Kit is maintained in an autoinhibited state is not known.  We report the 1.9-Å resoln. crystal structure of native c-Kit kinase in an autoinhibited conformation and compare it with active c-Kit kinase.  Autoinhibited c-Kit is stabilized by the juxtamembrane domain, which inserts into the kinase-active site and disrupts formation of the activated structure.  A 1.6-Å crystal structure of c-Kit in complex with STI-571 (Imatinib or Gleevec) demonstrates that inhibitor binding disrupts this natural mechanism for maintaining c-Kit in an autoinhibited state.  Together, these results provide a structural basis for understanding c-Kit kinase autoinhibition and will facilitate the structure-guided design of specific inhibitors that target the activated and autoinhibited conformations of c-Kit kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWJsKx1IzXQbVg90H21EOLACvtfcHk0lh-G_xawP-MMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlslOrtrc%253D&md5=df6065a62b44e4c2e6b020da0f797ab4</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M403319200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M403319200%26sid%3Dliteratum%253Aachs%26aulast%3DMol%26aufirst%3DC.%2BD.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DSchneider%26aufirst%3DT.%2BR.%26aulast%3DSkene%26aufirst%3DR.%2BJ.%26aulast%3DKraus%26aufirst%3DM.%2BL.%26aulast%3DScheibe%26aufirst%3DD.%2BN.%26aulast%3DSnell%26aufirst%3DG.%2BP.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DSang%26aufirst%3DB.-C.%26aulast%3DWilson%26aufirst%3DK.%2BP.%26atitle%3DStructural%2520basis%2520for%2520the%2520autoinhibition%2520and%2520STI-571%2520inhibition%2520of%2520c-Kit%2520tyrosine%2520kinase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D31655%26epage%3D31663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Deak, H. L.; Newcomb, J.; Nunes, J. J.; DiMauro, E. F.; Hodous, B. L.; Patel, V. F.; Boucher, C.; Cheng, A.; Epstein, L.; Gallant, P.; Huang, X.; Lee, J. H.; Schneider, S.; Turci, S. M.; Zhu, X.</span><span> </span><span class="NLM_article-title"><i>N</i>-3-(Phenylcarbamoyl)arylpyrimidine-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SAR</span>.  <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><div class="note"><p class="first last"><b>2008</b>, <i>18</i>, 1172–1176.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Deak%2C+H.+L.%3B+Newcomb%2C+J.%3B+Nunes%2C+J.+J.%3B+DiMauro%2C+E.+F.%3B+Hodous%2C+B.+L.%3B+Patel%2C+V.+F.%3B+Boucher%2C+C.%3B+Cheng%2C+A.%3B+Epstein%2C+L.%3B+Gallant%2C+P.%3B+Huang%2C+X.%3B+Lee%2C+J.+H.%3B+Schneider%2C+S.%3B+Turci%2C+S.+M.%3B+Zhu%2C+X.+N-3-%28Phenylcarbamoyl%29arylpyrimidine-5-carboxamides+as+potent+and+selective+inhibitors+of+Lck%3A+structure%2C+synthesis+and+SAR.+Bioorg.+Med.+Chem.+Lett.2008%2C+18%2C+1172%E2%80%931176."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeak%26aufirst%3DH.%2BL.%26atitle%3DN-3-%2528Phenylcarbamoyl%2529arylpyrimidine-5-carboxamides%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Lck%253A%2520structure%252C%2520synthesis%2520and%2520SAR%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsukura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niijima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotake, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horizoe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaoka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, S.</span><span> </span><span class="NLM_article-title">2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure−activity relationships toward hepatic glucose production induced via agonism of the A<sub>2B</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm990499b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=170-179&author=H.+Haradaauthor=O.+Asanoauthor=Y.+Hoshinoauthor=S.+Yoshikawaauthor=M.+Matsukuraauthor=Y.+Kabasawaauthor=J.+Niijimaauthor=Y.+Kotakeauthor=N.+Watanabeauthor=T.+Kawataauthor=T.+Inoueauthor=T.+Horizoeauthor=N.+Yasudaauthor=H.+Minamiauthor=K.+Nagataauthor=M.+Murakamiauthor=J.+Nagaokaauthor=S.+Kobayashiauthor=I.+Tanakaauthor=S.+Abe&title=2-Alkynyl-8-aryl-9-methyladenines+as+novel+adenosine+receptor+antagonists%3A+their+synthesis+and+structure%E2%88%92activity+relationships+toward+hepatic+glucose+production+induced+via+agonism+of+the+A2B+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm990499b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990499b%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DAsano%26aufirst%3DO.%26aulast%3DHoshino%26aufirst%3DY.%26aulast%3DYoshikawa%26aufirst%3DS.%26aulast%3DMatsukura%26aufirst%3DM.%26aulast%3DKabasawa%26aufirst%3DY.%26aulast%3DNiijima%26aufirst%3DJ.%26aulast%3DKotake%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DKawata%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DHorizoe%26aufirst%3DT.%26aulast%3DYasuda%26aufirst%3DN.%26aulast%3DMinami%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DMurakami%26aufirst%3DM.%26aulast%3DNagaoka%26aufirst%3DJ.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DI.%26aulast%3DAbe%26aufirst%3DS.%26atitle%3D2-Alkynyl-8-aryl-9-methyladenines%2520as%2520novel%2520adenosine%2520receptor%2520antagonists%253A%2520their%2520synthesis%2520and%2520structure%25E2%2588%2592activity%2520relationships%2520toward%2520hepatic%2520glucose%2520production%2520induced%2520via%2520agonism%2520of%2520the%2520A2B%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D170%26epage%3D179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Nagar, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicena, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schindler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veach, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">4236</span><span class="NLM_x">–</span> <span class="NLM_lpage">4243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=12154025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvFeltLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=4236-4243&author=B.+Nagarauthor=W.+G.+Bornmannauthor=P.+Pellicenaauthor=T.+Schindlerauthor=D.+R.+Veachauthor=W.+T.+Millerauthor=B.+Clarksonauthor=J.+Kuriyan&title=Crystal+structures+of+the+kinase+domain+of+c-Abl+in+complex+with+the+small+molecule+inhibitors+PD173955+and+imatinib+%28STI-571%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571)</span></div><div class="casAuthors">Nagar, Bhushan; Bornmann, William G.; Pellicena, Patricia; Schindler, Thomas; Veach, Darren R.; Miller, W. Todd; Clarkson, Bayard; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4236-4243</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The inadvertent fusion of the bcr gene with the abl gene results in a constitutively active tyrosine kinase (Bcr-Abl) that transforms cells and causes chronic myelogenous leukemia.  Small mol. inhibitors of Bcr-Abl that bind to the kinase domain can be used to treat chronic myelogenous leukemia.  We report crystal structures of the kinase domain of Abl in complex with two such inhibitors, imatinib (also known as STI-571 and Gleevec) and PD173955 (Parke-Davis).  Both compds. bind to the canonical ATP-binding site of the kinase domain, but they do so in different ways.  As shown previously in a crystal structure of Abl bound to a smaller variant of STI-571, STI-571 captures a specific inactive conformation of the activation loop of Abl in which the loop mimics bound peptide substrate.  In contrast, PD173955 binds to a conformation of Abl in which the activation loop resembles that of an active kinase.  The structure suggests that PD173955 would be insensitive to whether the conformation of the activation loop corresponds to active kinases or to that seen in the STI-571 complex.  In vitro kinase assays confirm that this is the case and indicate that PD173955 is at least 10-fold more inhibitory than STI-571.  The structures suggest that PD173955 achieves its greater potency over STI-571 by being able to target multiple forms of Abl (active or inactive), whereas STI-571 requires a specific inactive conformation of Abl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-5qYZHMOZCrVg90H21EOLACvtfcHk0lh-G_xawP-MMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvFeltLY%253D&md5=843213cd6038ed82a0e43dce56e81a91</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNagar%26aufirst%3DB.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DPellicena%26aufirst%3DP.%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DVeach%26aufirst%3DD.%2BR.%26aulast%3DMiller%26aufirst%3DW.%2BT.%26aulast%3DClarkson%26aufirst%3DB.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DCrystal%2520structures%2520of%2520the%2520kinase%2520domain%2520of%2520c-Abl%2520in%2520complex%2520with%2520the%2520small%2520molecule%2520inhibitors%2520PD173955%2520and%2520imatinib%2520%2528STI-571%2529%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26spage%3D4236%26epage%3D4243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breitfelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaus, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madwed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torcellini, C.</span><span> </span><span class="NLM_article-title">Pyrazole urea-based inhibitors of p38 MAP kinase: from lead compound to clinical candidate</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">2994</span><span class="NLM_x">–</span> <span class="NLM_lpage">3008</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020057r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2994-3008&author=J.+Reganauthor=S.+Breitfelderauthor=P.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=E.+Hickeyauthor=B.+Klausauthor=J.+Madwedauthor=M.+Moriakauthor=N.+Mossauthor=C.+Pargellisauthor=S.+Pavauthor=A.+Protoauthor=A.+Swinamerauthor=L.+Tongauthor=C.+Torcellini&title=Pyrazole+urea-based+inhibitors+of+p38+MAP+kinase%3A+from+lead+compound+to+clinical+candidate"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate</span></div><div class="casAuthors">Regan, John; Breitfelder, Steffen; Cirillo, Pier; Gilmore, Thomas; Graham, Anne G.; Hickey, Eugene; Klaus, Bernhard; Madwed, Jeffrey; Moriak, Monica; Moss, Neil; Pargellis, Chris; Pav, Sue; Proto, Alfred; Swinamer, Alan; Tong, Liang; Torcellini, Carol</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2994-3008</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report on a series of N-pyrazole, N'-aryl ureas and their mode of binding to p38 mitogen activated protein kinase.  Importantly, a key binding domain that is distinct from the ATP (ATP) binding site is exposed when the conserved activation loop, consisting in part of Asp168-Phe169-Gly170, adopts a conformation permitting lipophilic and hydrogen bonding interactions between this class of inhibitors and the protein.  We describe the correlation of the structure-activity relationships and crystallog. structures of these inhibitors with p38.  In addn., we incorporated another binding pharmacophore that forms a hydrogen bond at the ATP binding site.  This modification affords significant improvements in binding, cellular, and in vivo potencies resulting in the selection of Compd. 45 (BIRB 796) as a clin. candidate for the treatment of inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpotOOfLV3xRbVg90H21EOLACvtfcHk0lhnNreKCuge_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvFagt7k%253D&md5=e473f514179c8fe24ab3efccc292b6c6</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm020057r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020057r%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DBreitfelder%26aufirst%3DS.%26aulast%3DCirillo%26aufirst%3DP.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DHickey%26aufirst%3DE.%26aulast%3DKlaus%26aufirst%3DB.%26aulast%3DMadwed%26aufirst%3DJ.%26aulast%3DMoriak%26aufirst%3DM.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DTorcellini%26aufirst%3DC.%26atitle%3DPyrazole%2520urea-based%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%253A%2520from%2520lead%2520compound%2520to%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2994%26epage%3D3008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Wan, P. T. C.; Garnett, M. J.; Roe, S. M.; Lee, S.; Niculescu-Duvaz, D.; Good, V. M.; Jones, C. M.; Marshall, C. J.; Springer, C. J.; Barford, D.; Marais, R.</span><span> </span><span class="NLM_article-title">Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-Raf</span> (Cancer Genome Project).  <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span>− <span class="NLM_lpage">867</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2FS0092-8674%2804%2900215-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15035987" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivVyksLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2004&pages=855-867&author=P.+T.+C.+Wan&author=M.+J.+Garnett&author=S.+M.+Roe&author=S.+Lee&author=D.+Niculescu-Duvaz&author=V.+M.+Good&author=C.+M.+Jones&author=C.+J.+Marshall&author=C.+J.+Springer&author=D.+Barford&author=R.+Marais&title=Mechanism+of+activation+of+the+RAF-ERK+signaling+pathway+by+oncogenic+mutations+of+B-Raf"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF</span></div><div class="casAuthors">Wan, Paul T. C.; Garnett, Mathew J.; Roe, S. Mark; Lee, Sharlene; Niculescu-Duvaz, Dan; Good, Valerie M.; Project, Cancer Genome; Jones, C. Michael; Marshall, Christopher J.; Springer, Caroline J.; Barford, David; Marais, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">855-867</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Over 30 mutations of the B-RAF gene assocd. with human cancers have been identified, the majority of which are located within the kinase domain.  Here the authors show that of 22 B-RAF mutants analyzed, 18 have elevated kinase activity and signal to ERK in vivo.  Surprisingly, three mutants have reduced kinase activity towards MEK in vitro but, by activating C-RAF in vivo, signal to ERK in cells.  The structures of wild type and oncogenic V599EB-RAF kinase domains in complex with the RAF inhibitor BAY43-9006 show that the activation segment is held in an inactive conformation by assocn. with the P loop.  The clustering of most mutations to these two regions suggests that disruption of this interaction converts B-RAF into its active conformation.  The high activity mutants signal to ERK by directly phosphorylating MEK, whereas the impaired activity mutants stimulate MEK by activating endogenous C-RAF, possibly via an allosteric or transphosphorylation mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYiQicwc1xVLVg90H21EOLACvtfcHk0lhnNreKCuge_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivVyksLw%253D&md5=4cc020056c64e514286c000666da1972</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2804%2900215-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252804%252900215-6%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DP.%2BT.%2BC.%26atitle%3DMechanism%2520of%2520activation%2520of%2520the%2520RAF-ERK%2520signaling%2520pathway%2520by%2520oncogenic%2520mutations%2520of%2520B-Raf%26jtitle%3DCell%26date%3D2004%26volume%3D116%26spage%3D855%26epage%3D867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Revesz, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blum, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Padova, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buhl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feifel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gram, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiestand, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manning, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rucklin, G.</span><span> </span><span class="NLM_article-title">SAR of benzopyridines and benzophenones as p38a MAP kinase inhibitors with oral activity</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3601</span><span class="NLM_x">–</span> <span class="NLM_lpage">3605</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3601-3605&author=L.+Reveszauthor=E.+Blumauthor=F.+E.+Di+Padovaauthor=T.+Buhlauthor=R.+Feifelauthor=H.+Gramauthor=P.+Hiestandauthor=U.+Manningauthor=G.+Rucklin&title=SAR+of+benzopyridines+and+benzophenones+as+p38a+MAP+kinase+inhibitors+with+oral+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRevesz%26aufirst%3DL.%26aulast%3DBlum%26aufirst%3DE.%26aulast%3DDi%2BPadova%26aufirst%3DF.%2BE.%26aulast%3DBuhl%26aufirst%3DT.%26aulast%3DFeifel%26aufirst%3DR.%26aulast%3DGram%26aufirst%3DH.%26aulast%3DHiestand%26aufirst%3DP.%26aulast%3DManning%26aufirst%3DU.%26aulast%3DRucklin%26aufirst%3DG.%26atitle%3DSAR%2520of%2520benzopyridines%2520and%2520benzophenones%2520as%2520p38a%2520MAP%2520kinase%2520inhibitors%2520with%2520oral%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3601%26epage%3D3605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Manley, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brüggen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fendrich, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mestan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stolz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyhack, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strauss, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J.</span><span> </span><span class="NLM_article-title">Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">1697</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1697&publication_year=2004&pages=17-27&author=P.+W.+Manleyauthor=G.+Boldauthor=J.+Br%C3%BCggenauthor=G.+Fendrichauthor=P.+Furetauthor=J.+Mestanauthor=C.+Schnellauthor=B.+Stolzauthor=T.+Meyerauthor=B.+Meyhackauthor=W.+Starkauthor=A.+Straussauthor=J.+Wood&title=Advances+in+the+structural+biology%2C+design+and+clinical+development+of+VEGF-R+kinase+inhibitors+for+the+treatment+of+angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManley%26aufirst%3DP.%2BW.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DBr%25C3%25BCggen%26aufirst%3DJ.%26aulast%3DFendrich%26aufirst%3DG.%26aulast%3DFuret%26aufirst%3DP.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DStolz%26aufirst%3DB.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DMeyhack%26aufirst%3DB.%26aulast%3DStark%26aufirst%3DW.%26aulast%3DStrauss%26aufirst%3DA.%26aulast%3DWood%26aufirst%3DJ.%26atitle%3DAdvances%2520in%2520the%2520structural%2520biology%252C%2520design%2520and%2520clinical%2520development%2520of%2520VEGF-R%2520kinase%2520inhibitors%2520for%2520the%2520treatment%2520of%2520angiogenesis%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2004%26volume%3D1697%26spage%3D17%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Denni-Dischert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marterer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banziger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusuff, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batt, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geng, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michael, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.-M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taplin, F.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Versace, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cesarz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez, L. B.</span><span> </span><span class="NLM_article-title">The synthesis of a novel B-Raf kinase inhibitor</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">70</span><span class="NLM_x">–</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/doi/10.1021/op0501601" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11f&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yrs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2006&pages=70-77&author=D.+Denni-Dischertauthor=W.+Martererauthor=M.+Banzigerauthor=N.+Yusuffauthor=D.+Battauthor=T.+Ramseyauthor=P.+Gengauthor=W.+Michaelauthor=R.-M.+B.+Wangauthor=F.+Taplinauthor=R.+Versaceauthor=D.+Cesarzauthor=L.+B.+Perez&title=The+synthesis+of+a+novel+B-Raf+kinase+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11fR"><div class="casContent"><span class="casTitleNuber">11f</span><div class="casTitle"><span class="NLM_cas:atitle">The Synthesis of a Novel Inhibitor of B-Raf Kinase</span></div><div class="casAuthors">Denni-Dischert, Donatienne; Marterer, Wolfgang; Baenziger, Markus; Yusuff, Naeem; Batt, David; Ramsey, Tim; Geng, Peng; Michael, Walter; Wang, Run-Ming B.; Taplin, Francis, Jr.; Versace, Richard; Cesarz, David; Perez, Lawrence B.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Process Research & Development</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">70-77</span>CODEN:
                <span class="NLM_cas:coden">OPRDFK</span>;
        ISSN:<span class="NLM_cas:issn">1083-6160</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A scalable synthetic route to the title compd. [4,7']bis-isoquinolinyl-(2-tert-butyl-5-pyrimidinyl)amine [i.e., N-[(tert-butyl)pyrimidinyl][4,7'-biisoquinolin]-1-amine], an inhibitor of B-Raf kinase is described.  The key step in the synthesis is the Pd-catalyzed Negishi coupling of 4-bromo-1-chloroisoquinoline with trifluoromethanesulfonic acid isoquinoline-7-yl ester to yield 1-chloro-4,7'-biisoquinoline.  This intermediate is transformed to the desired drug substance in one addnl. step, by reaction with 2-tert-butyl-5-aminopyrimidine in the presence of NaH.  A special focus was put on the finally successful removal of traces of Zn and Pd in the drug substance, which came from the Negishi coupling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmtZWYzSm1GrVg90H21EOLACvtfcHk0lgfaWwYrM4OIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yrs7fK&md5=86a2ef46630b31506268f64481ecd734</span></div><a href="/servlet/linkout?suffix=cit11f&amp;dbid=16384&amp;doi=10.1021%2Fop0501601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop0501601%26sid%3Dliteratum%253Aachs%26aulast%3DDenni-Dischert%26aufirst%3DD.%26aulast%3DMarterer%26aufirst%3DW.%26aulast%3DBanziger%26aufirst%3DM.%26aulast%3DYusuff%26aufirst%3DN.%26aulast%3DBatt%26aufirst%3DD.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DGeng%26aufirst%3DP.%26aulast%3DMichael%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DR.-M.%2BB.%26aulast%3DTaplin%26aufirst%3DF.%26aulast%3DVersace%26aufirst%3DR.%26aulast%3DCesarz%26aufirst%3DD.%26aulast%3DPerez%26aufirst%3DL.%2BB.%26atitle%3DThe%2520synthesis%2520of%2520a%2520novel%2520B-Raf%2520kinase%2520inhibitor%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2006%26volume%3D10%26spage%3D70%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobleski, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metzger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wityak, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillooly, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuster, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doweyko, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diller, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrish, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodd, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schieven, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leftheris, K.</span><span> </span><span class="NLM_article-title">5-Cyanopyrimidine derivatives as a novel class of potent, selective, and orally active inhibitors of p38 MAP kinase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6261</span><span class="NLM_x">–</span> <span class="NLM_lpage">6270</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0503594" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6261-6270&author=C.+Liuauthor=S.+T.+Wrobleskiauthor=J.+Linauthor=G.+Ahmedauthor=A.+Metzgerauthor=J.+Wityakauthor=K.+M.+Gilloolyauthor=D.+J.+Shusterauthor=K.+W.+McIntyreauthor=S.+Pittauthor=D.+R.+Shenauthor=R.+F.+Zhangauthor=H.+Zhangauthor=A.+M.+Doweykoauthor=D.+Dillerauthor=I.+Hendersonauthor=J.+C.+Barrishauthor=J.+H.+Doddauthor=G.+L.+Schievenauthor=K.+Leftheris&title=5-Cyanopyrimidine+derivatives+as+a+novel+class+of+potent%2C+selective%2C+and+orally+active+inhibitors+of+p38+MAP+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11g&amp;dbid=16384&amp;doi=10.1021%2Fjm0503594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0503594%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DWrobleski%26aufirst%3DS.%2BT.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DAhmed%26aufirst%3DG.%26aulast%3DMetzger%26aufirst%3DA.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DShuster%26aufirst%3DD.%2BJ.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DPitt%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DD.%2BR.%26aulast%3DZhang%26aufirst%3DR.%2BF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDoweyko%26aufirst%3DA.%2BM.%26aulast%3DDiller%26aufirst%3DD.%26aulast%3DHenderson%26aufirst%3DI.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DDodd%26aufirst%3DJ.%2BH.%26aulast%3DSchieven%26aufirst%3DG.%2BL.%26aulast%3DLeftheris%26aufirst%3DK.%26atitle%3D5-Cyanopyrimidine%2520derivatives%2520as%2520a%2520novel%2520class%2520of%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520inhibitors%2520of%2520p38%2520MAP%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6261%26epage%3D6270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Rational design of inhibitors that bind to inactive conformations</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">358</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1038%2Fnchembio799" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=16783341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11h&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2006&pages=358-364&author=Y.+Liuauthor=N.+S.+Gray&title=Rational+design+of+inhibitors+that+bind+to+inactive+conformations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11hR"><div class="casContent"><span class="casTitleNuber">11h</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of inhibitors that bind to inactive kinase conformations</span></div><div class="casAuthors">Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">358-364</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The majority of kinase inhibitors, known as type I inhibitors that have been developed so far target the ATP binding site of the kinase in its active conformation, in which the activation loop is phosphorylated.  Recently, crystal structures of inhibitors such as imatinib, BIRB796, and sorafenib (BAY43-9006), known as type II inhibitors, have revealed a new binding mode that exploits an addnl. binding site immediately adjacent to the region occupied by ATP.  This pocket is made accessible by an activation-loop rearrangement that is characteristic of kinases in an inactive conformation.  The examn. of binding features of known type II inhibitors is discussed and a pharmacophore model currently used in the design of a new generation of structurally diverse type II inhibitors is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxahsMPlhgDbVg90H21EOLACvtfcHk0lgfaWwYrM4OIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlvFGjs7g%253D&md5=4a9347a44a2cf4a412c9741fdcc5696b</span></div><a href="/servlet/linkout?suffix=cit11h&amp;dbid=16384&amp;doi=10.1038%2Fnchembio799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio799%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DRational%2520design%2520of%2520inhibitors%2520that%2520bind%2520to%2520inactive%2520conformations%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2006%26volume%3D2%26spage%3D358%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Okram, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spraggon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warmuth, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">A general strategy for creating “inactive-conformation” Abl inhibitors</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">779</span><span class="NLM_x">–</span> <span class="NLM_lpage">786</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11i&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.1016%2Fj.chembiol.2006.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11i&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=16873026" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11i&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD28XntlGisL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2006&pages=779-786&author=B.+Okramauthor=A.+Nagleauthor=F.+J.+Adrianauthor=C.+Leeauthor=P.+Renauthor=X.+Wangauthor=T.+Simauthor=Y.+Xieauthor=X.+Wangauthor=G.+Xiaauthor=G.+Spraggonauthor=M.+Warmuthauthor=Y.+Liuauthor=N.+S.+Gray&title=A+general+strategy+for+creating+%E2%80%9Cinactive-conformation%E2%80%9D+Abl+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11iR"><div class="casContent"><span class="casTitleNuber">11i</span><div class="casTitle"><span class="NLM_cas:atitle">A General Strategy for Creating "Inactive-Conformation" Abl Inhibitors</span></div><div class="casAuthors">Okram, Barun; Nagle, Advait; Adrian, Francisco J.; Lee, Christian; Ren, Pingda; Wang, Xia; Sim, Taebo; Xie, Yongping; Wang, Xing; Xia, Gang; Spraggon, Glen; Warmuth, Markus; Liu, Yi; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">779-786</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Kinase inhibitors that bind to the ATP cleft can be broadly classified into two groups: Those that bind exclusively to the ATP site with the kinase assuming a conformation otherwise conducive to phosphotransfer (type I), and those that exploit a hydrophobic site immediately adjacent to the ATP pocket made accessible by a conformational rearrangement of the activation loop (type II).  To date, all type II inhibitors were discovered by using structure-activity-guided optimization strategies.  Here, we describe a general pharmacophore model of type II inhibition that enables a rational "hybrid-design" approach whereby a 3-trifluoromethylbenzamide functionality is appended to four distinct type I scaffolds in order to convert them into their corresponding type II counterparts.  We demonstrate that the designed compds. function as type II inhibitors by using biochem. and cellular kinase assays and by cocrystallog. with Abl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEmN-Rh-LxOLVg90H21EOLACvtfcHk0lgfaWwYrM4OIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntlGisL0%253D&md5=84514353c00e20f85225f62d00dc2529</span></div><a href="/servlet/linkout?suffix=cit11i&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2006.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2006.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DOkram%26aufirst%3DB.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DAdrian%26aufirst%3DF.%2BJ.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DRen%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DXia%26aufirst%3DG.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DWarmuth%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DA%2520general%2520strategy%2520for%2520creating%2520%25E2%2580%259Cinactive-conformation%25E2%2580%259D%2520Abl%2520inhibitors%26jtitle%3DChem.%2520Biol.%26date%3D2006%26volume%3D13%26spage%3D779%26epage%3D786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">PP1: 4-amino-5-(4-methylphenyl)-7-(<i>tert</i>-butyl)pyrazolo[3,4-<i>d</i>]pyrimidine. PP2: 4-amino-5-(4-chlorophenyl)-7-(<i>tert</i>-butyl)pyrazolo[3,4-<i>d</i>]pyrimidine)</p></div>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PP1%3A+4-amino-5-%284-methylphenyl%29-7-%28tert-butyl%29pyrazolo%5B3%2C4-d%5Dpyrimidine.+PP2%3A+4-amino-5-%284-chlorophenyl%29-7-%28tert-butyl%29pyrazolo%5B3%2C4-d%5Dpyrimidine%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zhu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomb, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stover, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toledo, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, K. A.</span><span> </span><span class="NLM_article-title">Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">651</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=651-666&author=X.+Zhuauthor=J.+L.+Kimauthor=J.+R.+Newcombauthor=P.+E.+Roseauthor=D.+R.+Stoverauthor=L.+M.+Toledoauthor=H.+Zhaoauthor=K.+A.+Morgenstern&title=Structural+analysis+of+the+lymphocyte-specific+kinase+Lck+in+complex+with+non-selective+and+Src+family+selective+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DNewcomb%26aufirst%3DJ.%2BR.%26aulast%3DRose%26aufirst%3DP.%2BE.%26aulast%3DStover%26aufirst%3DD.%2BR.%26aulast%3DToledo%26aufirst%3DL.%2BM.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DMorgenstern%26aufirst%3DK.%2BA.%26atitle%3DStructural%2520analysis%2520of%2520the%2520lymphocyte-specific%2520kinase%2520Lck%2520in%2520complex%2520with%2520non-selective%2520and%2520Src%2520family%2520selective%2520kinase%2520inhibitors%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D651%26epage%3D666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fraley, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrington, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McFall, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coll, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span> </span><span class="NLM_article-title">Property-based design of KDR kinase inhibitors</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.2174%2F0929867043455729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15032725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=709-719&author=M.+A.+Fraleyauthor=W.+F.+Hoffmanauthor=K.+L.+Arringtonauthor=R.+W.+Hungateauthor=G.+D.+Hartmanauthor=R.+C.+McFallauthor=K.+E.+Collauthor=K.+Rickertauthor=K.+A.+Thomasauthor=G.+B.+McGaughey&title=Property-based+design+of+KDR+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Property-based design of KDR kinase inhibitors</span></div><div class="casAuthors">Fraley, Mark E.; Hoffman, William F.; Arrington, Kenneth L.; Hungate, Randy W.; Hartman, George D.; McFall, Rosemary C.; Coll, Kathleen E.; Rickert, Keith; Thomas, Kenneth A.; McGaughey, Georgia B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">709-719</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Small mol. inhibitors of KDR kinase activity have typically possessed poor intrinsic phys. properties including low aq. soly. and high lipophilicity.  These features have often conferred limited cell permeability manifested in low levels of cell-based KDR inhibitory activity and oral bioavailability.  Thus, the design of inhibitors with appropriate phys. properties has played a crit. role in the development of clin. candidates.  We present a variety of structural modifications that have afforded improvements in phys. properties and thereby have addressed suboptimal cellular potency and pharmacokinetics for three unique classes of KDR kinase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_HN0OVe8qrLVg90H21EOLACvtfcHk0ljasoKOaPU1XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7s%253D&md5=e30e4de7e5a106f513e6cf1f83a50a4c</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.2174%2F0929867043455729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043455729%26sid%3Dliteratum%253Aachs%26aulast%3DFraley%26aufirst%3DM.%2BA.%26aulast%3DHoffman%26aufirst%3DW.%2BF.%26aulast%3DArrington%26aufirst%3DK.%2BL.%26aulast%3DHungate%26aufirst%3DR.%2BW.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26aulast%3DMcFall%26aufirst%3DR.%2BC.%26aulast%3DColl%26aufirst%3DK.%2BE.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DK.%2BA.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26atitle%3DProperty-based%2520design%2520of%2520KDR%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D709%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Heron, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blowers, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breed, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eden, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMiken, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortlock, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannifer, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauptit, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pink, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowsell, S.</span><span> </span><span class="NLM_article-title">SAR and inhibitor complex structure determination of a novel classs of potent and specific Aurora kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1320</span><span class="NLM_x">–</span> <span class="NLM_lpage">1323</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=1320-1323&author=N.+M.+Heronauthor=M.+Andersonauthor=D.+P.+Blowersauthor=J.+Breedauthor=J.+M.+Edenauthor=S.+Greenauthor=G.+B.+Hillauthor=T.+Johnsonauthor=F.+H.+Jungauthor=H.+H.+McMikenauthor=A.+A.+Mortlockauthor=A.+D.+Panniferauthor=R.+A.+Pauptitauthor=J.+Pinkauthor=N.+J.+Robertsauthor=S.+Rowsell&title=SAR+and+inhibitor+complex+structure+determination+of+a+novel+classs+of+potent+and+specific+Aurora+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeron%26aufirst%3DN.%2BM.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DBlowers%26aufirst%3DD.%2BP.%26aulast%3DBreed%26aufirst%3DJ.%26aulast%3DEden%26aufirst%3DJ.%2BM.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DHill%26aufirst%3DG.%2BB.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DJung%26aufirst%3DF.%2BH.%26aulast%3DMcMiken%26aufirst%3DH.%2BH.%26aulast%3DMortlock%26aufirst%3DA.%2BA.%26aulast%3DPannifer%26aufirst%3DA.%2BD.%26aulast%3DPauptit%26aufirst%3DR.%2BA.%26aulast%3DPink%26aufirst%3DJ.%26aulast%3DRoberts%26aufirst%3DN.%2BJ.%26aulast%3DRowsell%26aufirst%3DS.%26atitle%3DSAR%2520and%2520inhibitor%2520complex%2520structure%2520determination%2520of%2520a%2520novel%2520classs%2520of%2520potent%2520and%2520specific%2520Aurora%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D1320%26epage%3D1323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cherry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. H.</span><span> </span><span class="NLM_article-title">Recent kinase and kinase inhibitor X-ray structures: mechanisms of inhibition and selectivity insights</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Fjm7010996&amp;key=10.2174%2F0929867043455792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Fjm7010996&amp;key=15032722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm7010996&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=663-673&author=M.+Cherryauthor=D.+H.+Williams&title=Recent+kinase+and+kinase+inhibitor+X-ray+structures%3A+mechanisms+of+inhibition+and+selectivity+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Recent kinase and kinase inhibitor x-ray structures: mechanisms of inhibition and selectivity insights</span></div><div class="casAuthors">Cherry, M.; Williams, D. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">663-673</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent years have seen an explosion in the no. of publicly available x-ray crystal structures of protein kinases.  These structures have provided a wealth of information on the regulatory mechanisms, conformational plasticity and drugability of this important family of enzymes.  Drawing upon structural information, new insights into the development of protein kinase inhibitors are discussed including de-novo design, mol. templates for ATP competitive inhibitors and alternative mechanisms of inhibition.  The highly conserved nature of the ATP binding site is of central concern to drug development and the concept of a selectivity profile has arisen with structure-based design emerging as a key tool for addressing the challenges of specificity.  In addn., protein-ligand complexes, where the enzyme is in an inactive conformation, signify an alternate approach to protein kinase inhibition.  The belief that an inactive kinase presents a less conserved target is reviewed using observations on the structural changes occurring during protein kinase regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB19ovXBL1mrVg90H21EOLACvtfcHk0ljasoKOaPU1XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7w%253D&md5=63c621c012a6e1cc9f795565580d7492</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.2174%2F0929867043455792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043455792%26sid%3Dliteratum%253Aachs%26aulast%3DCherry%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26atitle%3DRecent%2520kinase%2520and%2520kinase%2520inhibitor%2520X-ray%2520structures%253A%2520mechanisms%2520of%2520inhibition%2520and%2520selectivity%2520insights%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D663%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Tokarski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newitt, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C. Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wittekind, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kish, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, F. Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzillerri, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klei, H. E.</span><span> </span><span class="NLM_article-title">The structure of dasatinib (BMS-354825) bound to activated ABL kinase domain elucidates its inhibitory activity against imatinib-resistant ABL mutants</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">5790</span><span class="NLM_x">–</span> <span class="NLM_lpage">5797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2006&pages=5790-5797&author=J.+S.+Tokarskiauthor=J.+A.+Newittauthor=C.+Y.+J.+Changauthor=J.+D.+Chengauthor=M.+Wittekindauthor=S.+E.+Kieferauthor=K.+Kishauthor=F.+Y.+F.+Leeauthor=R.+Borzillerriauthor=L.+J.+Lombardoauthor=D.+Xieauthor=Y.+Zhangauthor=H.+E.+Klei&title=The+structure+of+dasatinib+%28BMS-354825%29+bound+to+activated+ABL+kinase+domain+elucidates+its+inhibitory+activity+against+imatinib-resistant+ABL+mutants"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTokarski%26aufirst%3DJ.%2BS.%26aulast%3DNewitt%26aufirst%3DJ.%2BA.%26aulast%3DChang%26aufirst%3DC.%2BY.%2BJ.%26aulast%3DCheng%26aufirst%3DJ.%2BD.%26aulast%3DWittekind%26aufirst%3DM.%26aulast%3DKiefer%26aufirst%3DS.%2BE.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DF.%2BY.%2BF.%26aulast%3DBorzillerri%26aufirst%3DR.%26aulast%3DLombardo%26aufirst%3DL.%2BJ.%26aulast%3DXie%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26atitle%3DThe%2520structure%2520of%2520dasatinib%2520%2528BMS-354825%2529%2520bound%2520to%2520activated%2520ABL%2520kinase%2520domain%2520elucidates%2520its%2520inhibitory%2520activity%2520against%2520imatinib-resistant%2520ABL%2520mutants%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D68%26spage%3D5790%26epage%3D5797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><div class="note"><p class="first last">All kinases were tested at their apparent <i>K</i><sub>m</sub> of ATP with respect to 1 μM peptide substrate.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=All+kinases+were+tested+at+their+apparent+Km+of+ATP+with+respect+to+1+%CE%BCM+peptide+substrate."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hibbs, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarlinton, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grail, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maglitto, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stacker, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, A. R.</span><span> </span><span class="NLM_article-title">Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">301</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1995&pages=301-311&author=M.+L.+Hibbsauthor=D.+M.+Tarlintonauthor=J.+Armesauthor=D.+Grailauthor=G.+Hodgsonauthor=R.+Maglittoauthor=S.+A.+Stackerauthor=A.+R.+Dunn&title=Multiple+defects+in+the+immune+system+of+Lyn-deficient+mice%2C+culminating+in+autoimmune+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHibbs%26aufirst%3DM.%2BL.%26aulast%3DTarlinton%26aufirst%3DD.%2BM.%26aulast%3DArmes%26aufirst%3DJ.%26aulast%3DGrail%26aufirst%3DD.%26aulast%3DHodgson%26aufirst%3DG.%26aulast%3DMaglitto%26aufirst%3DR.%26aulast%3DStacker%26aufirst%3DS.%2BA.%26aulast%3DDunn%26aufirst%3DA.%2BR.%26atitle%3DMultiple%2520defects%2520in%2520the%2520immune%2520system%2520of%2520Lyn-deficient%2520mice%252C%2520culminating%2520in%2520autoimmune%2520disease%26jtitle%3DCell%26date%3D1995%26volume%3D83%26spage%3D301%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nishizumi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taniuchi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ilic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span> </span><span class="NLM_article-title">Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">549</span><span class="NLM_x">–</span> <span class="NLM_lpage">560</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1995&pages=549-560&author=H.+Nishizumiauthor=I.+Taniuchiauthor=Y.+Yamanashiauthor=D.+Kitamuraauthor=D.+Ilicauthor=S.+Moriauthor=T.+Watanabeauthor=T.+Yamamoto&title=Impaired+proliferation+of+peripheral+B+cells+and+indication+of+autoimmune+disease+in+lyn-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNishizumi%26aufirst%3DH.%26aulast%3DTaniuchi%26aufirst%3DI.%26aulast%3DYamanashi%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DD.%26aulast%3DIlic%26aufirst%3DD.%26aulast%3DMori%26aufirst%3DS.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26atitle%3DImpaired%2520proliferation%2520of%2520peripheral%2520B%2520cells%2520and%2520indication%2520of%2520autoimmune%2520disease%2520in%2520lyn-deficient%2520mice%26jtitle%3DImmunity%26date%3D1995%26volume%3D3%26spage%3D549%26epage%3D560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><div class="note"><p class="first last">Members of the parent aminoquinazoline class (ref <a onclick="showRef(event, 'cit6p'); return false;" href="javascript:void(0);" class="ref cit6p">6p</a>) demonstrated marginal effects on B cell proliferation. For example, compound <b>49</b> in ref <a onclick="showRef(event, 'cit6p'); return false;" href="javascript:void(0);" class="ref cit6p">6p</a> is a highly potent inhibitor of Lyn (IC<sub>50</sub> = 0.0004 μM) and a weak inhibitor of the anti-IgM F[ab]2-induced BCR-driven mouse B cell proliferation (IC<sub>50</sub> = 3.0 μM).</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Members+of+the+parent+aminoquinazoline+class+%28ref+6p%29+demonstrated+marginal+effects+on+B+cell+proliferation.+For+example%2C+compound+49+in+ref+6p+is+a+highly+potent+inhibitor+of+Lyn+%28IC50+%3D+0.0004+%CE%BCM%29+and+a+weak+inhibitor+of+the+anti-IgM+F%5Bab%5D2-induced+BCR-driven+mouse+B+cell+proliferation+%28IC50+%3D+3.0+%CE%BCM%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><div class="note"><p class="first last">EC<sub>50</sub> (fu) = (EC<sub>50</sub>)(mouse fu) = (175 nM)(0.022) = 4 nM.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=EC50+%28fu%29+%3D+%28EC50%29%28mouse+fu%29+%3D+%28175+nM%29%280.022%29+%3D+4+nM."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-si1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i59"><a href="/doi/suppl/10.1021/jm7010996">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_78761"></div></div></div></div></div><hr /></hr><p class="last">Elemental analysis and HPLC data, X-ray methods and data, exposures for <b>13b</b> in the mouse IL-2, and additional references. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm7010996/suppl_file/jm-2007-010996-si-rev">jm-2007-010996-si-rev (91.55 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm7010996/suppl_file/jm7010996-file002.pdf">jm7010996-file002.pdf (91.55 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm7010996&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2008.51.issue-6%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm7010996%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm7010996" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                785KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b60b0dc73d30","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
